Page 13 of 15

Re: U.S. government gave $3.7 million grant to Wuhan lab at

PostPosted: Tue Aug 17, 2021 8:45 am
by admin
Part 1 of 4

The Lab-Leak Theory: Inside the Fight to Uncover COVID-19’s Origins: Throughout 2020, the notion that the novel coronavirus leaked from a lab was off-limits. Those who dared to push for transparency say toxic politics and hidden agendas kept us in the dark.
by Katherine Eban
Vanity Fair
JUNE 3, 2021

I. A Group Called DRASTIC

Gilles Demaneuf is a data scientist with the Bank of New Zealand in Auckland. He was diagnosed with Asperger’s Syndrome ten years ago, and believes it gives him a professional advantage. “I’m very good at finding patterns in data, when other people see nothing,” he says.

Early last spring, as cities worldwide were shutting down to halt the spread of COVID-19, Demaneuf, 52, began reading up on the origins of SARS-CoV-2, the virus that causes the disease. The prevailing theory was that it had jumped from bats to some other species before making the leap to humans at a market in China, where some of the earliest cases appeared in late 2019. The Huanan wholesale market, in the city of Wuhan, is a complex of markets selling seafood, meat, fruit, and vegetables. A handful of vendors sold live wild animals—a possible source of the virus.

That wasn’t the only theory, though. Wuhan is also home to China’s foremost coronavirus research laboratory, housing one of the world’s largest collections of bat samples and bat-virus strains. The Wuhan Institute of Virology’s lead coronavirus researcher, Shi Zhengli, was among the first to identify horseshoe bats as the natural reservoirs for SARS-CoV, the virus that sparked an outbreak in 2002, killing 774 people and sickening more than 8,000 globally. After SARS, bats became a major subject of study for virologists around the world, and Shi became known in China as “Bat Woman” for her fearless exploration of their caves to collect samples. More recently, Shi and her colleagues at the WIV have performed high-profile experiments that made pathogens more infectious. Such research, known as “gain-of-function,” has generated heated controversy among virologists.


To some people, it seemed natural to ask whether the virus causing the global pandemic had somehow leaked from one of the WIV’s labs—a possibility Shi has strenuously denied.

On February 19, 2020, The Lancet, among the most respected and influential medical journals in the world, published a statement that roundly rejected the lab-leak hypothesis, effectively casting it as a xenophobic cousin to climate change denialism and anti-vaxxism. Signed by 27 scientists, the statement expressed “solidarity with all scientists and health professionals in China” and asserted: “We stand together to strongly condemn conspiracy theories suggesting that COVID-19 does not have a natural origin.”

The Lancet statement effectively ended the debate over COVID-19’s origins before it began. To Gilles Demaneuf, following along from the sidelines, it was as if it had been “nailed to the church doors,” establishing the natural origin theory as orthodoxy. “Everyone had to follow it. Everyone was intimidated. That set the tone.”


The statement struck Demaneuf as “totally nonscientific.” To him, it seemed to contain no evidence or information. And so he decided to begin his own inquiry in a “proper” way, with no idea of what he would find.

Image
Shi Zhengli, the Wuhan Institute of Virology’s lead coronavirus researcher, is frequently pictured in a full-body positive-pressure suit, though not all the labs there require one. BY JOHANNES EISELE/AFP/GETTY IMAGES.

Demaneuf began searching for patterns in the available data, and it wasn’t long before he spotted one. China’s laboratories were said to be airtight, with safety practices equivalent to those in the U.S. and other developed countries. But Demaneuf soon discovered that there had been four incidents of SARS-related lab breaches since 2004, two occurring at a top laboratory in Beijing. Due to overcrowding there, a live SARS virus that had been improperly deactivated, had been moved to a refrigerator in a corridor. A graduate student then examined it in the electron microscope room and sparked an outbreak.

Demaneuf published his findings in a Medium post, titled “The Good, the Bad and the Ugly: a review of SARS Lab Escapes.” By then, he had begun working with another armchair investigator, Rodolphe de Maistre. A laboratory project director based in Paris who had previously studied and worked in China, de Maistre was busy debunking the notion that the Wuhan Institute of Virology was a “laboratory” at all.
In fact, the WIV housed numerous laboratories that worked on coronaviruses. Only one of them has the highest biosafety protocol: BSL-4, in which researchers must wear full-body pressurized suits with independent oxygen. Others are designated BSL-3 and even BSL-2, roughly as secure as an American dentist’s office.

Having connected online, Demaneuf and de Maistre began assembling a comprehensive list of research laboratories in China. As they posted their findings on Twitter, they were soon joined by others around the world. Some were cutting-edge scientists at prestigious research institutes. Others were science enthusiasts. Together, they formed a group called DRASTIC, short for Decentralized Radical Autonomous Search Team Investigating COVID-19. Their stated objective was to solve the riddle of COVID-19’s origin.

State Department investigators say they were repeatedly advised not to open a “Pandora’s box.”


At times, it seemed the only other people entertaining the lab-leak theory were crackpots or political hacks hoping to wield COVID-19 as a cudgel against China. President Donald Trump’s former political adviser Steve Bannon, for instance, joined forces with an exiled Chinese billionaire named Guo Wengui to fuel claims that China had developed the disease as a bioweapon and purposefully unleashed it on the world. As proof, they paraded a Hong Kong scientist around right-wing media outlets until her manifest lack of expertise doomed the charade.

With disreputable wing nuts on one side of them and scornful experts on the other, the DRASTIC researchers often felt as if they were on their own in the wilderness, working on the world’s most urgent mystery. They weren’t alone. But investigators inside the U.S. government asking similar questions were operating in an environment that was as politicized and hostile to open inquiry as any Twitter echo chamber. When Trump himself floated the lab-leak hypothesis last April, his divisiveness and lack of credibility made things more, not less, challenging for those seeking the truth.

“The DRASTIC people are doing better research than the U.S. government,” says David Asher, a former senior investigator under contract to the State Department.

The question is: Why?


II. “A Can of Worms”

Since December 1, 2019, the SARS-CoV-2 virus that causes COVID-19 has infected more than 170 million people around the world and killed more than 3.5 million. To this day, we don’t know how or why this novel coronavirus suddenly appeared in the human population. Answering that question is more than an academic pursuit: Without knowing where it came from, we can’t be sure we’re taking the right steps to prevent a recurrence.

And yet, in the wake of the Lancet statement and under the cloud of Donald Trump’s toxic racism, which contributed to an alarming wave of anti-Asian violence in the U.S., one possible answer to this all-important question remained largely off-limits until the spring of 2021.

Behind closed doors, however, national security and public health experts and officials across a range of departments in the executive branch were locked in high-stakes battles over what could and couldn’t be investigated and made public.


A months long Vanity Fair investigation, interviews with more than 40 people, and a review of hundreds of pages of U.S. government documents, including internal memos, meeting minutes, and email correspondence, found that conflicts of interest, stemming in part from large government grants supporting controversial virology research, hampered the U.S. investigation into COVID-19’s origin at every step. In one State Department meeting, officials seeking to demand transparency from the Chinese government say they were explicitly told by colleagues not to explore the Wuhan Institute of Virology’s gain-of-function research, because it would bring unwelcome attention to U.S. government funding of it.

In an internal memo obtained by Vanity Fair, Thomas DiNanno, former acting assistant secretary of the State Department’s Bureau of Arms Control, Verification, and Compliance, wrote that staff from two bureaus, his own and the Bureau of International Security and Nonproliferation, “warned” leaders within his bureau “not to pursue an investigation into the origin of COVID-19” because it would “‘open a can of worms’ if it continued.”

There are reasons to doubt the lab-leak hypothesis. There is a long, well-documented history of natural spillovers leading to outbreaks, even when the initial and intermediate host animals have remained a mystery for months and years, and some expert virologists say the supposed oddities of the SARS-CoV-2 sequence have been found in nature.

Image
Dr. Robert Redfield, former director of the CDC, said he received death threats from fellow scientists after telling CNN he thought the virus likely escaped from a lab. “I expected it from politicians. I didn’t expect it from science,” he said. BY ANDREW HARNIK/GETTY IMAGES

But for most of the past year, the lab-leak scenario was treated not simply as unlikely or even inaccurate but as morally out-of-bounds. In late March, former Centers for Disease Control director Robert Redfield received death threats from fellow scientists after telling CNN that he believed COVID-19 had originated in a lab. “I was threatened and ostracized because I proposed another hypothesis,” Redfield told Vanity Fair. “I expected it from politicians. I didn’t expect it from science.”

With President Trump out of office, it should be possible to reject his xenophobic agenda and still ask why, in all places in the world, did the outbreak begin in the city with a laboratory housing one of the world’s most extensive collection of bat viruses, doing some of the most aggressive research?

Dr. Richard Ebright, board of governors professor of chemistry and chemical biology at Rutgers University, said that from the very first reports of a novel bat-related coronavirus outbreak in Wuhan, it took him “a nanosecond or a picosecond” to consider a link to the Wuhan Institute of Virology. Only two other labs in the world, in Galveston, Texas, and Chapel Hill, North Carolina, were doing similar research. “It’s not a dozen cities,” he said. “It’s three places.”

Then came the revelation that the Lancet statement was not only signed but organized by a zoologist named Peter Daszak, who has repackaged U.S. government grants and allocated them to facilities conducting gain-of-function research—among them the WIV itself. David Asher, now a senior fellow at the Hudson Institute, ran the State Department’s day-to-day COVID-19 origins inquiry. He said it soon became clear that “there is a huge gain-of-function bureaucracy” inside the federal government.

As months go by without a host animal that proves the natural theory, the questions from credible doubters have gained in urgency. To one former federal health official, the situation boiled down to this: An institute “funded by American dollars is trying to teach a bat virus to infect human cells, then there is a virus” in the same city as that lab. It is “not being intellectually honest not to consider the hypothesis” of a lab escape.

And given how aggressively China blocked efforts at a transparent investigation, and in light of its government’s own history of lying, obfuscating, and crushing dissent, it’s fair to ask if Shi Zhengli, the Wuhan Institute’s lead coronavirus researcher, would be at liberty to report a leak from her lab even if she’d wanted to.

On May 26, the steady crescendo of questions led President Joe Biden to release a statement acknowledging that the intelligence community had “coalesced around two likely scenarios,” and announce that he had asked for a more definitive conclusion within 90 days. His statement noted, “The failure to get our inspectors on the ground in those early months will always hamper any investigation into the origin of COVID-19.” But that wasn’t the only failure.

In the words of David Feith, former deputy assistant secretary of state in the East Asia bureau, “The story of why parts of the U.S. government were not as curious as many of us think they should have been is a hugely important one.”

III. “Smelled Like a Cover-Up”

On December 9, 2020, roughly a dozen State Department employees from four different bureaus gathered in a conference room in Foggy Bottom to discuss an upcoming fact-finding mission to Wuhan organized in part by the World Health Organization. The group agreed on the need to press China to allow a thorough, credible, and transparent investigation, with unfettered access to markets, hospitals, and government laboratories. The conversation then turned to the more sensitive question: What should the U.S. government say publicly about the Wuhan Institute of Virology?

A small group within the State Department’s Arms Control, Verification, and Compliance bureau had been studying the Institute for months. The group had recently acquired classified intelligence suggesting that three WIV researchers conducting gain-of-function experiments on coronavirus samples had fallen ill in the autumn of 2019, before the COVID-19 outbreak was known to have started.

As officials at the meeting discussed what they could share with the public, they were advised by Christopher Park, the director of the State Department’s Biological Policy Staff in the Bureau of International Security and Nonproliferation, not to say anything that would point to the U.S. government’s own role in gain-of-function research, according to documentation of the meeting obtained by Vanity Fair.


Only two other labs in the world, in Texas and North Carolina, were doing similar research. “It’s not a dozen cities,” Dr. Richard Ebright said. “It’s three places.”


Some of the attendees were “absolutely floored,” said an official familiar with the proceedings. That someone in the U.S. government could “make an argument that is so nakedly against transparency, in light of the unfolding catastrophe, was…shocking and disturbing.”

Park, who in 2017 had been involved in lifting a U.S. government moratorium on funding for gain-of-function research
, was not the only official to warn the State Department investigators against digging in sensitive places. As the group probed the lab-leak scenario, among other possibilities, its members were repeatedly advised not to open a “Pandora’s box,” said four former State Department officials interviewed by Vanity Fair. The admonitions “smelled like a cover-up,” said Thomas DiNanno, “and I wasn’t going to be part of it.”


Reached for comment, Chris Park told Vanity Fair, “I am skeptical that people genuinely felt they were being discouraged from presenting facts.” He added that he was simply arguing that it “is making an enormous and unjustifiable leap…to suggest that research of that kind [meant] that something untoward is going on.”

IV. An “Antibody Response”

There were two main teams inside the U.S. government working to uncover the origins of COVID-19: one in the State Department and another under the direction of the National Security Council. No one at the State Department had much interest in Wuhan’s laboratories at the start of the pandemic, but they were gravely concerned with China’s apparent cover-up of the outbreak’s severity. The government had shut down the Huanan market, ordered laboratory samples destroyed, claimed the right to review any scientific research about COVID-19 ahead of publication, and expelled a team of Wall Street Journal reporters.

In January 2020, a Wuhan ophthalmologist named Li Wenliang, who’d tried to warn his colleagues that the pneumonia could be a form of SARS was arrested, accused of disrupting the social order, and forced to write a self-criticism. He died of COVID-19 in February, lionized by the Chinese public as a hero and whistleblower.

“You had Chinese [government] coercion and suppression,” said David Feith of the State Department’s East Asia bureau. “We were very concerned that they were covering it up and whether the information coming to the World Health Organization was reliable.”

As questions swirled, Miles Yu, the State Department’s principal China strategist, noted that the WIV had remained largely silent. Yu, who is fluent in Mandarin, began mirroring its website and compiling a dossier of questions about its research. In April, he gave his dossier to Secretary of State Pompeo, who in turn publicly demanded access to the laboratories there.

It is not clear whether Yu’s dossier made its way to President Trump. But on April 30, 2020, the Office of the Director of National Intelligence put out an ambiguous statement whose apparent goal was to suppress a growing furor around the lab-leak theory. It said that the intelligence community “concurs with the wide scientific consensus that the COVID-19 virus was not manmade or genetically modified” but would continue to assess “whether the outbreak began through contact with infected animals or if it was the result of an accident at a laboratory in Wuhan.”

Image
State Department official Thomas DiNanno wrote a memo charging that staff from his bureau were “warned…not to pursue an investigation into the origin of COVID-19” because it would “‘open a can of worms’ if it continued.” SOURCE: U.S. DEPARTMENT OF STATE

“It was pure panic,” said former deputy national security adviser Matthew Pottinger. “They were getting flooded with queries. Someone made the unfortunate decision to say, ‘We basically know nothing, so let’s put out the statement.’”

Then, the bomb-thrower-in-chief weighed in. At a press briefing just hours later, Trump contradicted his own intelligence officials and claimed that he had seen classified information indicating that the virus had come from the Wuhan Institute of Virology. Asked what the evidence was, he said, “I can’t tell you that. I’m not allowed to tell you that.”

Trump’s premature statement poisoned the waters for anyone seeking an honest answer to the question of where COVID-19 came from. According to Pottinger, there was an “antibody response” within the government, in which any discussion of a possible lab origin was linked to destructive nativist posturing.

The revulsion extended to the international science community, whose “maddening silence” frustrated Miles Yu. He recalled, “Anyone who dares speak out would be ostracized.”

V. “Too Risky to Pursue”

The idea of a lab leak first came to NSC officials not from hawkish Trumpists but from Chinese social media users, who began sharing their suspicions as early as January 2020. Then, in February, a research paper coauthored by two Chinese scientists, based at separate Wuhan universities, appeared online as a preprint. It tackled a fundamental question: How did a novel bat coronavirus get to a major metropolis of 11 million people in central China, in the dead of winter when most bats were hibernating, and turn a market where bats weren’t sold into the epicenter of an outbreak?

The paper offered an answer: “We screened the area around the seafood market and identified two laboratories conducting research on bat coronavirus.” The first was the Wuhan Center for Disease Control and Prevention, which sat just 280 meters from the Huanan market and had been known to collect hundreds of bat samples. The second, the researchers wrote, was the Wuhan Institute of Virology.

The paper came to a staggeringly blunt conclusion about COVID-19: “the killer coronavirus probably originated from a laboratory in Wuhan.... Regulations may be taken to relocate these laboratories far away from city center and other densely populated places.” Almost as soon as the paper appeared on the internet, it disappeared, but not before U.S. government officials took note.[/b]

By then, Matthew Pottinger had approved a COVID-19 origins team, run by the NSC directorate that oversaw issues related to weapons of mass destruction. A longtime Asia expert and former journalist, Pottinger purposefully kept the team small, because there were so many people within the government “wholly discounting the possibility of a lab leak, who were predisposed that it was impossible,” said Pottinger. In addition, many leading experts had either received or approved funding for gain-of-function research. Their “conflicted” status, said Pottinger, “played a profound role in muddying the waters and contaminating the shot at having an impartial inquiry.

Image
Peter Daszak, who repackaged U.S. government grants and allocated the funds to research institutes including the WIV, arrives there on February 3, 2021, during a fact-finding mission organized in part by the World Health Organization. BY HECTOR RETAMAL/AFP/GETTY IMAGES.

As they combed open sources as well as classified information, the team’s members soon stumbled on a 2015 research paper by Shi Zhengli and the University of North Carolina epidemiologist Ralph Baric proving that the spike protein of a novel coronavirus could infect human cells. Using mice as subjects, they inserted the protein from a Chinese rufous horseshoe bat into the molecular structure of the SARS virus from 2002, creating a new, infectious pathogen.

This gain-of-function experiment was so fraught that the authors flagged the danger themselves, writing, “scientific review panels may deem similar studies…too risky to pursue.” In fact, the study was intended to raise an alarm and warn the world of “a potential risk of SARS-CoV re-emergence from viruses currently circulating in bat populations.” The paper’s acknowledgments cited funding from the U.S. National Institutes of Health and from a nonprofit called EcoHealth Alliance, which had parceled out grant money from the U.S. Agency for International Development. EcoHealth Alliance is run by Peter Daszak, the zoologist who helped organize the Lancet statement.

That a genetically engineered virus might have escaped from the WIV was one alarming scenario. But it was also possible that a research trip to collect bat samples could have led to infection in the field, or back at the lab.

The NSC investigators found ready evidence that China’s labs were not as safe as advertised. Shi Zhengli herself had publicly acknowledged that, until the pandemic, all of her team’s coronavirus research—some involving live SARS-like viruses—had been conducted in less secure BSL-3 and even BSL-2 laboratories.

In 2018, a delegation of American diplomats visited the WIV for the opening of its BSL-4 laboratory, a major event. In an unclassified cable, as a Washington Post columnist reported, they wrote that a shortage of highly trained technicians and clear protocols threatened the facility’s safe operations. The issues had not stopped the WIV’s leadership from declaring the lab “ready for research on class-four pathogens (P4), among which are the most virulent viruses that pose a high risk of aerosolized person-to-person transmission.”

Image
Memo
MRN: 18 BEIJING 138
Date/DTG: Jan 19, 2018 / 190739Z Jan 18
From: AMEMBASSY BEIJING
Action: WASHDC, SECSTATE ROUTINE
E.O.: 13526
TAGS: SHLH, ETRD, ECON, PGOV, CN
Captions: SENSITIVE
Reference: 17 WUHAN 48
Subject: China Opens First Bio Safety Level 4 Laboratory

1. (SBU) Summary and Comment: The Chinese Academy of Sciences (CAS) has recently established what is reportedly China's first Biosafety Level 4 (BSL-4) laboratory in Wuhan. This state-of-the-art facility is designed for prevention and control research on diseases that require the highest level of biosafety and biosecurity containment. Ultimately, scientists hope the lab will contribute to the development of new antiviral drugs and vaccines, but its current productivity is limited by a shortage of the highly trained technicians and investigators required to safely operate a BSL-4 laboratory and a lack of clarity in related Chinese government policies and guidelines. (b)(5) [DELETE] (b)(5) (b)(5) End Summary and Comment.

China Investing in Infectious Disease Control

2. (U) Between November 2002 and July 2003, China faced an outbreak of Severe Acute Respiratory Syndrome (SARS), which, according to the World Health Organization, resulting in 8,098 cases and leading to 774 deaths reported in 37 countries. A majority of cases occurred in China, where the fatality rate was 9.6%. This incident convinced China to prioritize international cooperation for infectious disease control. An aspect of this prioritization was China's work with the Jean Merieux BSL-4 Laboratory in Lyon, France, to build China's first high containment laboratory at Wuhan's Institute of Virology (WIV), an institute under the auspices of the Chinese Academy of Sciences (CAS). Construction took 11 years and $44 million USD. and construction on the facility was completed on January 31, 2015. Following two years of effort, which is not unusual for such facilities, the WIV lab was accredited in February 2017 by the China National Accreditation Service for Conformity Assessment. It occupies four floors and consists of over 32,000 square feet. WIV leadership now considers the lab operational and ready for research on class-four pathogens (P4), among which are the most virulent viruses that pose a high risk of aerosolized person-to-person transmission.

Unclear Guidelines on Virus Access and a Lack of Trained Talent Impede Research

3. (SBU) In addition to accreditation, the lab must also receive permission from the National Health and Family Planning Commission (NHFPC) to initiate research on specific highly contagious pathogens. According to some WIV scientists, it is unclear how NHFPC determines what viruses can or cannot be studied in the new laboratory. To date, WIV has obtained permission for research on three viruses: Ebola virus, Nipah virus, and Xinjiang hemorrhagic fever virus (a strain of Crimean Congo hemorrhagic fever found in China's Xinjiang Province). Despite this permission, however, the Chinese government has not allowed the WIV to import Ebola viruses for study in the BSL-4 lab. Therefore, WIV scientists are frustrated and have pointed out that they won't be able to conduct research project with Ebola viruses at the new BSL-4 lab despite of the permission.

(b)(6) [DELETE]

(b)(6) Thus, while the BSL-4 lab is ostensibly fully accredited, its utilization is limited by lack of access to specific organisms and by opaque government review and approval processes. As long as this situation continues, Beijing's commitment to prioritizing infectious disease control -- on the regional and international level, especially in relation to highly pathogenic viruses, remains in doubt.

(b)(6) [DELETE] noted that the new lab has a serious shortage of appropriately trained technicians and investigators needed to safely operate this high-containment laboratory. University of Texas Medical Branch in Galveston (UTMB), which has one of several well-established BSL-4 labs in the United States (supported by the National Institute of Allergy and Infectious Diseases (NIAID of NIH)), has scientific collaborations with WIV, which may help alleviate this talent gap over time. Reportedly, researchers from TMB are helping train technicians who work in the WIV BSL-4 lab. Despite this (b)(6) [DELETE] they would welcome more help from U.S. and international organizations as they establish "gold standard" operating procedures and training courses for the first time in China. As China is building more BSL-4 labs, including one in Harbin Veterinary Research Institute subordinated to the Chinese Academy of Agricultural Sciences (CAAS) for veterinary research use (b)(6) [DELETE] the training for technicians and investigators working on dangerous pathogens will certainly be in demand.

Despite Limitations. WIV Researchers Produce SARS Discoveries

6. (SBU) The ability of WIV scientists to undertake productive research despite limitations on the use of the new BSL-4 facility is demonstrated by a recent publication on the origins of SARS. Over a five-year study, (b)(6) [DELETE] (and their research team) widely sampled bats in Yunnan province with funding support from NIAID/NIH, USAID, and several Chinese funding agencies. The study results were published in PLoS Pathogens online on Nov. 30, 2017 (1), and it demonstrated that a SARS-like corona viruses isolated from horseshoe bats in a single cave contain all the building blocks of the pandemic SARS-coronavirus genome that caused the human outbreak. These results strongly suggest that the highly pathogenic SARS-coronavirus originated in this bat population. Most importantly, the researchers also showed that various SARS-like coronaviruses can interact with ACE2, the human receptor identified for SARS-coronavirus. This finding strongly suggests that SARS-like coronaviruses from bats can be transmitted to humans to cause SARS-like disease. From a public health perspective, this makes the continued surveillance of SARS-like coronaviruses in bats and study of the animal-human interface critical to future emerging corona virus outbreak prediction and prevention (b)(5) [DELETE] (b)(5) WIV scientists are allowed to study the SARS-like coronaviruses isolated from bats while they are precluded from studying human-disease causing SARS coronavirus in their new BSL-4 lab until permission for such work is granted by the NHFCP.

1. Hu B, Zeng L-P, Yang X-L, Ge X-Y, Zhang W, Li B, et a1. (2017) Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog 13(11): e1006698. https://doi.org/10.1371/journal.ppat.1006698

Signature: BRANSTAD
Drafted By: (b)(6) [DELETE]
Cleared By: (b)(6) [DELETE]
Approved By: (b)(6) [DELETE]
Released By: (b)(6) [DELETE]
Info: CHINA POSTS COLLECTIVE ROUTINE
Dissemination Rule: Archive Copy

UNCLASSIFIED
SBU


On February 14, 2020, to the surprise of NSC officials, President Xi Jinping of China announced a plan to fast-track a new biosecurity law to tighten safety procedures throughout the country’s laboratories. Was this a response to confidential information? “In the early weeks of the pandemic, it didn’t seem crazy to wonder if this thing came out of a lab,” Pottinger reflected.

Apparently, it didn’t seem crazy to Shi Zhengli either. A Scientific American article first published in March 2020, for which she was interviewed, described how her lab had been the first to sequence the virus in those terrible first weeks.
It also recounted how:

[S]he frantically went through her own lab’s records from the past few years to check for any mishandling of experimental materials, especially during disposal. Shi breathed a sigh of relief when the results came back: none of the sequences matched those of the viruses her team had sampled from bat caves. “That really took a load off my mind,” she says. “I had not slept a wink for days.”

As the NSC tracked these disparate clues, U.S. government virologists advising them flagged one study first submitted in April 2020. Eleven of its 23 coauthors worked for the Academy of Military Medical Sciences, the Chinese army’s medical research institute. Using the gene-editing technology known as CRISPR, the researchers had engineered mice with humanized lungs, then studied their susceptibility to SARS-CoV-2. As the NSC officials worked backward from the date of publication to establish a timeline for the study, it became clear that the mice had been engineered sometime in the summer of 2019, before the pandemic even started. The NSC officials were left wondering: Had the Chinese military been running viruses through humanized mouse models, to see which might be infectious to humans?

Believing they had uncovered important evidence in favor of the lab-leak hypothesis, the NSC investigators began reaching out to other agencies. That’s when the hammer came down. “We were dismissed,” said Anthony Ruggiero, the NSC’s senior director for counterproliferation and biodefense. “The response was very negative.”


VI. Sticklers for Accuracy

By the summer of 2020, Gilles Demaneuf was spending up to four hours a day researching the origins of COVID-19, joining Zoom meetings before dawn with European collaborators and not sleeping much. He began to receive anonymous calls and notice strange activity on his computer, which he attributed to Chinese government surveillance. “We are being monitored for sure,” he says. He moved his work to the encrypted platforms Signal and ProtonMail.

As they posted their findings, the DRASTIC researchers attracted new allies. Among the most prominent was Jamie Metzl, who launched a blog on April 16 that became a go-to site for government researchers and journalists examining the lab-leak hypothesis. A former executive vice president of the Asia Society, Metzl sits on the World Health Organization’s advisory committee on human genome editing and served in the Clinton administration as the NSC’s director for multilateral affairs. In his first post on the subject, he made clear that he had no definitive proof and believed that Chinese researchers at the WIV had the “best intentions.” Metzl also noted, “In no way do I seek to support or align myself with any activities that may be considered unfair, dishonest, nationalistic, racist, bigoted, or biased in any way.”

Blocking pro-democracy activist from attending event

Pro-democracy activist and secretary-general of Demosisto Joshua Wong was allegedly disallowed by Asia Society Hong Kong from speaking at a book launch originally scheduled to take place at its Hong Kong venue on June 28, 2017. It was understood that Asia Society Hong Kong was approached by PEN Hong Kong to co-curate the book launch, but negotiations stalled upon the former's request for a more diverse panel of speakers. PEN Hong Kong, a non-profit organization supporting literature and freedom of expression, eventually decided to relocate the launch of Hong Kong 20/20: Reflections on a Borrowed Place – of which Wong was one of the authors – to the Foreign Correspondents Club. Joshua Wong says that Asia Society Hong Kong needs to give a “reasonable explanation” for the incident.

“The mission of PEN Hong Kong is to promote literature and defend the freedom of expression. To bar one of the contributors to our anthology, whether it is Joshua Wong or somebody else, from speaking at our launch event would undermine and in fact contravene that mission,” said PEN Hong Kong President Jason Y. Ng.

Back to November 2016, Asia Society Hong Kong also canceled a scheduled screening of Raise The Umbrellas, a documentary on the 2014 Occupy protests with appearance of Joshua Wong. Asia Society Hong Kong has similarly cited the lack of balanced speaker representation at the pre-screening talk as the reason for not screening the film.

US Congressman Chris Smith, co-chairperson of the Congressional-Executive Commission on China, expressed that “The Asia Society has some explaining to do after two events that featured Joshua Wong prominently were canceled over the past nine months,” said the New Jersey representative. “I commend PEN Hong Kong for not appeasing the Asia Society’s demands.”....

On July 10, 2017, Forbes magazine ran an article revealing Hong Kong real estate magnate and Asia Society Co-chair Ronnie Chan (a US citizen) to be the political force behind the Joshua Wong incident. It alleged that wealthy Asians have been behind US think tanks and NGOs and effectively turning them into foreign policy tools of the People's Republic of China (Beijing).

-- Asia Society, by Wikipedia


On December 11, 2020, Demaneuf—a stickler for accuracy—reached out to Metzl to alert him to a mistake on his blog. The 2004 SARS lab escape in Beijing, Demaneuf pointed out, had led to 11 infections, not four. Demaneuf was “impressed” by Metzl’s immediate willingness to correct the information. “From that time, we started working together.”

“If the pandemic started as part of a lab leak, it had the potential to do to virology what Three Mile Island and Chernobyl did to nuclear science.”


Metzl, in turn, was in touch with the Paris Group, a collective of more than 30 skeptical scientific experts who met by Zoom once a month for hours-long meetings to hash out emerging clues. Before joining the Paris Group, Dr. Filippa Lentzos, a biosecurity expert at King’s College London, had pushed back online against wild conspiracies. No, COVID-19 was not a bioweapon used by the Chinese to infect American athletes at the Military World Games in Wuhan in October 2019.

The 2019 Military World Games and Sick Athletes

The 7th International Military Sports Council Military World Games (MWGs) opened in Wuhan on October 18, 2019. The games are similar to the Olympic games but consist of military athletes with some added military disciplines. The MWGs in Wuhan drew 9,308 athletes, representing 109 countries, to compete in 329 events across 27 sports. Twenty-five countries sent delegations of more than 100 athletes, including Russia, Brazil, France, Germany, and Poland. [65] ["Military Games to Open Friday in China.” China Daily, 17 Oct. 2019, http://www.china.org.cn/sports/2019- 10/17/content_75311946.htm.]

The PRC government recruited 236,000 volunteers for the games, which required 90 hotels, three railroad stations, and more than 2,000 drivers. [66] [“2019 Military World Games Kicks off in Central China's Wuhan.” CISION, 17 Oct. 2019, http://www.prnewswire.com/news-releases ... orldgames- kicks-off-in-central-chinas-wuhan-300940464.html.] An archived version of the competition’s website from October 20, 2019, lists the more than thirty venues that hosted events for the MWGs across Wuhan and the broader Hubei province. [67] [“Competition Venues.” Wuhan 2019 Military World Games, https://web.archive.org/web/20191020154 ... on_venues/.] The live website is no longer accessible – it is unclear why it was removed.

During the games, many of the international athletes became sick with what now appear to be symptoms of COVID-19. In one interview, an athlete from Luxembourg described Wuhan as a “ghost town,”[68] [Houston, Michael. “More athletes claim they contracted COVID-19 at Military World Games in Wuhan.” Inside the Games, 17 May 2020, https://www.insidethegames.biz/articles ... s-covid-19] and recalls having his temperature taken upon arriving at the city’s airport. In an interview with The Financial Post, a Canadian newspaper, one member of the Canadian Armed Forces who participated in the games said (emphasis added):

This was a city of 15 million people that was in lockdown. It was strange, but we were told this was to make it easy for the Games’ participants to get around. [I got] very sick 12 days after we arrived, with fever, chills, vomiting, insomnia.… On our flight to come home, 60 Canadian athletes on the flight were put in isolation [at the back of the plane] for the 12-hour flight. We were sick with symptoms ranging from coughs to diarrhea and in between. [69] [Francis, Diane. “Diane Francis: Canadian Forces Have Right to Know If They Got COVID at the 2019 Military World Games in Wuhan.” Financial Post, 25 June 2021, https://financialpost.com/diane-francis ... taryworld- games-in-wuhan.]


The service member also revealed his family members became ill as his symptoms increased, [70] [Ibid.] a development that is consistent with both human-to-human transmission of a viral infection and COVID-19. Similar claims about COVID-19 like symptoms have been made by athletes from Germany, France, Italy, [71] [Houston.] and Sweden. [72] [Liao, George. “Coronavirus May Have Been Spreading since Wuhan Military Games Last October.” Taiwan News, 13 May 2020, http://www.taiwannews.com.tw/en/news/3932712.]

By cross referencing the listed MWG venues with publicly available mapping data, it is possible to visualize the venues (in black) in relation to the WIV Headquarters (in red) and the abovementioned hospitals (in blue). The green figures represent athletes who have publicly expressed their belief they contracted COVID-19 while in Wuhan and are mapped at the venues which hosted the events in which they competed. Some of these athletes resided in the military athletes’ village.

Image
Map 2: WIV Headquarters, Hospitals, MWG Venues, and Sick Athletes

At least four countries who sent delegations to the MWGs have now confirmed the presence of SARS-CoV-2 or COVID-19 cases within their borders in November and December 2019, before the news of an outbreak first became public....

As stated above, athletes from France, Italy, and Sweden also complained of illnesses with symptoms similar to COVID-19 while at the MWGs in Wuhan. The presence of SARS-CoV-2 in four countries, on two separate continents, suggests a common source. If, as presumed, SARS-CoV-2 first infected humans in Wuhan before spreading to the rest of the world, the 2019 Military World Games in Wuhan appears to be a key vector in the global spread – in other words, potentially one of the first “super spreader” events.

-- The Origins of COVID-19: An Investigation of the Wuhan Institute of Virology, by House Foreign Affairs Committee


But the more she researched, the more concerned she became that not every possibility was being explored. On May 1, 2020, she published a careful assessment in the Bulletin of the Atomic Scientists describing just how a pathogen could have escaped the Wuhan Institute of Virology. She noted that a September 2019 paper in an academic journal by the director of the WIV’s BSL-4 laboratory, Yuan Zhiming, had outlined safety deficiencies in China’s labs. “Maintenance cost is generally neglected,” he had written. “Some BSL-3 laboratories run on extremely minimal operational costs or in some cases none at all.”

Alina Chan, a young molecular biologist and postdoctoral fellow at the Broad Institute of MIT and Harvard University, found that early sequences of the virus showed very little evidence of mutation. Had the virus jumped from animals to humans, one would expect to see numerous adaptations, as was true in the 2002 SARS outbreak. To Chan, it appeared that SARS-CoV-2 was already “pre-adapted to human transmission,” she wrote in a preprint paper in May 2020.

But perhaps the most startling find was made by an anonymous DRASTIC researcher, known on Twitter as @TheSeeker268. The Seeker, as it turns out, is a young former science teacher from Eastern India. He had begun plugging keywords into the China National Knowledge Infrastructure, a website that houses papers from 2,000 Chinese journals, and running the results through Google Translate.

One day last May, he fished up a thesis from 2013 written by a master’s student in Kunming, China. The thesis opened an extraordinary window into a bat-filled mine shaft in Yunnan province and raised sharp questions about what Shi Zhengli had failed to mention in the course of making her denials.

Re: U.S. government gave $3.7 million grant to Wuhan lab at

PostPosted: Tue Aug 17, 2021 8:45 am
by admin
Part 2 of 4

VII. The Mojiang Miners

In 2012, six miners in the lush mountains of Mojiang county in southern Yunnan province were assigned an unenviable task: to shovel out a thick carpet of bat feces from the floor of a mine shaft. After weeks of dredging up bat guano, the miners became gravely ill and were sent to the First Affiliated Hospital at the Kunming Medical University in Yunnan’s capital. Their symptoms of cough, fever, and labored breathing rang alarm bells in a country that had suffered through a viral SARS outbreak a decade earlier.

The hospital called in a pulmonologist, Zhong Nanshan, who had played a prominent role in treating SARS patients and would go on to lead an expert panel for China’s National Health Commission on COVID-19. Zhong, according to the 2013 master’s thesis, immediately suspected a viral infection. He recommended a throat culture and an antibody test, but he also asked what kind of bat had produced the guano. The answer: the rufous horseshoe bat, the same species implicated in the first SARS outbreak.

Within months, three of the six miners were dead. The eldest, who was 63, died first. “The disease was acute and fierce,” the thesis noted. It concluded: “the bat that caused the six patients to fall ill was the Chinese rufous horseshoe bat.” Blood samples were sent to the Wuhan Institute of Virology, which found that they were positive for SARS antibodies, a later Chinese dissertation documented.

Image
A memorial for Dr. Li Wenliang, who was celebrated as a whistleblower in China after sounding the alarm about COVID-19 in January 2020. He later died of the disease. BY MARK RALSTON/AFP/GETTY IMAGES.

But there was a mystery at the heart of the diagnosis. Bat coronaviruses were not known to harm humans. What was so different about the strains from inside the cave? To find out, teams of researchers from across China and beyond traveled to the abandoned mine shaft to collect viral samples from bats, musk shrews, and rats.

In an October 2013 Nature study, Shi Zhengli reported a key discovery: that certain bat viruses could potentially infect humans without first jumping to an intermediate animal. By isolating a live SARS-like bat coronavirus for the first time, her team had found that it could enter human cells through a protein called the ACE2 receptor.

In subsequent studies in 2014 and 2016, Shi and her colleagues continued studying samples of bat viruses collected from the mine shaft, hoping to figure out which one had infected the miners. The bats were bristling with multiple coronaviruses. But there was only one whose genome closely resembled SARS. The researchers named it RaBtCoV/4991.

The significance of the Master’s thesis

These findings of the thesis are significant in several ways.

First, in the light of the current coronavirus pandemic it is evident the miners’ symptoms very closely resemble those of COVID-19 (Huang et al, 2020; Tay et al., 2020; M. Zhou et al., 2020). Anyone presenting with them today would immediately be assumed to have COVID-19. Likewise, many of the treatments given to the miners have become standard for COVID-19 (Tay et al., 2020).

Second, the remote meeting with Zhong Nanshan is significant. It implies that the illnesses of the six miners were of high concern and, second, that a SARS-like coronavirus was considered a likely cause.

Third, the abstract, the conclusions, and the general inferences to be made from the Master’s thesis contradict Zheng-li Shi’s assertion that the miners died from a fungal infection. Fungal infection as a potential primary cause was raised but largely discarded.

Fourth, if a SARS-like coronavirus was the source of their illness the implication is that it could directly infect human cells. This would be unusual for a bat coronavirus (Ge et al., 2013). People do sometimes get ill from bat faeces but the standard explanation is histoplasmosis, a fungal infection and not a virus (McKinsey and McKinsey, 2011; Pan et al., 2013).

Fifth, the sampling by the Shi lab found that bat coronaviruses were unusually abundant in the mine (Ge at al., 2016). Among their findings were two betacoronaviruses, one of which was RaTG13 (then known as BtCoV/4991). In the coronavirus world betacoronaviruses are special in that both SARS and MERS, the most deadly of all coronaviruses, are both betacoronaviruses. Thus they are considered to have special pandemic potential, as the concluding sentence of the Shi lab publication which found RaTG13 implied: “special attention should particularly be paid to these lineages of coronaviruses” (Ge at al., 2016). In fact, the Shi and other labs have for years been predicting that bat betacoronaviruses like RaTG13 would go pandemic; so to find RaTG13 where the miners fell ill was a scenario in perfect alignment with their expectations.

The Mojiang miners passaging proposal

How does the Master’s thesis inform the search for a plausible origin of the pandemic?

In our previous article we briefly discussed how the pandemic might have been caused either by a virus collection accident, or through viral passaging, or through genetic engineering and a subsequent lab escape. The genetic engineering possibility deserves attention and is extensively assessed in an important preprint (Segreto and Deigin, 2020).

We do not definitively rule out these possibilities. Indeed it now seems that the Shi lab at the WIV did not forget about RaTG13 but were sequencing its genome in 2017 and 2018. However, we believe that the Master’s thesis indicates a much simpler explanation.

We suggest, first, that inside the miners RaTG13 (or a very similar virus) evolved into SARS-CoV-2, an unusually pathogenic coronavirus highly adapted to humans. Second, that the Shi lab used medical samples taken from the miners and sent to them by Kunming University Hospital for their research. It was this human-adapted virus, now known as SARS-CoV-2­, that escaped from the WIV in 2019.

We refer to this COVID-19 origin hypothesis as the Mojiang Miners Passage (MMP) hypothesis.

Passaging is a standard virological technique for adapting viruses to new species, tissues, or cell types. It is normally done by deliberately infecting a new host species or a new host cell type with a high dose of virus. This initial viral infection would ordinarily die out because the host’s immune system vanquishes the ill-adapted virus. But, in passaging, before it does die out a sample is extracted and transferred to a new identical tissue, where viral infection restarts. Done iteratively, this technique (called “serial passaging” or just “passaging”) intensively selects for viruses adapted to the new host or cell type (Herfst et al., 2012).

At first glance RaTG13 is unlikely to have evolved into SARS-CoV-2 since RaTG13 is approximately 1,200 nucleotides (3.8%) different from SARS-CoV-2. Although RaTG13 is the most closely related virus to SARS-CoV-2, this sequence difference still represents a considerable gap. In a media statement evolutionary virologist Edward Holmes has suggested this gap represents 20-50 years of evolution and others have suggested similar figures.

We agree that ordinary rates of evolution would not allow RaTG13 to evolve into SARS-CoV-2 but we also believe that conditions inside the lungs of the miners were far from ordinary. Five major factors specific to the hospitalised miners favoured a very high rate of evolution inside them.

i) When viruses infect new species they typically undergo a period of very rapid evolution because the selection pressure on the invading pathogen is high. The phenomenon of rapid evolution in new hosts is well attested among corona- and other viruses
(Makino et al., 1986; Baric et al., 1997; Dudas and Rambaut 2016; Forni et al., 2017).

ii) Judging by their clinical symptoms such as the CT scans, all the miner’s infections were primarily of the lungs. This localisation likely occurred initially because the miners were exerting themselves and therefore inhaling the disturbed bat guano deeply. As miners, they may already have had damaged lung tissues (patient 3 had suspected pneumoconiosis) and/or particulate matter was present that irritated the tissues and may have facilitated initial viral entry.

In contrast, standard coronavirus infections are confined to the throat and upper respiratory tract. They do not normally reach the lungs (Perlman and Netland, 2009). Lungs are far larger tissues by weight (kilos vs grammes) than the upper respiratory tract. There was therefore likely a much larger quantity of virus inside the miners than would be the case in an ordinary coronavirus infection.

Comparing a typical coronavirus respiratory tract infection with the extent of infected lungs in the miners from a purely mathematical point of view indicates the potential scale of this quantitative difference. The human aerodigestive tract is approximately 20cm in length and 5cm in circumference, i.e. approximately 100 cm2 in surface area. The surface area of a human lung ranges from 260,000-680,000 cm2(Hasleton, 1972). The amount of potentially infected tissue in an average lung is therefore approximately 4500-fold greater than that available to a normal coronavirus infection. The amount of virus present in the infected miners, sufficient to hospitalise all of them and kill half of them, was thus proportionately very large.

Evolutionary change is in large part a function of the population size. The lungs of the miners, we suggest, supported a very high viral load leading to proportionately rapid viral evolution.

Furthermore, according to the Master’s thesis, the immune systems of the miners were compromised and remained so even for those discharged. This weakness on the part of the miners may also have encouraged evolution of the virus.

iii) The length of infection experienced by the miners (especially patients 2, 3 and 4) far exceeded that of an ordinary coronavirus infection. From first becoming too sick to work in the mine, patient 2 survived 57 days until he died. Patient 3 survived 120 days after stopping work. Patient 4 survived 117 days and then was discharged as cured. Each had been exposed in the mine for 14 days prior to the onset of severe symptoms; thus each presumably had nascent infections for some time before calling in sick (See Table 2 of the thesis).

In contrast, in ordinary coronavirus infections the viral infection is cleared within about ten to fourteen days after being acquired (Tay et al., 2020). Thus, unlike most sufferers from coronavirus infection, the hospitalised miners had very long-term bouts of disease characterised by a continuous high load of virus. In the cases of patients 3 and 4 their illnesses lasted over 4 months.

iv) Coronaviruses are well known to recombine at very high rates: 10% of all progeny in a cell can be recombinants (Makino et al., 1986; Banner and Lai, 1991; Dudas and Rambaut, 2016). In normal virus evolution the mutation rate and the selection pressure are the main foci of attention. But in the case of a coronavirus adapting to a new host where many mutations distributed all over the genome are required to fully adapt to the new host, the recombination rate is likely to be highly influential in determining the overall speed of adaptation by the virus population (Baric et al., 1997).


Inside the miners a large tissue was simultaneously infected by a population of poorly-adapted viruses, with each therefore under pressure to adapt. Even if the starting population of virus lacked any diversity, many individual viruses would have acquired mutations independently but only recombination would have allowed these mutations to unite in the same genome. To recombine, viruses must be present in the same cell. In such a situation the particularities of lung tissues become potentially important because the existence of airways (bronchial tubes, etc.) allows partially-adapted viruses from independent viral populations to travel to distal parts of the lung (or even the other lung) and encounter other such partially-adapted viruses and populations. This movement around the lungs would likely have resulted in what amounted to a passaging effect without the need for a researcher to infect new tissues. Indeed, in the Master’s thesis the observation is several times made that areas of the lungs of a specific patient would appear to heal even while other parts of the lungs would become infected.

v) There were also a number of unusual things about the bat coronaviruses in the mine. They were abnormally abundant but also there were many different kinds, often causing co-infections of the bats (Ge et al., 2016). Viral co-infections are often more infectious or more pathogenic (Latham and Wilson, 2007).


As the WIV researchers remarked about the bats in the mine:

“we observed a high rate of co-infection with two coronavirus species and interspecies infection with the same coronavirus species within or across bat families. These phenomena may be owing to the diversity and high density of bat populations in the same cave, facilitating coronavirus intra- and interspecies transmissions, which may result in recombination and acceleration of coronavirus evolution.” (Ge et al., 2016).


The diversity of coronaviruses in the mine suggests that the miners were similarly exposed and that their illness may potentially have begun as co-infections.

Combining these observations, we propose that the miners’ lungs offered an unprecedented opportunity for accelerated evolution of a highly bat-adapted coronavirus into a highly human-adapted coronavirus and that decades of ordinary coronavirus evolution could easily have been condensed into months. However, we acknowledge that these conditions were unique.
They and their scale have no exact scientific precedent we can refer to and they would be hard to replicate in a lab; thus it is important to emphasize that our proposal is fully consistent with the underlying principles of viral evolution as understood today.

In support of the MMP theory we also know something about the samples taken from the miners. According to the Master’s thesis, samples were taken from patients for “scientific research” and blood samples (at least) were sent to the WIV.

“In the later stage we worked with Dr. Zhong Nan Shan and did some sampling. The patient* tested positive for serum IgM by the WuHan Institute of Virology. It suggested the existence of virus infection” (p62 in the section “Comprehensive Analysis”.)

(*The original does not specify the number of patients tested.)

The Master’s thesis also states its regret that no samples for research were taken from patients 1 and 2, implying that samples were taken from all the others.

We further know that, on June 27th, 2012, the doctors performed an unexplained thymectomy on patient 4. The thymus is an immune organ that can potentially be removed without greatly harming the patient and it could have contained large quantities of virus. Beyond this the Master’s thesis is unfortunately unclear on the specifics of what sampling was done, for what purpose, and where each particular sample went.

Given the interests of the Shi lab in zoonotic origins of human disease, once such a sample was sent to them, it would have been obvious and straightforward for them to investigate how a virus from bats had managed to infect these miners. Any viruses recoverable from the miners would likely have been viewed by them as a unique natural experiment in human passaging offering unprecedented and otherwise-impossible-to-obtain insights into how bat coronaviruses can adapt to humans.

The logical course of such research would be to sequence viral RNA extracted directly from unfrozen tissue or blood samples and/or to generate live infectious clones for which it would be useful (if not imperative) to amplify the virus by placing it in human cell culture. Either technique could have led to accidental infection of a lab researcher.


Our supposition as to why there was a time lag between sample collection (in 2012/2013) and the COVID-19 outbreak is that the researchers were awaiting BSL-4 lab construction and certification, which was underway in 2013 but delayed until 2018.

We propose that, when frozen samples derived from the miners were eventually opened in the Wuhan lab they were already highly adapted to humans to an extent possibly not anticipated by the researchers. One small mistake or mechanical breakdown could have led directly to the first human infection in late 2019.

Thus, one of the miners, most likely patient 3, or patient 4 (whose thymus was removed), was effectively patient zero of the COVID-19 epidemic.
In this scenario, COVID-19 is not an engineered virus; but, equally, if it had not been taken to Wuhan and no further molecular research had been performed or planned for it then the virus would have died out from natural causes, rather than escaped to initiate the COVID-19 pandemic....

Further questions

The hypothesis that SARS-CoV-2 evolved in the Mojiang miner’s lungs potentially resolves many scientific questions about the origin of the pandemic. But it raises others having to do with why this information has not come to light hitherto. The most obvious of these concern the actions of the Shi lab at the WIV.

Why did the Shi lab not acknowledge the miners’ deaths in any paper describing samples taken from the mine (Ge et al., 2016 and P. Zhou et al., 2020)? Why in the title of the Ge at al. 2016 paper did the Shi lab call it an “abandoned” mine? When they published the sequence of RaTG13 in Feb. 2020, why did the Shi lab provide a new name (RaTG13) for BtCoV/4991 when they had by then cited BtCoV/4991 twice in publications and once in a genome sequence database and when their sequences were from the same sample and 100% identical (P. Zhou et al., 2020)? If it was just a name change, why no acknowledgement of this in their 2020 paper describing RaTG13 (Bengston, 2020)? These strange and unscientific actions have obscured the origins of the closest viral relatives of SARS-CoV-2, viruses that are suspected to have caused a COVID-like illness in 2012 and which may be key to understanding not just the origin of the COVID-19 pandemic but the future behaviour of SARS-CoV-2.

These are not the only questionable actions associated with the provenance of samples from the mine. There were five scientific publications that very early in the pandemic reported whole genome sequences for SARS-CoV-2 (Chan et al., 2020; Chen et al., 2020; Wu et al., 2020; P. Zhou et al., 2020; Zhu et al., 2020). Despite three of them having experienced viral evolutionary biologists as authors (George Gao, Zheng-li Shi and Edward Holmes) only one of these (Chen et al., 2020) succeeded in identifying the most closely related viral sequence by far: BtCoV/4991 a viral sequence in the possession of the Shi lab at the WIV that differed from SARS-CoV-2 by just 5 nucleotides.

-- A Proposed Origin for SARS-CoV-2 and the COVID-19 Pandemic [W/Comments], by Jonathan Latham, PhD and Allison Wilson, PhD


On February 3, 2020, with the COVID-19 outbreak already spreading beyond China, Shi Zhengli and several colleagues published a paper noting that the SARS-CoV-2 virus’s genetic code was almost 80% identical to that of SARS-CoV, which caused the 2002 outbreak. But they also reported that it was 96.2% identical to a coronavirus sequence in their possession called RaTG13, which was previously detected in “Yunnan province.” They concluded that RaTG13 was the closest known relative to SARS-CoV-2.

In the following months, as researchers around the world hunted for any known bat virus that might be a progenitor of SARS-CoV-2, Shi Zhengli offered shifting and sometimes contradictory accounts of where RaTG13 had come from and when it was fully sequenced. Searching a publicly available library of genetic sequences, several teams, including a group of DRASTIC researchers, soon realized that RaTG13 appeared identical to RaBtCoV/4991—the virus from the shaft where the miners fell ill in 2012 with what looked like COVID-19.

In July, as questions mounted, Shi Zhengli told Science magazine that her lab had renamed the sample for clarity. But to skeptics, the renaming exercise looked like an effort to hide the sample’s connection to the Mojiang mine.


Their questions multiplied the following month when Shi, Daszak, and their colleagues published an account of 630 novel coronaviruses they had sampled between 2010 and 2015. Combing through the supplementary data, DRASTIC researchers were stunned to find eight more viruses from the Mojiang mine that were closely related to RaTG13 but had not been flagged in the account. Alina Chan of the Broad Institute said it was “mind-boggling” that these crucial puzzle pieces had been buried without comment.

In October 2020, as questions about the Mojiang mine shaft intensified, a team of journalists from the BBC tried to access the mine itself. They were tailed by plainclothes police officers and found the road conveniently blocked by a broken-down truck.

Shi, by now facing growing scrutiny from the international press corps, told the BBC: “I’ve just downloaded the Kunming Hospital University’s student’s master’s thesis and read it…. The conclusion is neither based on evidence nor logic. But it’s used by conspiracy theorists to doubt me. If you were me, what would you do?”

VIII. The Gain-of-Function Debate

On January 3, 2020, Dr. Robert Redfield, director of the U.S. Centers for Disease Control and Prevention, got a phone call from his counterpart Dr. George Fu Gao, head of the Chinese Center for Disease Control and Prevention. Gao described the appearance of a mysterious new pneumonia, apparently limited to people exposed at a market in Wuhan. Redfield immediately offered to send a team of specialists to help investigate.

But when Redfield saw the breakdown of early cases, some of which were family clusters, the market explanation made less sense. Had multiple family members gotten sick via contact with the same animal? Gao assured him there was no human-to-human transmission, says Redfield, who nevertheless urged him to test more widely in the community. That effort prompted a tearful return call. Many cases had nothing to do with the market, Gao admitted. The virus appeared to be jumping from person to person, a far scarier scenario.

Image
Former deputy national security adviser Matthew Pottinger said the “conflicted” status of leading experts who had either approved or received funding for gain-of-function research “played a profound role in muddying the waters and contaminating the shot at having an impartial inquiry.” BY JABIN BOTSFORD/THE WASHINGTON POST/GETTY IMAGES.

Redfield immediately thought of the Wuhan Institute of Virology. A team could rule it out as a source of the outbreak in just a few weeks, by testing researchers there for antibodies. Redfield formally reiterated his offer to send specialists, but Chinese officials didn’t respond to his overture.

Redfield, a virologist by training, was suspicious of the WIV in part because he’d been steeped in the yearslong battle over gain-of-function research. The debate engulfed the virology community in 2011, after Ron Fouchier, a researcher at the Erasmus Medical Center in Rotterdam, announced that he had genetically altered the H5N1 avian influenza strain to make it transmissible among ferrets, who are genetically closer to humans than mice. Fouchier calmly declared that he’d produced “probably one of the most dangerous viruses you could make.”

In the ensuing uproar, scientists battled over the risks and benefits of such research. Those in favor claimed it could help prevent pandemics, by highlighting potential risks and accelerating vaccine development. Critics argued that creating pathogens that didn’t exist in nature ran the risk of unleashing them.

In October 2014, the Obama administration imposed a moratorium on new funding for gain-of-function research projects that could make influenza, MERS, or SARS viruses more virulent or transmissible. But a footnote to the statement announcing the moratorium carved out an exception for cases deemed “urgently necessary to protect the public health or national security.”

In the first year of the Trump administration, the moratorium was lifted
and replaced with a review system called the HHS P3CO Framework (for Potential Pandemic Pathogen Care and Oversight). It put the onus for ensuring the safety of any such research on the federal department or agency funding it. This left the review process shrouded in secrecy. “The names of reviewers are not released, and the details of the experiments to be considered are largely secret,” said the Harvard epidemiologist Dr. Marc Lipsitch, whose advocacy against gain-of-function research helped prompt the moratorium. (An NIH spokesperson told Vanity Fair that “information about individual unfunded applications is not public to preserve confidentiality and protect sensitive information, preliminary data, and intellectual property.”)

Inside the NIH, which funded such research, the P3CO framework was largely met with shrugs and eye rolls, said a longtime agency official: “If you ban gain-of-function research, you ban all of virology.” He added, “Ever since the moratorium, everyone’s gone wink-wink and just done gain-of-function research anyway.”

British-born Peter Daszak, 55, is the president of EcoHealth Alliance, a New York City–based nonprofit with the laudable goal of preventing the outbreak of emerging diseases by safeguarding ecosystems. In May 2014, five months before the moratorium on gain-of-function research was announced, EcoHealth secured a NIAID grant of roughly $3.7 million, which it allocated in part to various entities engaged in collecting bat samples, building models, and performing gain-of-function experiments to see which animal viruses were able to jump to humans. The grant was not halted under the moratorium or the P3CO framework.

By 2018, EcoHealth Alliance was pulling in up to $15 million a year in grant money from an array of federal agencies, including the Defense Department, the Department of Homeland Security, and the U.S. Agency for International Development, according to 990 tax exemption forms it filed with the New York State Attorney General’s Charities Bureau. Shi Zhengli herself listed U.S. government grant support of more than $1.2 million on her curriculum vitae: $665,000 from the NIH between 2014 and 2019; and $559,500 over the same period from USAID. At least some of those funds were routed through EcoHealth Alliance.

EcoHealth Alliance’s practice of divvying up large government grants into smaller sub-grants for individual labs and institutions gave it enormous sway within the field of virology. The sums at stake allow it to “purchase a lot of omertà” from the labs it supports, said Richard Ebright of Rutgers. (In response to detailed questions, an EcoHealth Alliance spokesperson said on behalf of the organization and Daszak, “We have no comment.”)

As the pandemic raged, the collaboration between EcoHealth Alliance and the WIV wound up in the crosshairs of the Trump administration. At a White House COVID-19 press briefing on April 17, 2020, a reporter from the conspiratorial right-wing media outlet Newsmax asked Trump a factually inaccurate question about a $3.7 million NIH grant to a level-four lab in China. “Why would the U.S. give a grant like that to China?” the reporter asked.

Trump responded, “We will end that grant very quickly,” adding, “Who was president then, I wonder.”


Barack Obama's tenure as the 44th president of the United States began with his first inauguration on January 20, 2009, and ended on January 20, 2017.

-- Presidency of Barack Obama, by Wikipedia


A week later, an NIH official notified Daszak in writing that his grant had been terminated. The order had come from the White House, Dr. Anthony Fauci later testified before a congressional committee. The decision fueled a firestorm: 81 Nobel Laureates in science denounced the decision in an open letter to Trump health officials, and 60 Minutes ran a segment focused on the Trump administration’s shortsighted politicization of science.

77 US Nobel Laureates in Science

May 21, 2020

Dear Secretary Azar and Director Collins:

The 77 signatories of this letter, American Nobel Laureates in Physiology or Medicine, Chemistry, and Physics, are gravely concerned about the recent cancellation of a grant from the National Institutes of Health (NIH) to Dr. Peter Daszak at the EcoHealth Alliance in New York. We believe that this action sets a dangerous precedent by interfering in the conduct of science and jeopardizes public trust in the process of awarding federal funds for research.

For many years, Dr. Daszak and his colleagues have been conducting highly regarded, NIH-supported research on coronaviruses and other infectious agents, focusing on the transmission of these viruses from animal hosts to human beings. Their work depends on productive collaborations with scientists in other countries, including scientists in Wuhan, China, where the current pandemic caused by a novel coronavirus arose. Now is precisely the time when we need to support this kind of research if we aim to control the pandemic and prevent subsequent ones.

As has now been widely reported, the grant to the EcoHealth Alliance was abruptly terminated by NIH on April 24, 2020, just a few days after President Trump responded to a question from a reporter who erroneously claimed that the grant awarded millions of dollars to investigators in Wuhan. Despite the misrepresentation of Dr. Daszak’s grant, despite the high relevance of the studies to the current pandemic, and despite the very high priority score that his application for renewal had received during peer review, the NIH informed Dr. Daszak and his colleagues that the grant was being terminated because “NIH does not believe that the current project outcomes align with the program goals and agency priorities.” Such explanations are preposterous under the circumstances.

We are scientists who have devoted our careers to research, both in medical and related scientific disciplines that bear on the overall health and well-being of society, as well as fundamental scientific research, much of it supported by NIH and other federal agencies. We take pride in our nation’s widely admired system for allocating funds based on expert review and public health needs. The abrupt revoking of the award to Dr. Daszak contravenes these basic tenets and deprives the nation and the world of highly regarded science that could help control one of the greatest health crises in modern history and those that may arise in the future.

We ask that you act urgently to conduct and release a thorough review of the actions that led to the decision to terminate the grant, and that, following this review, you take appropriate steps to rectify the injustices that may have been committed in revoking it.


Peter Agre Chemistry 2003 James P. Allison Medicine 2018
Sidney Altman Chemistry 1989 Frances H. Arnold Chemistry 2018
David Baltimore Medicine 1975 Barry Clark Barish Physics 2017
Paul Berg Chemistry 1980 J. Michael Bishop Medicine 1989
Elizabeth H. Blackburn Medicine 2009 Michael S. Brown Medicine 1985
William C. Campbell Medicine 2015 Mario R. Capecchi Medicine 2007
Thomas R. Cech Chemistry 1989 Martin Chalfie Chemistry 2008
Steven Chu Physics 1997 Elias James Corey Chemistry 1990
Robert F. Curl Jr. Chemistry 1996 Johann Deisenhofer Chemistry 1988
Andrew Z. Fire Medicine 2006 Edmond H. Fischer Medicine 1992
Joachim Frank Chemistry 2017 Jerome I. Friedman Physics 1990
Walter Gilbert Chemistry 1980 Sheldon Glashow Physics 1979
Joseph L. Goldstein Medicine 1985 Carol W. Greider Medicine 2009
David J. Gross Physics 2004 Roger Guillemin Medicine 1977
Leland H. Hartwell Medicine 2001 Dudley R. Herschbach Chemistry 1986
Roald Hoffmann Chemistry 1981 H. Robert Horvitz Medicine 2002
Louis J. Ignarro Medicine 1998 William G. Kaelin Jr. Medicine 2019
Eric R. Kandel Medicine 2000 Wolfgang Ketterle Physics 2001
Brian K. Kobilka Chemistry 2012 Roger D. Kornberg Chemistry 2006
Robert J. Lefkowitz Chemistry 2012 Anthony J. Leggett Physics 2003
Michael Levitt Chemistry 2013 Roderick MacKinnon Chemistry 2003
John C. Mather Physics 2006 Craig C. Mello Medicine 2006
William E. Moerner Chemistry 2014 Mario J. Molina Chemistry 1995
Ferid Murad Medicine 1998 Douglas D. Osheroff Physics 1996
James Peebles Physics 2019 Saul Perlmutter Physics 2011
William D. Phillips Physics 1997 H. David Politzer Physics 2004
Sir Richard J. Roberts Medicine 1993 Michael Rosbash Medicine 2017
James E. Rothman Medicine 2013 Randy W. Schekman Medicine 2013
Richard R. Schrock Chemistry 2005 Gregg L. Semenza Medicine 2019
Phillip A. Sharp Medicine 1993 Hamilton O. Smith Medicine 1978
George P. Smith Chemistry 2018 Horst L. Stormer Physics 1998
Thomas C. Sudhof Medicine 2013 Jack W. Szostak Medicine 2009
Joseph H. Taylor Jr. Physics 1993 Kip Stephen Thorne Physics 2017
Susumu Tonegawa Medicine 1987 Daniel C. Tsui Physics 1998
Harold E. Varmus Medicine 1989 Steve Weinberg Physics 1979
Rainer Weiss Physics 2017 Carl E. Wieman Physics 2001
Eric F. Wieschaus Medicine 1995 Torsten N. Wiesel Medicine 1981
Frank Wilczek Physics 2004 Robert Woodrow Wilson Physics 1978
Michael W. Young Medicine 2017


Daszak appeared to be the victim of a political hit job, orchestrated to blame China, Dr. Fauci, and scientists in general for the pandemic, while distracting from the Trump administration’s bungled response. “He’s basically a wonderful, decent human being” and an “old-fashioned altruist,” said the NIH official. “To see this happening to him, it really kills me.”

Image
Department of Health & Human Services
National Institutes of Health
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland 20892

8 July 2020

Drs. Aleksei Chmura and Peter Daszak
EcoHealth Alliance, Inc.
460 W. 34th St.
Suite 1701
New York, NY 100001

Re: NIH Grant R01 A11 10964

Dear Drs. Chmura and Daszak:

In follow-up to my previous letter of April 24, 2020, I am writing to notify you that the National Institute of Allergy and Infectious Diseases (NIAID), an Institute within the National Institutes of Health (NIH), under the Department of Health and Human Services (HHS), has withdrawn its termination of grant R01AI110964, which supports the project Understanding the Risk of Bat Coronavirus Emergence. Accordingly, the grant is reinstated.

However, as you are aware, the NIH has received reports that the Wuhan Institute of Virology (WIV), a subrecipient of EcoHealth Alliance under R01AI110964, has been conducting research at its facilities in China that pose serious bio-safety concerns and, as a result, create health and welfare threats to the public in China and other countries, including the United States. Grant award R01AI110964 is subject to biosafety requirements set forth in the NIH Grants Policy Statement (e.g., NIH GPS, Section 4.1.24 “Public Health Security”) and the Notice of Award (e.g., requiring that “Research funded under this grant must adhere to the [CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL)].”). Moreover, NIH grant recipients are expected to provide safe working conditions for their employees and foster work environments conducive to high-quality research. NIH GPS, Section 4. The terms and conditions of the grant award flow down to subawards to subrecipients. 45 C.F.R. § 75.101.

As the grantee, EcoHealth Alliance was required to “monitor the activities of the subrecipient as necessary to ensure that the subaward is used for authorized purposes, in compliance with Federal statutes, regulations, and the terms and conditions of the subaward . . .” 45 C.F.R. § 75.352(d). We have concerns that WIV has not satisfied safety requirements under the award, and that EcoHealth Alliance has not satisfied its obligations to monitor the activities of its subrecipient to ensure compliance.

Moreover, as we have informed you through prior Notices of Award, this award is subject to the Transparency Act subaward and executive compensation reporting requirement of 2 C.F.R. Part 170. To date you have not reported any subawards in the Federal Subaward Reporting System.

Therefore, effective the date of this letter, July 8, 2020, NIH is suspending all activities related to R01AI110964, until such time as these concerns have been addressed to NIH’s satisfaction.
This suspension is taken in accordance with 45 C.F.R. § 75.371, Remedies for Noncompliance, which permits suspension of award activities in cases of non-compliance, and the NIH GPS, Section 8.5.2, which permits NIH to take immediate action to suspend a grant when necessary to protect the public health and welfare. This action is not appealable in accordance with 42 C.F.R. § 50.404 and the NIH GPS Section 8.7, Grant Appeals Procedures. However, EcoHealth Alliance has the opportunity to provide information and documentation demonstrating that WIV and EcoHealth Alliance have satisfied the above-mentioned requirements.

Specifically, to address the NIH’s concerns, EcoHealth must provide the NIH with the following information and materials, which must be complete and accurate:

1. Provide an aliquot of the actual SARS-CoV-2 virus that WIV used to determine the viral sequence.

2. Explain the apparent disappearance of Huang Yanling, a scientist / technician who worked in the WIV lab but whose lab web presence has been deleted.

3. Provide the NIH with WIV’s responses to the 2018 U.S. Department of State cables regarding safety concerns.

4. Disclose and explain out-of-ordinary restrictions on laboratory facilities, as suggested, for example, by diminished cell-phone traffic in October 2019, and the evidence that there may have been roadblocks surrounding the facility from October 14-19, 2019.

5. Explain why WIV failed to note that the RaTG13 virus, the bat-derived coronavirus in its collection with the greatest similarity to SARS-CoV-2, was actually isolated from an abandoned mine where three men died in 2012 with an illness remarkably similar to COVID-19, and explain why this was not followed up.

6. Additionally, EcoHealth Alliance must arrange for WIV to submit to an outside inspection team charged to review the lab facilities and lab records, with specific attention to addressing the question of whether WIV staff had SARS-CoV-2 in their possession prior to December 2019. The inspection team should be granted full access to review the processes and safety of procedures of all of the WIV field work (including but not limited to collection of animals and biospecimens in caves, abandoned man-made underground cavities, or outdoor sites). The inspection team could be organized by NIAID, or, if preferred, by the U.S. National Academy of Sciences.

7. Lastly, EcoHealth Alliance must ensure that all of its subawards are fully reported in the Federal Subaward Reporting System


During this period of suspension, NIH will continue to review the activities under this award, taking into consideration information provided by EcoHealth Alliance, to further assess compliance by EcoHealth Alliance and WIV, including compliance with other terms and conditions of award that may be implicated. Additionally, during the period of suspension, EcoHealth Alliance may not allow research under this project to be conducted. Further, no funds from grant R01AI110964 may be provided to or expended by EcoHealth Alliance or any subrecipients; all such charges are unallowable. It is EcoHealth Alliance’s responsibility as the recipient of this grant award to ensure that the terms of this suspension are communicated to and understood by all subrecipients. EcoHealth Alliance must provide adequate oversight to ensure compliance with the terms of the suspension. Any noncompliance of the terms of this suspension must be immediately reported to NIH. Once the original award is reinstated, NIH will take additional steps to restrict all funding in the HHS Payment Management System in the amount of $369,819. EcoHealth Alliance will receive a revised Notice of Award from NIAID indicating the suspension of these research activities and funding restrictions as a specific condition of award.

Please note that this action does not preclude NIH from taking additional corrective or enforcement actions pursuant to 45 CFR Part 75, including, but not limited to, terminating the grant award. NIH may also take other remedies that may be legally available if NIH discovers other violations of terms and conditions of award on the part of EcoHealth Alliance or WIV.

Sincerely,

Michael S Lauer, MD
NIH Deputy Director for Extramural Research
Email: Michael.Lauer@nih.gov

cc: Dr. Erik Stemmy
Ms. Emily Linde


In July, the NIH attempted to backtrack. It reinstated the grant but suspended its research activities until EcoHealth Alliance fulfilled seven conditions, some of which went beyond the nonprofit’s purview and seemed to stray into tinfoil-hat territory. They included: providing information on the “apparent disappearance” of a Wuhan Institute of Virology researcher, who was rumored on social media to be patient zero, and explaining diminished cell phone traffic and roadblocks around the WIV in October 2019.

But conspiracy-minded conservatives weren’t the only ones looking askance at Daszak. Ebright likened Daszak’s model of research—bringing samples from a remote area to an urban one, then sequencing and growing viruses and attempting to genetically modify them to make them more virulent—to [b]“looking for a gas leak with a lighted match.” Moreover, Ebright believed that Daszak’s research had failed in its stated purpose of predicting and preventing pandemics through its global collaborations.

It soon emerged, based on emails obtained by a Freedom of Information group called U.S. Right to Know, that Daszak had not only signed but organized the influential Lancet statement, with the intention of concealing his role and creating the impression of scientific unanimity.

Under the subject line, “No need for you to sign the “Statement” Ralph!!,” he wrote to two scientists, including UNC’s Dr. Ralph Baric, who had collaborated with Shi Zhengli on the gain-of-function study that created a coronavirus capable of infecting human cells: “you, me and him should not sign this statement, so it has some distance from us and therefore doesn’t work in a counterproductive way.” Daszak added, “We’ll then put it out in a way that doesn’t link it back to our collaboration so we maximize an independent voice.”

Baric agreed, writing back, “Otherwise it looks self-serving and we lose impact.”

Baric did not sign the statement. In the end, Daszak did. At least six other signers had either worked at, or had been funded by, EcoHealth Alliance. The statement ended with a declaration of objectivity: “We declare no competing interests.”

Daszak mobilized so quickly for a reason, said Jamie Metzl: “If zoonosis was the origin, it was a validation… of his life work…. But if the pandemic started as part of a lab leak, it had the potential to do to virology what Three Mile Island and Chernobyl did to nuclear science.” It could mire the field indefinitely in moratoriums and funding restrictions.

IX. Dueling Memos

By the summer of 2020, the State Department’s COVID-19 origins investigation had gone cold. Officials in the Bureau of Arms Control, Verification, and Compliance went back to their normal work: surveilling the world for biological threats. “We weren’t looking for Wuhan,” said Thomas DiNanno. That fall, the State Department team got a tip from a foreign source: Key information was likely sitting in the U.S. intelligence community’s own files, unanalyzed. In November, that lead turned up classified information that was “absolutely arresting and shocking,” said a former State Department official. Three researchers at the Wuhan Institute of Virology, all connected with gain-of-function research on coronaviruses, had fallen ill in November 2019 and appeared to have visited the hospital with symptoms similar to COVID-19, three government officials told Vanity Fair.

While it is not clear what had sickened them, “these were not the janitors,” said the former State Department official. “They were active researchers. The dates were among the absolute most arresting part of the picture, because they are smack where they would be if this was the origin.” The reaction inside the State Department was, “Holy shit,” one former senior official recalled. “We should probably tell our bosses.” The investigation roared back to life.

[W]e now believe it’s time to completely dismiss the wet market as the source of the outbreak. We also believe the preponderance of the evidence proves the virus did leak from the WIV and that it did so sometime before September 12, 2019.

This is based upon multiple pieces of evidence laid out in the report, including:

The sudden removal of the WIV’s virus and sample database in the middle of the night on September 12, 2019 and without explanation;

• Safety concerns expressed by top PRC scientists in 2019 and unusually scheduled maintenance at the WIV;
Athletes at the Military World Games held in Wuhan in October 2019 who became sick with symptoms similar to COVID-19 both while in Wuhan and also shortly after returning to their home countries;
• Satellite imagery of Wuhan in September and October 2019 that showed a significant uptick in the number of people at local hospitals surrounding the WIV’s headquarters, coupled with an unusually high number of patients with symptoms similar to COVID-19;

• The installation of a People’s Liberation Army’s bioweapons expert as the head of the WIV’s Biosafety Level 4 lab (BSL-4), possibly as early as late 2019; and
• Actions by the Chinese Communist Party and scientists working at or affiliated with the WIV to hide or coverup the type of research being conducted at there.

-- The Origins of COVID-19: An Investigation of the Wuhan Institute of Virology, by House Foreign Affairs Committee


An intelligence analyst working with David Asher sifted through classified channels and turned up a report that outlined why the lab-leak hypothesis was plausible. It had been written in May by researchers at the Lawrence Livermore National Laboratory, which performs national security research for the Department of Energy. But it appeared to have been buried within the classified collections system.

A classified study of the origin of SARS-CoV-2 conducted a year ago by scientists at the Lawrence Livermore National Laboratory, the Department of Energy’s premier biodefense research institution, concluded the novel coronavirus at the heart of the current pandemic may have originated in a laboratory in China, Sinclair has learned.

Researchers at Livermore’s “Z Division,” the lab’s intelligence unit, issued the report May 27, 2020, classified “Top Secret.” Its existence is previously undisclosed. The Z Division report assessed that both the lab-origin theory and the zoonotic theory were plausible and warranted further investigation. Sinclair has not reviewed the report but confirmed its contents through interviews with multiple sources who read it or were briefed on its contents.

In an email to Sinclair, a Livermore spokesperson confirmed the existence of the report but declined to provide additional information. “Because the report you are referring to is classified,” wrote Lynda Seaver, director of public affairs, “it would be inappropriate for our lab to discuss this.”


-- Classified study found COVID-19 could have originated in Chinese lab, by James Rosen, ABC7 News, 5/3/21


Image
Jamie Metzl’s blog became a go-to site for government researchers and journalists examining the lab-leak hypothesis. In his first post on the subject, he wrote, “In no way do I seek to support or align myself with any activities that may be considered unfair, dishonest, nationalistic, racist, bigoted, or biased in any way.” BY ALEX WONG/GETTY IMAGES.

Now the officials were beginning to suspect that someone was actually hiding materials supportive of a lab-leak explanation. “Why did my contractor have to pore through documents?” DiNanno wondered. Their suspicion intensified when Department of Energy officials overseeing the Lawrence Livermore lab unsuccessfully tried to block the State Department investigators from talking to the report’s authors.

Their frustration crested in December, when they finally briefed Chris Ford, acting undersecretary for Arms Control and International Security. He seemed so hostile to their probe that they viewed him as a blinkered functionary bent on whitewashing China’s malfeasance. But Ford, who had years of experience in nuclear nonproliferation, had long been a China hawk. Ford told Vanity Fair that he saw his job as protecting the integrity of any inquiry into COVID-19’s origins that fell under his purview. Going with “stuff that makes us look like the crackpot brigade” would backfire, he believed.

Image

Christopher Ashley Ford (born 1967) is an American lawyer and government official who served from January 2018 until January 2021 as Assistant Secretary of State for International Security and Non-Proliferation. He was nominated to that position by President Donald Trump, and confirmed unanimously by the U.S. Senate on December 21, 2017. After October 21, 2019, Ford also, by delegation from Secretary of State Michael Pompeo, performed the duties of the Under Secretary of State for Arms Control and International Security until his resignation from the Department of State on January 8, 2021.

Before his appointment as Assistant Secretary of State, Ford served in the Trump Administration as Special Assistant to the President and Senior Director for Weapons of Mass Destruction and Counterproliferation on the United States National Security Council staff, and a senior U.S. State Department official in the George W. Bush Administration working on issues of nuclear proliferation and arms control verification and compliance policy. He has also worked as a Senate staffer, as well as for the Hudson Institute.

-- Christopher Ashley Ford, by Wikipedia


There was another reason for his hostility. He’d already heard about the investigation from interagency colleagues, rather than from the team itself, and the secrecy left him with a “spidey sense” that the process was a form of “creepy freelancing.” He wondered: Had someone launched an unaccountable investigation with the goal of achieving a desired result?

He was not the only one with concerns. As one senior government official with knowledge of the State Department’s investigation said, “They were writing this for certain customers in the Trump administration. We asked for the reporting behind the statements that were made. It took forever. Then you’d read the report, it would have this reference to a tweet and a date. It was not something you could go back and find.”

After listening to the investigators’ findings, a technical expert in one of the State Department’s bioweapons offices “thought they were bonkers,” Ford recalled.

The State Department team, for its part, believed that Ford was the one trying to impose a preconceived conclusion: that COVID-19 had a natural origin. A week later, one of them attended the meeting where Christopher Park, who worked under Ford, allegedly advised those present not to draw attention to U.S. funding of gain-of-function research.

With deep distrust simmering, the State Department team convened a panel of experts to confidentially “red team” the lab-leak hypothesis. The idea was to pummel the theory and see if it still stood. The panel took place on the evening of January 7, one day after the insurrection at the Capitol. By then, Ford had announced his plan to resign.

Twenty-nine people logged on to a secure State Department video call that lasted three hours, according to meeting minutes obtained by Vanity Fair. The scientific experts included Ralph Baric, Alina Chan, and the Stanford microbiologist David Relman.

Asher invited Dr. Steven Quay, a breast cancer specialist who’d founded a biopharmaceutical company, to present a statistical analysis weighing the probability of a lab origin versus a natural one. Scissoring Quay’s analysis, Baric noted that its calculations failed to account for the millions of bat sequences that exist in nature but remain unknown. When a State Department adviser asked Quay whether he’d ever done a similar analysis, he replied there’s “a first time for everything,” according to the meeting minutes.

Though they questioned Quay’s findings, the scientists saw other reasons to suspect a lab origin. Part of the WIV’s mission was to sample the natural world and provide early warnings of “human capable viruses,” said Relman. The 2012 infections of six miners was “worthy of banner headlines at the time.” Yet those cases had never been reported to the WHO.

Baric added that, if SARS-CoV-2 had come from a “strong animal reservoir,” one might have expected to see “multiple introduction events,” rather than a single outbreak, though he cautioned that it didn’t prove “[this] was an escape from a laboratory.” That prompted Asher to ask, “Could this not have been partially bioengineered?”

Re: U.S. government gave $3.7 million grant to Wuhan lab at

PostPosted: Tue Aug 17, 2021 9:50 am
by admin
Part 3 of 4

Ford was so troubled by what he viewed as the panel’s weak evidence, and the secretive inquiry that preceded it, that he stayed up all night summarizing his concerns in a four-page memo. After saving it as a PDF so it couldn’t be altered, he emailed the memo to multiple State Department officials the next morning.

Image
Memo
From: Ford, Christopher A <FordCA@state.gov>
Sent: Friday, January 8, 2021 4:15:55 PM
To: Biegun, Stephen E <BiegunSE@state.gov>; StilwellDR@state.gov>; Berkowitz, Peter <BerkowitzP@state.gov> [DELETE] Krach, Keith J <KrachKJ@state.gov>
Cc: [DELETE] DiNanno, Thomas G <DiNannoTG@state.gov>; [DELETE]; Yu, Miles <YuMM@state.gov>; [DELETE]; Feith, David <FeithD@state.gov> [DELETE]
Subject: Summary of January 7, 2021, scientific panel discussion organized by AVC on the origins of SARS-CoV-2

Good afternoon, all:

We had a really valuable discussion yesterday evening with a fascinating panel of scientific experts organized by AVC on the question of the origins of the SARS-CoV-2 virus. It was something of a marathon session that lasted nearly three hours, and produced important insight on a number of fronts. I wrote up a summary of the event last night, and want to share it with all of you. I've attached in-line text below, as well as a PDF of the same information. (I didn't know what form will be more useful to you, so I adopted a "belt and suspenders" approach.) It's a long document, but hopefully interesting, and the issues are important.

Best.

- Chris

The Hon. Christopher A. Ford
Assistant Secretary for International Security and Nonproliferation
Performing the Duties of the Under Secretary for Arms Control and International Security ("T")
U.S. Department of State
Washington, D.C.
United States of America
Tel. (202) 647-1522
fordca@state.gov

TEXT FOLLOWS:

SUMMARY OF JANUARY 7, 2021, AVC PANEL DISCUSSION ORIGINS OF SARS-CoV-2 AND THE PANDEMIC

Yesterday evening, at my insistence, AVC convened a panel of scientists to discuss arguments made by a contractor on AVC's payroll that the Wuhan Institute of Virology (WIV) was most likely the origin of the SARS-CoV-2, the virus that causes the disease COVID-19. AVC has apparently been briefing this argument inside the Department and some interagency partners for some weeks, apparently on instructions from a staffer at S/P who told them they should not inform me or others of this work, nor involve the Intelligence Community. (I learned of this project only in mid-December, when AVC came to brief me on their contractor's findings, and immediately asked AVC to set up an opportunity for these scientific claims to be discussed and evaluated by scientific experts.) If well-founded, AVC's findings would be extremely significant, and have huge policy and political consequences, so I asked the Bureau to set up a scientific panel in order to help assess the validity of AVC's assessments. Several outside scientists picked by AVC served on the panel, and representatives from my office, AVC, ISN, OES, EAP, and INR, as well as NSC staff, also attended and took part in the nearly three-hour meeting. (I myself also attended.) It was a very valuable discussion.

AVC's argument is heavily based upon what it claims is the statistical improbability of SARS-CoV-2 occurring naturally, through zoonotic transmission outside of a laboratory. Under examination at the expert panel, however, these claims largely fell apart.

The panel did seem to agree on the importance of pressing China to show more transparency and asking tough questions about the origins of SARS-CoV-2. In particular, it was generally agreed that it's important to collect more data, including through widespread sampling of coronaviruses in the wild. There was also agreement that China's so far unexplained failure to report details of a cluster of six cases of pneumonia in 2013, three of which proved lethal, connected to a mine shaft in Yunnan where scientists later found the closest known relative to SARS-CoV-2 (a virus known as "RaTG13") was a grave public health failure that needs to be investigated. Beijing should have reported these prior illnesses to the international health community, and the viruses potentially associated with them, in order to inform coronavirus researchers and public health officials about the potential threat. All participants seemed also to agree that China should be pressed for answers about such things as the nature of any work done at WIV on novel coronaviruses, whether any safety incidents occurred, what data is in WIV's virus sequencing database (which was mysteriously taken offline early in the pandemic), and when exactly the PRC realized (despite its early representations) that SARS-CoV-2 was only in its "wet market" environmental samples -- and not its live animal samples -- leading them to conclude that the market was not the source of the outbreak.

These sorts of questions should indeed provide us with lots of grist for pressing China for answers and highlighting its non-transparency and history of failing to report (or even covering up) critical information. I am asking AVC and ISN to collaborate on drawing up a list of questions and points that could be useful in this regard.

When it comes to the statistical analysis AVC has used to show that SARS-CoV-2 was most probably the product of a laboratory release, to include genetic engineering of the virus, however, AVC's case rests primarily on a non-published Bayesian statistical analysis prepared for AVC by one scientist -- a pathologist, rather than a virologist, epidemiologist, or infectious disease modeler, who admitted to us that he had "never done a Bayesian analysis before" this -- who participated in the panel. AVC did not provide us with the actual paper before yesterday's discussion, so most other participants had not had the chance to study it in detail. (INR's resident epidemiologist, who has used Bayesian analysis frequently, has concerns about the validity of applying this underlying model and data to this hypothesis, and is presently reviewing the document.)

On the basis even of what was discussed in the meeting yesterday, however, AVC's statistical case seems notably weak. Their analysis revolves around drawing conclusions about how statistically likely it is that SARS-CoV-2 appeared naturally (zoonotically) compared to being engineered in or released from a laboratory, largely based upon differences between SARS-CoV-2 and other bat coronaviruses.

Over the course of a nearly three-hour discussion, however, it appeared that this statistical analysis is crippled by the fact that we have essentially no data to support key model inputs. Critically, we have no data on the vast majority of bat coronaviruses that exist in the wild -- which is to say, we have very little of baseline information against which AVC's analysis compares SARS-CoV-2. (At present, only perhaps 0.02 percent of such bat viruses, and perhaps 20 percent of bats though to carry coronaviruses have apparently been sampled, and there is enormous diversity in the bat virus population.) This is certainly a good argument for doing much more sample collection, and for pressing the PRC to do things like restore public access to WIV's virus sequencing database (and presumably excoriating and embarrassing the CCP if it refuses). But our general lack of knowledge about the diversity of bat coronaviruses that exist that is, the comprehensiveness of the comparison set -- undermines AVC's arguments about laboratory origin being likely because of the improbability of SARS-CoV-2 developing from any known coronavirus. (By loose analogy, in politics, it 's hard to learn much from comparing poll results if you have only a very small sample size and have no idea whether your samples are actually representative of the population at large.)

The assertion that WIV kept "thousands of coronaviruses" was also questioned in our discussion, since while it is true that WIV sequenced great numbers of viruses, such sequencing most commonly involves the possession of viral genomic material rather than live viruses. (This may have bearing on the risk of accidental release from a laboratory, since only live viruses entail a risk of infection, and genetic material is not infectious.) One of the panelists also noted the incredible difficulty of isolating live virus from bat samples, which are usually fecal samples, and that this is extremely unreliable and usually not successful. We don't seem to know anything about how many, and which, live viruses were actually kept at WIV -- which is, again, a powerful reason to ask more tough questions of the PRC, but not at this point reason to conclude laboratory escape.

Similarly, AVC has argued that based on the degree of difference between SARS-CoV-2 and its closest known relatives -- the above mentioned "Ra TG 13" coronavirus from the mine in Yunnan -- it is highly unlikely that SARS-CoV-2 occurred through natural genetic evolution, and thus more likely to have been engineered. This analysis is also gravely flawed, however, since it assumes that RaTG13 is the immediate precursor of SARS-CoV-2. But the panelists seemed to agree that RaTG13 was probably not the immediate precursor of SARS-CoV-2: it is merely the closest known relative -- which is a big difference -- and they all freely admitted we still have an exceedingly poor grasp of what's really "out there" in the bat virus world. As one panelist put it, we'd do better to collect more data than to "mess around with" trying to do statistical probabilities on the basis of such an incomplete data set; the resulting uncertainties are just too huge to make that approach useful.

(Note: The panelists agreed that AVC's supposedly statistical claims about WIV as a point of origin might be much more compelling if we discovered that WIV had actually done work with a precursor virus that really was much closer to SARS-CoV-2 than any yet known. End Note.)

Another problem related to assertions made about the likelihood that SARS-CoV-2 came from WIV that were based on WIV's proximity to "patient zero" for the COVID-19 pandemic, and the claim that there's no known evidence of human exposure to SARS-like coronaviruses in the Wuhan area compared to looking at exposure rates in human populations near a cave in Yunnan known to have SARS-like bat coronaviruses. There was disagreement, however, about the degree to which these geographic matters tell us anything useful. One panelist pointed out that although a point of origin in Wuhan seems more likely than transit from Yunnan, we actually don't know when or where "patient zero" actually was in the first place. Moreover, it was also pointed out that SARS-CoV-2 symptoms vary hugely from asymptomatic to very symptomatic (raising the possibility that cases will be missed, especially early in an outbreak before everyone knows to be looking for the disease), contagion can occur days before symptoms manifest, large numbers of people go back and forth between Yunnan and Wuhan all the time, and large parts of China, particularly rural areas where exposure to animals in higher, have poor health care systems and disease surveillance. Accordingly, conclusions on such bases, multiple participants noted, are not likely to be strongly compelling. While there did seem to be agreement that while there are likely more potential virus precursors in the Yunnan area than in Wuhan, it is still hard to draw too many conclusions at this point because relatively little was known about the total universe of bat coronavirus anywhere. (This lack of data was perhaps the strongest recurring theme of the scientific discussion.)

I hope this summary of the discussion was useful, for those of us involved found it very much so. In concluding this account, let me add two notes that were not discussed in yesterday's marathon scientific discussion, but that I believe to be important:

First, I would strongly caution against arguing that the PRC was "required" by the Biological Weapons Convention (BWC) to report all of its work at WIV, for that is not the case. In fact, the confidence-building mechanisms (CBMs) of the BWC expressly require only reporting on Biosafety Level Four (BS L-4) facilities, which China has done. (Work with most coronaviruses is not, in fact, normally conducted under BSL-4 conditions, whether in China or the United States.) The BWC's CBMs merely "suggest" reporting on BSL- 3 facilities if they are the highest-level ones that a given country possesses, and despite AVC's suggestions, it is not suspicious that the PRC stopped reporting on BSL-3s when their first BSL-4 facility opened (at WIV): doing exactly that is permissible under the BWC CBMs, and in fact this is what one would expect if they actually followed the instructions set forth in the BWC's CBM guide. (As I pointed out to David Stilwell last weekend, that guide is available online at https://unoda-web.s3-accelerate.amazona ... e-2015.pdf.)

I would also caution you against suggesting that there is anything inherently suspicious -- and suggestive of biological warfare activity -- about People's Liberation Army (PLA) involvement at WIV on classified projects. It's certainly possible that the PLA did secret BW work at WIV, but we have no information to suggest this. And it would be difficult to say that military involvement in classified virus research is intrinsically problematic, since the U.S. Army has been deeply involved in virus research in the United States for many years.

In any event, thanks for your patience with a long message. I thought the scientific discussion yesterday evening was extraordinarily valuable, and it should be very helpful in allowing us to fine-tune our messaging to and about the PRC. In the event that the Chinese suddenly respond to such questioning with an uncharacteristic degree of transparency and honesty, the global health community will be able to acquire more and better data, which may help clear up these critical questions, and increase the world's preparedness for the next pandemic. If, on the other hand, the PRC stonewalls and dissimulates, its refusal to entertain or respond to such pointed and important questions will help us expose the CCP even further as being disingenuously irresponsible in an area critical to global health security. In either event, therefore, yesterday evening's discussion will have been very helpful. My thanks to Tom DiNanno, Janey Wright, Thomas Cherry, and David Asher for setting up the meeting.


In the memo, Ford criticized the panel’s “lack of data” and added, “I would also caution you against suggesting that there is anything inherently suspicious—and suggestive of biological warfare activity—about People’s Liberation Army (PLA) involvement at WIV on classified projects. [ i]t would be difficult to say that military involvement in classified virus research is intrinsically problematic, since the U.S. Army has been deeply involved in virus research in the United States for many years.”

Image
Response to Former Assistant Secretary Ford's "SUMMARY OF JANUARY 7, 2021, AVC PANEL DISCUSSION ORIGINS OF SARS-CoV-2 AND THE PANDEMIC"
12/9/2021 [actually 1/9/2021]

AVC is providing the following response in light of the fact that Former Assistant Secretary Ford’s memo was an inaccurate and misleading rendition of the event that mischaracterized the panel's exchanges and used references out of context.

• This event was not convened at the former assistant secretary’s “insistence”

It was conceived, organized, and hosted by AVC following weeks of emails and discussions between AVC personnel and several eminent scientists. The ground work that led to this concept was part of AVC’s preparation for the drafting of the annual compliance report and was further advanced by the knowledge, provided by S/P staff, that Department leadership desired to have the issue examined by a panel of outside experts. Former Assistant Secretary Ford’s only “insistence” in this matter was to insist on attending at the last minute, and to insist on disrupting the discussions between the experts by posing long-winded and ill-informed questions the purpose of which appeared to be to disrupt the proceedings and discredit the entire effort. That violated the ground rules established for what was to be an exchange of views between the scientific panel members with time reserved at the end of the panel discussion for questions or comments by the State attendees.

• The panel was NOT convened to “discuss arguments made by a contractor on AVC’s payroll”

The panel was convened to conduct a peer level review of draft studies by two scientists. The comments of the participants were not for attribution and the panel was understood to be only a starting point in a continuing dialogue. The panelists were never briefed on any AVC assessment or working hypothesis nor were they made aware of internal USG deliberations. AVC’s draft findings were never the topic of discussion – though the discussions went a long way toward validating some of AVC’s current findings. AVC is at a loss to understand Former Assistant Secretary Ford’s apparent confusion or previous lack of interest in this topic, one of the most important matters of the past twelve months.

• Former Assistant Secretary Ford was briefed on AVC’s initial classified and unclassified findings back on December 2nd.

AVC took the initiative to brief the former assistant secretary and ISN technical experts on AVC’s initial findings. AVC received no comments from, nor any followup by, the former assistant secretary nor his staff after the brief. During that brief, however, T staff made clear their apprehension and contempt for AVC engagement on SARS-COV-2 origins as part of our compliance analysis.

• Since AVC’s engagement with the interagency on this issue, the NIC has amended its previous assessment and is now much closer to AVC’s initial findings which did not accept the proposition of a natural occurrence of the virus to the exclusion of a lab escape possibility (despite the NIC’s apparent refusal to consider a number of important technical and open source evidence). A chronology of AVC interagency engagement is attached.

• When Former Assistant Secretary Ford implied agreement among panelists on various points, his summary mischaracterized the nature and content of the exchange of views.

This was not a policy deliberation within the department. As the moderator clearly explained in the introduction, the focus of the exchange was NOT to find agreement, it was to discover where there were questions or uncertainty such that the hypotheses and associated data sets before the panel could be refined and improved. The panel did not take a poll, and silence never implied consent. The panel was not there to validate the former assistant secretary’s notions of what policy should be pursued, but to critique and refine the draft analyses of Dr. Quay and Dr. Chan.

• AVC’s findings to date have never included “a non-published Bayesian statistical analysis”.

AVC requested the NIC to conduct a Bayesian analysis of COVID-19’s origin based on scientific and intelligence evidence in December. Despite the importance of this question and the resources at the NIC’s disposal, the NIC, to our knowledge, has not conducted the requested analysis. Having not received the requested analysis from the NIC, AVC requested that Dr. Steven Quay extend his current investigation into the origins of COVID-19 to include a Bayesian analysis of two important competing hypotheses in his findings. AVC knows of no similar substantive scientific analysis prior to AVC’s request to Dr. Quay. It was this work which was the focus of the scientific panel – NOT AVC’s findings.

• The Bayesian statistical analysis that was the subject of the evening’s discussion was NOT prepared by a pathologist.

Dr. Quay is a renowned biochemist Phd, MD, and biotech entrepreneur with 78 patents to his name (bio attached). Moreover, Former Assistant Secretary Ford failed to acknowledge the contributions of Dr. Chan, whose work was also the subject of this panel’s discussion. Her deep expertise of Chinese duplicity and lack of transparency was very insightful and helpful as AVC looks at compliance issues. The fact that AVC was able to attract such eminent scientists, across multiple biological disciplines, all focused on the question of COVID-19’s origin, for more than two and a half hours, to review Dr. Quay’s and Dr. Chan’s work, speaks very highly of their competence to make original contributions on this important matter. Despite the cynical attempt to impugn Dr. Quay’s qualifications in this matter Dr. Ford praised the panel diversity and qualifications the same day he penned his memo. Most who attended this review of Dr. Quay’s work do not know that he has also collaborated with a very highly qualified bio statistician regarding this and previous work. This individual was not available and thus his contributions were not included in the discussion. The CVs of the panelists are attached, which demonstrate the extraordinarily high and diversified level of scientific expertise present on this panel.

• AVC and Dr. Quay welcomed any inputs from INR’s epidemiologist.

• The former assistant secretary misunderstood a key point of the scientific discussion when he states, “this statistical analysis is crippled by the fact that we have essentially no data to support key model inputs. Critically, we have no data on the vast majority of bat coronaviruses that exist in the wild”.


On the contrary, we don’t need to know every bat coronavirus genome to understand the likelihood of a zoonotic vs. lab origin. We merely need to reliably estimate the number of bat coronaviruses there are, and factor this into our weighting of our present knowledge about bat coronaviruses. This is how Bayesian analysis works. Fortunately for the world, and unbeknownst to some of the panelists, this calculation had already been done, conservatively so, by Dr. Daszak who is one of the world’s greatest proponents of the zoonotic origin hypothesis.

• The former assistant secretary’s identification of what is NOT known about the parthenogenic contents of the Chinese labs, while true, is totally irrelevant to the Bayesian approach which focuses on what we DO know, specifically what current evidence can be quantified and weighed.

This approach allows us to consider all relevant quantifiable evidence in order to calculate the likelihood of a given hypothesis. Bayesian analysis was designed to help determine the probability of an event when there is uncertainty and data is incomplete, which as Dr. Muller, the moderator, pointed out, is the circumstance in almost all scientific inquiry. Dr. Ford’s injection of personal viewpoints was entirely inappropriate and disruptive of the flow of the panel members’ discussion.

• The former assistant secretary’s RaTG13 strawman completely misrepresented AVC’s findings.

AVC has never assumed that RaTG13 is the immediate precursor of SARS-CoV-2. RaTG13 is significant for other reasons having to do with its potential as a backbone for the creation of a parthenogenic chimeric viruses. It is also significant given the suspect behavior of PRC scientists regarding disclosure of information about this virus and the clouded and questionable nature of previous disclosures about its origin, genomic structure, and laboratory experimentation.

• The former assistant secretary is mistaken if he is implying that AVC, or any of the scientists, would “conclude laboratory escape” based on Dr. Quay’s paper or any of the discussions.

Again, this was not a policy discussion aimed at reaching a consensus conclusion. The purpose of the panel was to assist Dr. Quay in refining his Bayesian analysis of two different hypotheses, laboratory origin being one and zoonotic origin being the other. This entire effort was intended to be a discussion among scientific experts on the two presentations, deliberately avoiding the introduction of any policy issues or attempts to force a conclusion or consensus – as was made clear by the ground rules, the opening comments by Dr. Muller as moderator, and AVC SBO DiNanno as host. It should be noted that no panelist questioned the Bayesian approach. The moderator of the panel, Dr. Muller, and the majority of the panel, without objection from any member, believed that a Bayesian analysis was an appropriate tool for an investigation of this question and that the appropriate next step was to identify elements of that analysis that were in question and attempt to refine the model. The only significant questions raised dealt with the weighting, or ability to assign weights, to individual elements of the Dr. Quay’s 19-element assessment. That being said, inputs were solicited by the panel and are welcome.

• Either through misunderstanding of the moderator’s instructions, or on purpose, the former assistant secretary managed on multiple occasions to sidetrack the panel discussion away from its scientific mission by interjecting comments and questions in violation of the ground rules under which the panel members agreed to participate in this event.

• Over the past months, members of Former Assistant Secretary Ford’s staff, and some AVC staff members, warned AVC leadership not to pursue an investigation into the origin of COVID-19. Both AVC and ISN staff members stated that AVC would “open a can of worms” if it continued.


When asked, none of these staff members could or would elaborate, but their reluctance to pursue this effort was evidenced by failure to provide information when requested and a complete lack of responses to briefings and presentations that were undertaken by AVC. AVC will continue to pursue its statutory mandate to investigate all matters dealing with BWC compliance including aspects of this pandemic that may indicate a failure by the PRC to honor its treaty obligations and commitments.

• The actions of Dr. Ford regarding this entire effort, including his interruption of the panel discussion and the parting shot of his memorandum to the Secretary, appears to be part of a continuing effort to impose his pre-conceived conclusion about the origin of the virus uninformed by the mass of open source material presented by AVC or the substance of the exchanges that took place during the panel discussion. His attitude and that of his staff was also demonstrated by a hostility to even posing questions to the PRC related to the Biological Weapons Convention or the WHO International Health Regulations, the latter of which are legally-binding, clearly violated, and related to the origin of the virus and the activities that took place at the Wuhan Institute of Virology.

On January 7th AVC was honored to host a scientific discussion involving several of the world’s most accomplished experts in the fields of biochemistry, molecular biology, zoonotic diseases, immunology, biological warfare, aerosol physics, and synthetic biology, regarding the first substantive scientific Bayesian analysis of two COVID-19 origin hypotheses. They graciously devoted almost three hours of their time without compensation to help refine Dr. Quay’s outstanding work, agreed to consider further refinement of his analysis, and are to be commended for those selfless contributions to get to the root causes of the global pandemic.


Thomas DiNanno sent back a five-page rebuttal to Ford’s memo the next day, January 9 (though it was mistakenly dated “12/9/21”). He accused Ford of misrepresenting the panel’s efforts and enumerated the obstacles his team had faced: “apprehension and contempt” from the technical staff; warnings not to investigate the origins of COVID-19 for fear of opening a “can of worms”; and a “complete lack of responses to briefings and presentations.” He added that Quay had been invited only after the National Intelligence Council failed to provide statistical help.

A year’s worth of mutual suspicions had finally spilled out into dueling memos.

The State Department investigators pushed on, determined to go public with their concerns. They continued a weeks-long effort to declassify information that had been vetted by the intelligence community. On January 15, five days before President Joe Biden’s swearing in, the State Department released a fact sheet about activity at the Wuhan Institute of Virology, disclosing key information: that several researchers there had fallen ill with COVID-19-like symptoms in autumn 2019, before the first identified outbreak case; and that researchers there had collaborated on secret projects with China’s military and “engaged in classified research, including laboratory animal experiments, on behalf of the Chinese military since at least 2017.”

The statement withstood “aggressive suspicion,” as one former State Department official said, and the Biden administration has not walked it back. “I was very pleased to see Pompeo’s statement come through,” said Chris Ford, who personally signed off on a draft of the fact sheet before leaving the State Department. “I was so relieved that they were using real reporting that had been vetted and cleared.”

X. A Fact-Finding Mission to Wuhan

In early July, the World Health Organization invited the U.S. government to recommend experts for a fact-finding mission to Wuhan, a sign of progress in the long-delayed probe of COVID-19’s origins. Questions about the WHO’s independence from China, the country’s secrecy, and the raging pandemic had turned the anticipated mission into a minefield of international grudges and suspicion.

Within weeks, the U.S. government submitted three names to the WHO: an FDA veterinarian, a CDC epidemiologist, and an NIAID virologist. None were chosen. Instead, only one representative from the U.S. made the cut: Peter Daszak.

It had been evident from the start that China would control who could come and what they could see. In July, when the WHO sent member countries a draft of the terms governing the mission, the PDF document was titled, “CHN and WHO agreed final version,” suggesting that China had preapproved its contents.

Part of the fault lay with the Trump administration, which had failed to counter China’s control over the scope of the mission when it was being hammered out two months earlier. The resolution, forged at the World Health Assembly, called not for a full inquiry into the origins of the pandemic but instead for a mission “to identify the zoonotic source of the virus.” The natural-origin hypothesis was baked into the enterprise. “It was a huge difference that only the Chinese understood,” said Jamie Metzl. “While the [Trump] administration was huffing and puffing, some really important things were happening around the WHO, and the U.S. didn’t have a voice.”

Image
In 2012, the prominent pulmonologist Zhong Nanshan consulted on a case of miners who fell ill after digging bat feces out of a cave in Mojiang county. Their symptoms of cough, fever, and labored breathing recalled the 2002 SARS outbreak but also foreshadowed the COVID-19 pandemic. FROM TPG/GETTY IMAGES.

On January 14, 2021, Daszak and 12 other international experts arrived in Wuhan to join 17 Chinese experts and an entourage of government minders. They spent two weeks of the monthlong mission quarantined in their hotel rooms. The remaining two-week inquiry was more propaganda than probe, complete with a visit to an exhibit extolling President Xi’s leadership. The team saw almost no raw data, only the Chinese government analysis of it.

They paid one visit to the Wuhan Institute of Virology, where they met with Shi Zhengli
, as recounted in an annex to the mission report. One obvious demand would have been access to the WIV’s database of some 22,000 virus samples and sequences, which had been taken offline. At an event convened by a London organization on March 10, Daszak was asked whether the group had made such a request. He said there was no need: Shi Zhengli had stated that the WIV took down the database due to hacking attempts during the pandemic. “Absolutely reasonable,” Daszak said. “And we did not ask to see the data…. As you know, a lot of this work has been conducted with EcoHealth Alliance…. We do basically know what’s in those databases. There is no evidence of viruses closer to SARS-CoV-2 than RaTG13 in those databases, simple as that.”

In fact, the database had been taken offline on September 12, 2019, three months before the official start of the pandemic, a detail uncovered by Gilles Demaneuf and two of his DRASTIC colleagues.

Re: U.S. government gave $3.7 million grant to Wuhan lab at

PostPosted: Tue Aug 17, 2021 10:51 am
by admin
Part 4 of 4

After two weeks of fact finding, the Chinese and international experts concluded their mission by voting with a show of hands on which origin scenario seemed most probable. Direct transmission from bat to human: possible to likely. Transmission through an intermediate animal: likely to very likely. Transmission through frozen food: possible. Transmission through a laboratory incident: extremely unlikely.

On March 30, 2021, media outlets around the world reported on the release of the mission’s 120-page report. Discussion of a lab leak took up less than two pages. Calling the report “fatally flawed,” Jamie Metzl tweeted: “They set out to prove one hypothesis, not fairly examine all of them.”

The report also recounted how Shi rebutted conspiracy theories and told the visiting team of experts that “there had been no reports of unusual diseases, none diagnosed, and all staff tested negative for SARS-CoV-2 antibodies.” Her statement directly contradicted the findings summarized in the January 15 State Department fact sheet. “That was a willful lie by people who know it’s not true,” said a former national security official.

Image
United States Government Expert Analysis on the WHO-Convened Global Study of the Origins of SARS-CoV-2 Joint China-WHO Report
April 5, 2021

TOPLINE POINTS

• While the report includes some new relevant information potentially related to the origins of COVID-19, the report has not significantly improved our understanding of how the virus might have started circulating in Wuhan, which was called for in the study’s Terms of Reference (TOR) for the investigation.

• Conclusions made by the joint expert team lack raw data and/or supporting information in the final report and annexes. In fact, some sections of the report appear to contradict or undermine conclusions in other parts of the report.

• The information and analyses presented in the report did not provide clear scientific support for any one hypothesis, and additional work is needed to identify the origins and circumstances leading to the emergence of SAR-CoV-2 in the hopes of reducing the probability of a similar event.

• The report does not provide substantive guidance for future investigations, such as prevention of new outbreaks/spillover events, design of studies of novel outbreaks of unknown origin, or lessons on treatments/risk factors for patients.

Methodology

• When reviewed by the international experts, Phase 1 studies appear to have needed additional data and analyses, and some of those analyses may still be underway. The need to refine the design of the studies and interpretation of the analyses suggests problems in the initial parts of the investigation.

• The report does not appear to have fulfilled the TOR, which lays out more extensive studies, such as comprehensive epidemiological analyses and mapping of supply chains of animals and products.

• Summary data were presented to the external panel, but raw data did not seem to be available for analyses, other than viral genome sequence data.

• The report revealed several types of tests and studies that were not yet completed, despite the long time elapsed and potential relevance to the origins of the virus, for example retrospective testing of all available clinical and surveillance samples from Wuhan.

• Some referenced articles have not been peer-reviewed and others appear to have been withdrawn. References claimed to support infectivity actually appear to describe stability.4

Key Findings

• The report lists four possible pathways of emergence, but it does not include a description of how these hypotheses were generated, would be tested, or how a decision would be made between them to decide that one is more likely than another. Therefore, it is difficult to understand how each of these could have a probability assigned to it.

• The qualitative risk assessment does not discuss the level of uncertainty associated with different classifications.

• The analysis of the possible pathways of emergence (p.115-123) does not link up well to the three sections presenting the analyses by the working groups. They are a blanket statement of likely versus unlikely, with no link to why the data presented in the report makes one more or less likely.

• The report only provides a cursory look at the laboratory incident hypothesis, and the evidence presented seems insufficient to deem the hypothesis “extremely unlikely.”

• The joint team’s assessment is that “introduction through cold/ food chain products is considered a possible pathway.” Although such a pathway is theoretically possible, there is no evidence presented in the report to indicate that it is, in reality, an actual pathway. The report notes the probability of a cold-chain contamination with the virus from a reservoir is very low, it is not emphatically stated in the up-front summary.

• Lack of key data and information on fomite transmission, such as infectious dose, undermines the conclusions about transmission via cold-chain products.

• Alternate explanations for contamination of containers or packaging, such by handling through a COVID-19 infected person, are not adequately explored.

• The three sections presenting working group analyses read more like generalized literature reviews without linkages to the possible pathways of emergence. The report does not bring the three analyses together or discuss how the data from across the analyses informed their conclusions. For example, data from the Huanan Seafood Market is examined by all three working groups, but at no point is that information all clearly brought together to make an overall statement about the role of the Huanan Seafood Market in the early spread of SARS-Cov_2.

Report Recommendations

• The report does not appear to prioritize among the various recommendations, and recommendations may have feasibility challenges at this stage of the pandemic. For example, results of farm surveys could be confounded by human to animal transmission over the past year.

• Phase 2 studies are not well laid-out, with specific, targeted questions to ask to resolve origins questions.

USG EXPERT ANALYSIS

Main Findings of Working Groups

• Epidemiology


• The report concluded that none of the data analyzed showed evidence of widespread circulation of SARS-CoV-2 in Wuhan before December 2019, although could not exclude the possibility of undetected low-level circulation, and suggested additional research to investigate this issue.

• Contrary to the TOR’s mandate for the mission to analyze “in-depth reviews of hospital records for cases compatible with COVID-19 before December (page 6), most data analysis and interpretation has been performed on previously compiled assessments from limited sources (a few hospitals and centers). Data are primarily presented as already processed, summary data. It is not evident that raw data was made available to be examined or re-analyzed by the team, or that the team had access to ask for more information beyond what was presented. The data presented do not show the extensive mild/asymptomatic cases that should have been likely before the severe cases were detected. The selection of only two hospitals in Wuhan which show extremely low cases of influenza (e.g., Annex: Figure 3 shows only 20-60 adult confirmed influenza cases in peak influenza season) warrants further discussion.

• The epidemiologic data provided was difficult to follow and the different pieces didn’t seem to be consistent with each other. For example, the trends in Influenza-like illness (ILI) data seemed relatively flat year-round in previous years and early in 2019, which was surprising given the seasonal nature of influenza (page 19, figure 1). The 2017-2018 influenza season was a severe epidemic in the Northern hemisphere (as documented by China in the peer-reviewed literature: e.g. https://bmcinfectdis.biomedcentral.com/ articles/10.1186/s12879-019-4181-2 ) and thus Wuhan data showing a flat baseline was inconsistent with previously published data, with the graphic presented in Annex: Figure 1 (page 137), and not expected. Furthermore, Figures 4 and 5 do not correlate to the data presented in Figures 1-3 reporting ILI cases and percent influenza in adults and pediatrics from one hospital each.

• Several types of disease surveillance and mortality data presented from Fall 2019 indicate no evidence of the early circulation of SARS-CoV-2, however the possibility was not excluded and follow-on studies were recommended to further explore this issue. It is unclear why some of the follow-on work is recommended. For example, it is suggested that next steps include further review of data on respiratory illnesses from on-site clinics at the Military Games in October 2019. However, in the discussion of the Military Games and other international events -- it is noted that there are no clusters of fever or respiratory illness.

• Additionally, an increase in ILI and laboratory confirmed influenza cases was noted in December 2019, particularly in children. Details were not provided on which subtype(s) were present in these children or if samples were also tested for COVID-19. These results were also not consistent and did not correlate with data on deaths during the same time period, or in next month, as those were found to be in older adults. Without access to the raw data it is difficult to understand the trends in respiratory cases before and during December 2019, and into January 2020.

• Although early reported cases were linked to the Huanan market (or other markets), there were as many cases not linked to markets and also sporadic cases in the community earlier than the first markets cases. This suggests that the virus was circulating unnoticed in the community prior to the first clusters detected associated with the Huanan market.

• The report is not clear about which team considered the 92 cases to be compatible with SAR-CoV-2 infection, the team from 233 health institutions or the international team.

• Investigation into possible earlier cases should have occurred and is still needed. This is another example of a missed opportunity to further evaluate the initial cases.

• It is not clear how many “other cases” were reviewed and how they were excluded as incompatible. This appears to be a missed opportunity to thoroughly review the epidemiological studies to identify other possible exposures.

• USG Position

• The report’s conclusions are based on limited data sets which likely should be expanded. The recommendations to look further into details and an expanded data set derived from more hospitals and local, regional and national registers are reasonable and justified. However, it seems rather unlikely that new conclusions will be drawn from surveillance data. Thus, new approaches should be considered such as intensified testing of archived material and blood bank specimens (mentioned by the team) to find answers for the emergence of SARS-CoV-2.

• Molecular Epidemiology

• Combining worldwide and early molecular epidemiology was well done. Overall, this section has the format of a manuscript/review article rather than an investigation report. Conclusions, such as linking genomic with epidemiological data, sequence quality control and studying closely related bat sequences, are supported and justified. Other conclusions, such as spreading event at the Huanan Market and unrecognized circulations/introductions, are rather hypothetical. Environmental sample sequences from other countries need to be further verified and supported by additional investigations. This seems very vague and lacks strategy/concept.

• Some new genetic analyses were generated as part of this study, which is useful to the origin questions. One of the conclusions is that genetic sequences diversity indicates additional sources or unrecognized circulation, but that is not correlated with the epidemiologic data section.

• Viral genome sequences from the earliest human cases in December 2019 were not included for analysis and comparison, only sequences available after January 2020. Based on sequences available to date, molecular analyses suggest the virus most likely emerged between September and November 2019.

• The sequences available for analysis from January 2020 already showed different sequences clusters present in the infected people.

• Access to viral genomes from the first cases in December, if they exist, would be more informative to better characterize the earliest sequences and cases, and perhaps better inform on timeline and source of emergence.

• USG Position:

• There is a need for more early sequences if material is still available/ accessible. This would include specimens from human cases (e.g., blood draws), animals (wildlife and domestic) and environment. A worldwide accessible database needs to be implemented with quality control at entering level. Data analysis needs to be performed by a team of international experts rather than local/national entities. A global effort seems possible on this topic if all countries and researchers agree to a joint concept/strategy.

• Animal and Environmental Studies

• The report concludes that coronaviruses that are phylogenetically related to SARS-CoV-2 have been identified in multiple animals, but did not identify a specific host. This section of the report includes material on possible cold chain transmission.

• A significant amount of work has been summarized in this section, unfortunately, with little outcome in identifying the source/reservoir/intermediate host. Some of the presentations, such as the presentation on SARS-CoV-2 in mink in the Netherlands, is odd and appears peripheral to information requested in the TOR. The link to bats has some evidence based on coronavirus diversity in bats (based on the literature, not findings from the investigation) but this report does not present sufficient data to make conclusions.

• Environmental sampling seems insufficient as it is largely related to the Huanan Market. The same holds true for frozen food and cold-chain products, as the portion of the report looking at cold-chain transmission is 2 pages long (p.110-111) and includes minimal data to analyze the possibility of infection as a result of frozen foods, nor citations to support the assertions. All laboratory evidence so far speaks against frozen food as a source, but current investigations seem insufficient for final conclusions.

• Samples (sample types not clear besides feces) were collected and tested from a number of different wild and domestic animal species, including rabbits, cats, dogs, rodents, porcupines, poultry, swine etc., from different locations and times (total numbers, timing and locations are a bit hard to follow and summarize). All samples tested as a part of this effort were negative for SARS Cov-2 and for antibodies to SARS CoV-2.

• Previous and other published data were also presented and summarize the SARS CoV-2 related viruses sequences detected in bats and pangolins to date. These data support the potential for bats and/or pangolins to be a potential part of the transmission chain of spillover of the virus from animals to people.

• USG Position:

• An area with little attention so far seems to be wildlife farms/traders and breeding farms of wildlife species (nearby or far-away) including illegal farming .If a potential animal source cannot be identified on the nearby consumer market, one should go up the trading and production line. This could be geographically far away as wildlife products are often brought in from long distances. Environmental sampling on different markets within and outside the province may be helpful. The identification of the origin is less likely to be determined through environmental sampling, but data could be supportive. While frozen food and cold-chain products have not been excluded by the current investigations, it is noteworthy that no evidence has been presented is occurring. Further investigations are warranted because viruses are rather stable in cold environments and while contaminated food products could theoretically be a source of infection, there remains no direct evidence of transmission of COVID-19 via cold chain products to date nor does the report present any such evidence. However, highest priority would be investigations into wildlife farms and breeding facilities around Wuhan and greater China, and discussion of frozen or cold-chain food products should differentiate between frozen wildlife products and commercial products. In addition, studies examining wildlife for potential reservoir/amplifying species in China should be expanded. Finally, a global effort should be initiated to look into reservoir/intermediate host species.

Possible Pathways of Emergence

• Direct zoonotic transmission


• Data from this report did not shed any additional light on this hypothesis.

• While the global scientific community agrees that this is a likely source, the studies documented in the report did not uncover much new information on the original virus reservoir—no analysis of new data, or visits to possible locations in Wuhan or elsewhere.

• The published data to date show that the most closely related viruses, but not any sequences identical to SARS CoV-2, have been found in a number of Rhinolophid bats species in China, Japan Cambodia and Thailand. This is also the group of bats that has been shown to carry SARS CoV-1 related viruses. This is still the strongest evidence to date based on the published literature that bats may be linked in some way to the emergence of SAR CoV-2.

• USG Position:

• The evidence provided in the report does not support this hypothesis over others; however, the published data fit best with the hypotheses of either a direct zoonotic transmission or transmission via an intermediate animal host.

• Introduction through intermediate host followed by zoonotic transmission

• Data from this report did not shed much additional light on this hypothesis. There is some evidence to support an intermediate animal host or hosts may be linked to transmission to people.

• Published data to date show that pangolins also carry viruses related to SARS CoV-2 (90% similarity). Additionally, also from the literature and/or experimental studies, other species have been shown to be susceptible to COVID-19 infection.

• Introduction via an intermediate host is not well separated from “direct zoonotic transmission,” and it is not clear what evidence would distinguish these two hypotheses.

• USG Position:

• The evidence provided in the report does not support this hypothesis over others; however, the published data fit best with the hypotheses of either a direct zoonotic transmission or transmission via an intermediate animal host.

• Introduction through the cold/food chain

• The joint team’s assessment is that “introduction through cold/ food chain products is considered a possible pathway.” Although such a pathway is theoretically possible, the evidence presented in the report does not suggest that it is, in reality, an actual pathway.

• Currently, there are no data to support the hypothesis that the introduction came through foodborne transmission; therefore, it is not likely that the introduction came through foodborne transmission. However, this route of transmission cannot be excluded either at the moment.

• Not only is infection via frozen food items considered low likelihood, for this to be the source of the original Wuhan infections, there would need to be a high level of SARSCoV- 2 infection in another community for food products to carry enough virus to provide an infectious dose. It seems unlikely that such a high rate of infection in any other city or country would have been missed.

• This section included discussion of environmental sampling and description of vendors at the Huanan market, a description of the supply chain for and sampling of animals at the market (in Jan – March, 2020), domestic animal testing, and further testing of livestock and captive wildlife for SARS-CoV-2. It also includes discussion of what is termed the “study on cold-chain products”. However, it does not appear to be a well-designed study, but rather some opportunistic surveillance; the sampling design and any rationale for it is not discussed.

• They present data from China that indicate that some imported cold-chain samples have tested positive and that some workers at import facilities had Covid-19 which demonstrates an association, but not causality.

• Furthermore, they do not provide any details about the analytical methods or provide any details of the handling of the product before it was sampled to control for potential contamination within China. Note that from our understanding the imported products are sampled at a special warehouse that the products are moved to after they clear Chinese customs and many of the positives were from samples collected on the outside packaging, leaving opportunity for contamination from workers to have occurred.

• Lastly, they do not discuss the false positive rate of the tests used (or provide data on the performance of positive and negative controls). Note that we heard at one point, only about 40 samples of imported cold-chain product out of about 1.5 million samples tested positive (or < 0.003%).

• The report does not discuss the temporal relationship between tests and cases or any potential confounding factors (e.g., person-to-person spread, or transfer of RNA from already infected, asymptomatic cases to the packaging), which are key considerations for drawing conclusions about causality rather than associations.

• Documented evidence or peer-reviewed scientific publications are needed to support these statements.

• This paragraph points to the potential for other exposures besides cold-chain seafood.

• The report focuses a great deal on the exterior packaging of frozen products. More information is needed about the potential for the shipping container itself to serve as the point of contamination. More information is needed to document the traceability of particular shipping containers. Consideration needs to be given to the point at which the shipping container may have become contaminated, such as when it was in a shipping yard in China.

• This is noteworthy, as there is a recommendation to conduct further testing of stored product. It is also interesting that no domestic products were sampled and tested.

• There is no further information about these “index cases” and how they were evaluated for other exposures.

• This supports the argument against this theory and is the same conclusion many other countries, including the United States has reached.

• USG Position:

• Although it might be theoretically possible that the cold-chain could be involved in transmission of CoV-2, there is no credible evidence presented in the report to support that it actually occurred. If contaminated food entered markets such as the Huanan Market, one would likely have to assume that clusters/outbreaks would have occurred in another location, which has not yet been detected.

• Introduction through a laboratory incident

• The main report does not describe sufficient investigation into a potential laboratory incident, and there are no data presented in the report on this scenario. In the Annex, there are short visits described to Hubei CDC, Wuhan CDC and Wuhan Institute of Virology (WIV), though there is limited discussion of potential laboratory accidents or examination of records to dismiss the possibility. Possibilities for a lab-associated origin could include: direct infection of a laboratory worker; infection of a field worker collecting animal specimens; or improper disposal of an infected animal from a laboratory resulting in a human being infected.

• The report reveals that WIV leadership said none of the staff tested positive for the virus or antibodies to the virus, however there were few details provided on employee health monitoring, dates of antibody and PCR screening, and numbers of lab members tested on those dates.

• Data presented regarding laboratory visits by the team to investigate possible sources of the outbreak also does not include adequate data to examine possible exposure by laboratory workers in the field while sampling bats or other animals, which could have led to the first case.

• USG Position:

There was minimal investigation into this possibility. The assessment of this hypothesis being extremely unlikely is justified based on the narratives provided by the labs, however one should not give the impression that this is based on data derived from a forensic investigation of the laboratory.

Recommendations for Next Steps

The lack of definitive conclusions in the report is not surprising given the mandate of the team and the circumstances in interacting with the Chinese colleagues and the difficulty tracing the origins of emerging infectious diseases.

On a positive note, the report summarizes a tremendous amount of data (published or unpublished) and provides reasonable and justified recommendations for second-phase investigations. It also lays out many deficiencies as well as needs for future investigations. Finally, it provides two likely (not surprising) scenarios for the emergence of SARS-CoV-2 in the human population. Future investigations should be more timely and better prepared with direct involvement of the team leading the investigation and countries/laboratories performing it. On a negative note, the report does not exclude any of the four scenarios or provide support for any scenario beyond what was known previously. There was no direct investigation into the scenario of a laboratory incident – something that the investigation was not set up to allow. One could view the report as a decent start into a second-phase investigation. Future studies need to focus on broader searching for virus hosts (e.g., expanding animals sampled), more coherent hypothesis testing, and specific targeted questions that refine details about the origins of the virus/outbreak. Every recommendation for Phase 2 work should specify joint review to ensure the WHO team has access to data it needs to conduct thorough analyses.

Identifying the source of an epidemic/pandemic is not an easy task and success is not a given. The biggest lesson learned from the investigation/report is that transparency and real-time information/data sharing is key in the fight against infectious disease events of global dimension. It is also important to acknowledge that trying to do these "origin" studies after outbreaks/ epidemics/ pandemics start is never going to be easy. For many outbreaks, the source and spillover mechanism were not conclusively identified during or after the outbreaks, or the understanding of the origins came many years later. We must understand that expanded efforts to understand new pathogens and where they come from before there are widespread outbreaks is needed. Otherwise, we will continue to do the same thing over and over again—that is, wait until after outbreaks start while hoping for better results on sources of the pathogens.

Origins Review USG Expert Group
Mara Burr, JD, LLM
Director, Multilateral Relations
Office of Global Affairs
US Department of Health and Human Services
Mara.Burr@hhs.gov
Ray Arthur, PhD


An internal U.S. government analysis of the mission’s report, obtained by Vanity Fair, found it to be inaccurate and even contradictory, with some sections undermining conclusions made elsewhere and others relying on reference papers that had been withdrawn. Regarding the four possible origins, the analysis stated, the report “does not include a description of how these hypotheses were generated, would be tested, or how a decision would be made between them to decide that one is more likely than another.” It added that a possible laboratory incident received only a “cursory” look, and the “evidence presented seems insufficient to deem the hypothesis ‘extremely unlikely.’

The report’s most surprising critic was the WHO’s director himself, Dr. Tedros Adhanom Ghebreyesus of Ethiopia. With the credibility of the World Health Organization on the line, he appeared to acknowledge the report’s shortcomings at a press event the day of its release. “As far as WHO is concerned all hypotheses remain on the table,” he said. “We have not yet found the source of the virus, and we must continue to follow the science and leave no stone unturned as we do.”

His statement reflected “monumental courage,” said Metzl. “Tedros risked his entire career to defend the integrity of the WHO.” (The WHO declined to make Tedros available for an interview.)

By then, an international coalition of roughly two dozen scientists, among them DRASTIC researcher Gilles Demaneuf and EcoHealth critic Richard Ebright at Rutgers, had found a way around what Metzl described as a “wall of rejections” by scientific journals. With Metzl’s guidance, they began publishing open letters in early March. Their second letter, issued on April 7, condemned the mission report and called for a full investigation into the origin of COVID-19. It was picked up widely by national newspapers.

A growing number of people were demanding to know what exactly had gone on inside the Wuhan Institute of Virology. Were the claims in the State Department’s fact sheet—of sick researchers and secret military research—accurate?

Metzl had managed to question Shi directly a week before the release of the mission report. At a March 23 online lecture by Shi, hosted by Rutgers Medical School, Metzl asked if she had full knowledge of all the research being done at the WIV and all the viruses held there, and if the U.S. government was correct that classified military research had taken place. She responded:

We—our work, our research is open, and we have a lot of international collaboration. And from my knowledge, all our research work is open, is transparency. So, at the beginning of COVID-19, we heard the rumors that it’s claimed in our laboratory we have some project, blah blah, with army, blah blah, these kinds of rumors. But this is not correct because I am the lab’s director and responsible for research activity. I don’t know any kind of research work performed in this lab. This is incorrect information.


A major argument against the lab-leak theory hinged on the presumption that Shi was telling the truth when she said the WIV was not hiding any virus samples that are closer cousins to SARS-CoV-2. In Metzl’s view, if she was lying about the military’s involvement, or anything else, then all bets were off.

XI. Inside the Wuhan Institute of Virology

In January 2019, the Wuhan Institute of Virology issued a press release hailing Shi Zhengli’s “distinguished and pioneering achievement in discovery and characterization of important bat-borne viruses.” The occasion was her election as a fellow of the prestigious American Academy of Microbiology—just the latest milestone in a glittering scientific career. In China, the celebrated “Bat Woman” was easily recognizable from photos showing her in a full-body positive-pressure suit inside the WIV’s BSL-4 lab.

Shi was a fixture at international virology conferences, thanks to her “state-of-the-art” work, said James LeDuc, the longtime director of the BSL-4 Galveston National Laboratory in Texas. At the international meetings he organized, Shi was a regular, along with Ralph Baric from UNC. “She’s a charming person, completely fluent in English and French,” said LeDuc. Sounding almost wistful, he added, “This is how science works. You get everyone together, they share their data, go out and have a beer.”

Shi’s journey to the top of the virology field had begun with treks to remote bat caves in southernmost China. In 2006, she trained at the BSL-4 Jean Merieux-Inserm Laboratory in Lyon, France. She was named director of the WIV’s Center for Emerging Infectious Diseases in 2011, and its BSL-3 lab director in 2013.

It’s hard to think of anyone, anywhere, who was better prepared to meet the challenge of COVID-19. On December 30, 2019, at around 7 p.m., Shi received a call from her boss, the director of the Wuhan Institute of Virology, according to an account she gave to Scientific American. He wanted her to investigate several cases of patients hospitalized with a mysterious pneumonia: “Drop whatever you are doing and deal with it now.”

The next day, by analyzing seven patient samples, her team became one of the first to sequence and identify the ailment as a novel SARS-related coronavirus. By January 21, she had been appointed to lead the Hubei Province COVID-19 Emergency Scientific Research Expert Group. At a terrifying moment, in a country that exalted its scientists, she had reached a pinnacle.

But her ascent came at a cost. There is reason to believe she was hardly free to speak her mind or follow a scientific path that didn’t conform to China’s party line. Though Shi had planned to share isolated samples of the virus with her friend James LeDuc in Galveston, Beijing officials blocked her. And by mid-January, a team of military scientists led by China’s top virologist and biochemical expert, Major General Chen Wei, had set up operations inside the WIV.

Under scrutiny from governments including her own, with bizarre conspiracy theories and legitimate doubts swirling around her, she began lashing out at critics. “The 2019 novel coronavirus is a punishment from nature for humanity’s uncivilized habits,” she wrote in a February 2 post on WeChat, a popular social media app in China. “I, Shi Zhengli, guarantee on my life that it has nothing to do with our lab. May I offer some advice to those people who believe and spread bad media rumors: shut your dirty mouths.”

Though Shi has portrayed the WIV as a transparent hub of international research beset by false allegations, the State Department’s January fact sheet painted a different picture: of a facility conducting classified military research, and hiding it, which Shi adamantly denies. But a former national security official who reviewed U.S. classified materials told Vanity Fair that inside the WIV, military and civilian researchers are “doing animal research in the same fricking space.”

While that, in and of itself, does not prove a lab leak, Shi’s alleged lies about it are “absolutely material,” said a former State Department official. “It speaks to the honesty and credibility of the WIV that they kept this secret…. You have a web of lies, coercion, and disinformation that is killing people.”

Vanity Fair sent Shi Zhengli and the director of the Wuhan Institute of Virology detailed questions. Neither responded to multiple requests for comment by email and phone.

As officials at the NSC tracked collaborations between the WIV and military scientists—which stretch back 20 years, with 51 coauthored papers—they also took note of a book flagged by a college student in Hong Kong. Written by a team of 18 authors and editors, 11 of whom worked at China’s Air Force Medical University, the book, Unnatural Origin of SARS and New Species of Man-Made Viruses as Genetic Bioweapons, explores issues surrounding the development of bioweapons capabilities.

Claiming that terrorists using gene editing had created SARS-CoV-1 as a bioweapon, the book contained some alarming practical trade craft: “Bioweapon aerosol attacks are best conducted during dawn, dusk, night or cloudy weather because ultraviolet rays can damage the pathogens.” And it cited collateral benefits, noting that a sudden surge of hospitalizations could cause a healthcare system to collapse. One of the book’s editors has collaborated on 12 scientific papers with researchers at the WIV.


Image
University of North Carolina virologist Ralph Baric collaborated with Shi Zhengli on a gain-of-function coronavirus experiment in 2015. In February 2020, he privately expressed support for Peter Daszak’s Lancet statement dismissing the lab-leak theory. More recently, he signed a letter calling for a transparent investigation of all hypotheses. BY CHRISTOPHER JANARO /BLOOMBERG /GETTY IMAGES.

The book’s dramatic rhetoric could have been hype by Chinese military researchers trying to sell books, or a pitch to the People’s Liberation Army for funding to launch a biowarfare program. When a reporter with the Rupert Murdoch–owned newspaper The Australian published details from the book under the headline “Chinese Held Talks on Bioweapons Benefits,” the Global Times, a Chinese state-owned media outlet, ridiculed the article, noting that the book was for sale on Amazon.

Image
No results for "The Unnatural Origin of Sars and New Species of Man-Made Viruses as Genetic Bioweapons" in Books
Search: 8/24/21 at Amazon.com


BEIJING: Chinese military scientists allegedly investigated weaponising coronaviruses five years before the COVID-19 pandemic and may have predicted a World War III fought with biological weapons, according to media reports referring to documents obtained by the US State Department.

According to 'The Sun' newspaper in the UK, quoting reports first released by 'The Australian', the "bombshell" documents obtained by the US State Department reportedly show the Chinese People's Liberation Army (PLA) commanders making the sinister prediction.


US officials allegedly obtained the papers which were written by military scientists and senior Chinese public health officials in 2015 as part of their own investigation into the origins of COVID-19.

Chinese scientists described SARS coronaviruses, of which COVID is one example, as presenting a "new era of genetic weapons".

Coronaviruses are a large family of viruses, several of which cause respiratory diseases in humans – ranging from a common cold to Severe Acute Respiratory Syndrome (SARS).

The PLA papers referenced seem to fantasise that a bioweapon attack could cause the "enemy's medical system to collapse".

It references work by US Air Force colonel Michael J. Ainscough, who predicted World War III may be fought with bioweapons.

The paper also includes musing that SARS "which hit China in 2003" could have been a man-made bioweapon deliberately unleashed by "terrorists".

They reportedly boasted the viruses could be "artificially manipulated into an emerging human disease virus, then weaponised and unleashed in a way never seen before".


The document lists some of China's top public health figures among the authors and has been revealed in an upcoming book on the origins of COVID, titled 'What Really Happened In Wuhan'.

China reported the first COVID-19 case in the central Chinese city of Wuhan in late 2019 and since then the deadly disease has become a pandemic, affecting more than 157,789,300 people and causing over 3,285,200 deaths worldwide.

Tom Tugendhat MP and Australian politician James Paterson said the document raises major concerns about China's transparency on the origins of COVID-19.

Tugendhat, chairman of the House of Commons Foreign Affairs Select Committee, was quoted in ‘The Sun' as saying: "China's evident interest in bioweapons is extremely concerning.

Even under the tightest controls these weapons are dangerous.

"This document raises major concerns about the ambitions of some of those who advise the top party leadership."

Peter Jennings, the executive director of the Australian Strategic Policy Institute (ASPI), told news. com. au that the document is as close to a "smoking gun" as we've got.


"I think this is significant because it clearly shows that Chinese scientists were thinking about military application for different strains of the coronavirus and thinking about how it could be deployed," said Jennings.


"It begins to firm up the possibility that what we have here is the accidental release of a pathogen for military use," added Jennings.

He also said that the document may explain why China has been so reluctant for outside investigations into the origins of COVID-19.

"If this was a case of transmission from a wet market it would be in China's interest to co-operate, we've had the opposite of that."

Among the 18 listed authors of the document are People's Liberation Army scientists and weapons experts.

Robert Potter, a cyber security specialist who analyses leaked Chinese government documents was asked by The Australian to verify the paper.

He says the document definitely is not fake.

"We reached a high confidence conclusion that it was genuine. It's not fake but it's up to someone else to interpret how serious it is," Potter told news. com.au.


"It emerged in the last few years, they (China) will almost certainly try to remove it now it's been covered."

Questions remain over the origins of the deadly virus after a much derided World Health Organisation (WHO) probe earlier this year, with the organisation ordering a further investigation which factors in the possibly of a lab leak.

Most scientists have said there is no evidence that COVID-19 is manmade, but questions remain whether it may have escaped from a secretive biolab in Wuhan, from where the pandemic originated.

China is known to have been carrying out high risk "gain of function" research at the Wuhan Institute of Virology (WIV), which is near the outbreak's ground zero at the Huanan Seafood Market.

There is no evidence so far to suggest it was intentionally released by China.

Meanwhile, in Beijing, the state-run Global Times newspaper slammed The Australian for publishing the article to smear China.

An academic book that explores bioterrorism and possibilities of viruses being used in warfare was interpreted as a conspiracy theory by The Australian, which deliberately and malignantly intends to invent pretexts to smear China, Chen Hong, a professor and director of the Australian Studies Center at East China Normal University, told the newspaper.

"It is a shame for anti-China forces in Australia to back their own ideology against China at the expense of basic professional journalistic ethics, conspiring to twist the real meaning of the book," Chen said.


-- Chinese scientists discussed weaponising coronavirus in 2015: A paper titled The Unnatural Origin of SARS and New Species of Man-Made Viruses as Genetic Bioweapons suggested that World War Three would be fought with biological weapons, by The New Indian Express, 5/10/21


The inflammatory idea of SARS-CoV-2-as-bioweapon has gained traction as an alt-right conspiracy theory, but civilian research under Shi’s supervision that has yet to be made public raises more realistic concerns. Shi’s own comments to a science journal, and grant information available on a Chinese government database, suggest that in the past three years her team has tested two novel but undisclosed bat coronaviruses on humanized mice, to gauge their infectiousness.

In April 2021, in an editorial in the journal Infectious Diseases & Immunity, Shi resorted to a familiar tactic to contain the cloud of suspicion enveloping her: She invoked scientific consensus, just as the Lancet statement had. “The scientific community strongly dismisses these unproven and misleading speculations and generally accepts that SARS-CoV-2 has a natural origin and was selected either in an animal host before zoonotic transfer, or in humans following zoonotic transfer,” she wrote.


But Shi’s editorial had no muzzling effect. On May 14, in a statement published in Science Magazine, 18 prominent scientists called for a “transparent, objective” investigation into COVID-19’s origins, noting, “We must take hypotheses about both natural and laboratory spillovers seriously until we have sufficient data.”

Among the signers was Ralph Baric. Fifteen months earlier, he had worked behind the scenes to help Peter Daszak stage-manage the Lancet statement. The scientific consensus had been smashed to smithereens.


XII. Out of the Shadows

By spring of 2021, the debate over COVID-19’s origins had become so noxious that death threats were flying in both directions.

In a CNN interview on March 26, Dr. Redfield, the former CDC director under Trump, made a candid admission: “I am of the point of view that I still think the most likely etiology of this pathogen in Wuhan was from a laboratory, you know, escaped.” Redfield added that he believed the release was an accident, not an intentional act. In his view, nothing that happened since his first calls with Dr. Gao changed a simple fact: The WIV needed to be ruled out as a source, and it hadn’t been.

After the interview aired, death threats flooded his inbox. The vitriol came not just from strangers who thought he was being racially insensitive but also from prominent scientists, some of whom used to be his friends. One said he should just “wither and die.”

Peter Daszak was getting death threats too, some from QAnon conspirators.

Inside the U.S. government, meanwhile, the lab-leak hypothesis had survived the transition from Trump to Biden. On April 15, Director of National Intelligence Avril Haines told the House Intelligence Committee that two “plausible theories” were being weighed: a lab accident or natural emergence.

Even so, lab-leak talk was mostly confined to right-wing news outlets through April, gleefully flogged by Tucker Carlson and studiously avoided by most of the mainstream media. In Congress, the Energy and Commerce Committee’s Republican minority had launched its own inquiry, but there was little buy-in from Democrats and the NIH didn’t provide responses to its lengthy list of demands for information.

The ground began to shift on May 2, when Nicholas Wade
, a former New York Times science writer known in part for writing a controversial book about how genes shape the social behavior of different races, published a lengthy essay on Medium. In it, he analyzed the scientific clues both for and against a lab leak, and excoriated the media for its failure to report on the dueling hypotheses. Wade devoted a full section to the “furin cleavage site,” a distinctive segment of SARS-CoV-2’s genetic code that makes the virus more infectious by allowing it to efficiently enter human cells.
Image
“When I first saw the furin cleavage site in the viral sequence, with its arginine codons, I said to my wife it was the smoking gun for the origin of the virus,” said David Baltimore, an eminent virologist and former president of CalTech. “These features make a powerful challenge to the idea of a natural origin for SARS2,” he said.

-- The origin of COVID: Did people or nature open Pandora’s box at Wuhan?, by Nicholas Wade

Within the scientific community, one thing leapt off the page. Wade quoted one of the world’s most famous microbiologists, Dr. David Baltimore, saying that he believed the furin cleavage site “was the smoking gun for the origin of the virus.” Baltimore, a Nobel Laureate and pioneer in molecular biology, was about as far from Steve Bannon and the conspiracy theorists as it was possible to get. His judgment, that the furin cleavage site raised the prospect of gene manipulation, had to be taken seriously.

With questions growing, NIH director Dr. Francis Collins released a statement on May 19 asserting that “neither NIH nor NIAID have ever approved any grant that would have supported ‘gain-of-function’ research on coronaviruses that would have increased their transmissibility or lethality for humans.”

On May 24, the WHO’s decision-making body, the World Health Assembly, kicked off a virtual edition of its annual conference. In the weeks leading up to it, a parade of high-profile stories broke, including two front-page reports in The Wall Street Journal and a long Medium post from a second former New York Times science reporter. Not surprisingly, China’s government fired back during the conference, saying that it would not participate in further inquiries within its borders.

On May 28, two days after President Biden announced his 90-day intelligence review, the U.S. Senate passed a unanimous resolution, which Jamie Metzl had helped shape, calling on the World Health Organization to launch a comprehensive investigation into the origins of the virus.

Will we ever know the truth? Dr. David Relman of Stanford University School of Medicine has been advocating for an investigation like the 9/11 Commission to examine COVID-19’s origins. But 9/11 took place in one day, he said, whereas “this has so many different manifestations, consequences, responses across nations. All of that makes it a hundred-dimensional problem.”

The bigger problem is that so much time has gone by. “With every passing day and week, the kinds of information that might prove helpful will have a tendency to dissipate and disappear,” he said. “The world ages and things get moved, and biological signals degrade.”

China obviously bears responsibility for stonewalling investigators. Whether it did so out of sheer authoritarian habit or because it had a lab leak to hide is, and may always be, unknown.

The United States deserves a healthy share of blame as well. Thanks to their unprecedented track record of mendacity and race-baiting, Trump and his allies had less than zero credibility. And the practice of funding risky research via cutouts like EcoHealth Alliance enmeshed leading virologists in conflicts of interest at the exact moment their expertise was most desperately needed.

Now, at least, there appears to be the prospect of a level inquiry—the kind Gilles Demaneuf and Jamie Metzl had wanted from the start. “We needed to create a space where all of the hypotheses could be considered,” Metzl said.

If the lab-leak explanation proves accurate, history may credit Demaneuf and his fellow doubters for breaking the dam—not that they have any intention of stopping. They are now knee-deep in examining the WIV’s construction orders, sewage output, and cell phone traffic. The thought driving Paris Group cofounder Virginie Courtier forward is simple: “There are unanswered questions,” she says, “and a few human beings know the answers.”

Additional reporting by Lili Pike, with research assistance from Stan Friedman.

Re: U.S. government gave $3.7 million grant to Wuhan lab at

PostPosted: Tue Aug 17, 2021 11:13 am
by admin
Fight Over Covid’s Origins Renews Debate on Risks of Lab Work
by Carl Zimmer and James Gorman
New York Times
June 20, 2021

At a Senate hearing on efforts to combat Covid-19 last month, Senator Rand Paul of Kentucky asked Dr. Anthony S. Fauci whether the National Institutes of Health had funded “gain-of-function” research on coronaviruses in China.

“Gain-of-function research, as you know, is juicing up naturally occurring animal viruses to infect humans,” the senator said.

Dr. Fauci, the nation’s top infectious disease expert, flatly rejected the claim: “Senator Paul, with all due respect, you are entirely and completely incorrect, that the N.I.H. has not ever and does not now fund gain-of-function research in the Wuhan Institute.”

This exchange, and the bit of scientific jargon at the heart of it, has gained traction in recent weeks, usually by people suggesting that the coronavirus was engineered, rather than having jumped from animals to humans, the explanation favored by most experts on coronaviruses. The uproar has also drawn attention back to a decade-long debate among scientists over whether certain gain-of-function research is too risky to allow.

Spurred by some contested bird flu experiments in 2012, the U.S. government adjusted its policies for oversight of certain types of pathogen studies. But some critics in the scientific community say that the policy is overly restrictive and that its enforcement has been far from transparent.

The stakes of the debate could not be higher. Too little research on emerging viruses will leave us unprepared for future pandemics. But too little attention to the safety risks will increase the chances that an experimental pathogen may escape a lab through an accident and cause an outbreak of its own.

Sorting out the balance of risks and benefits of the research has proved over the years to be immensely challenging. And now, the intensity of the politics and rhetoric over the lab leak theory threatens to push detailed science policy discussions to the sidelines.

“It’s just going to make it harder to get back to a serious debate,” said Marc Lipsitch, an epidemiologist at the Harvard T.H. Chan School of Public Health who has urged the government to be more transparent about its support of gain-of-function research.

read the rest of the nyt article ...

Re: U.S. government gave $3.7 million grant to Wuhan lab at

PostPosted: Tue Aug 17, 2021 11:30 am
by admin
Part 1 of 4

The Origins of COVID-19: An Investigation of the Wuhan Institute of Virology
by House Foreign Affairs Committee
Lead Republican Michael T. McCaul
Report Minority Staff
One Hundred Seventeenth Congress
August 2021

The National Institutes of Health (NIH) today [December 19, 2017] lifted a 3-year moratorium on funding gain-of-function (GOF) research on potential pandemic viruses such as avian flu, SARS, and MERS, opening the door for certain types of research to resume.

Donald Trump's tenure as the 45th president of the United States began with his inauguration on January 20, 2017 and ended on January 20, 2021.

-- Presidency of Donald Trump, by Wikipedia

“The Godfather of [gain-of-function virology research], the head of the pyramid, is a guy you may have heard of called Anthony Fauci,” Rogin said. “So, Anthony Fauci, the hero of the pandemic, is the most important person in the world of gain-of-function research there is . . . Basically, he is the one disbursing all the grants for this, he is the one who pushed to turn it back on after Obama turned it off, that’s another crazy story, he turned it back on without really consulting the White House.”

“He consulted the Office of Science and Technology Policy, which is part of the White House, but the White House put a pause on it and he undid the pause,” Rogin continued. “The details are a little sketchy. I’m not saying he did anything necessarily wrong or illegal, but I’m saying that a lot of people that I know inside the Trump administration had no idea that he had turned this back on. He found a way to turn it back on in the mess of the Trump administration because the Trump administration is full of a bunch of clowns, so you could get things done if you knew how to work the system.”

As Rogin himself admits, “the details are a little sketchy,” and we’ll have to take a look at the sourcing included in whatever article this piece of news appears in before alleging any wrongdoing.


-- Fauci Reportedly Relaunched NIH Gain-of-Function Research without Consulting White House, by Jack Crowe, National Review, April 27, 2021

The action coincides with today's release of a US Department of Health and Human Services (HHS) framework for guiding funding decisions about proposed research involving pathogens that have enhanced potential for creating pandemics.

Experts involved in the discussions welcomed the development, but some said the new framework still leaves key unanswered questions, such as how to responsibly report findings from the funded lab work in medical journals. Meanwhile, in research labs, some scientists plan to resume experiments and are relieved the pause has ended. Both groups are eager to see how the new review process works in real life.

In a statement today, NIH Director Francis Collins, MD, PhD, said "We have a responsibility to ensure that research with infectious agents is conducted responsibly, and that we consider the potential biosafety and biosecurity risks associated with such research." He added that he is confident that the review process spelled out in the new framework "will help to facilitate the safe, secure, and responsible conduct of this type of research in a manner that maximizes the benefits to public health."...

In light of controversial research on H5N1 viruses in 2012, the Obama administration in 2014 announced a pause of federally funded GOF research and asked a government advisory group to reevaluate federal GOF funding policies and put together recommendations to help officials make their decisions.

The expert group, called the National Science Advisory Board for Biosecurity (NSABB), commissioned a 1,000-page risk-benefit assessment to help them make their final guidance
, which they finalized in June 2016, along with an ethics white paper. As part of the process, the NSABB held two National Academies symposia on GOF issues....

The framework, condensed into a 6-page document, spells out a multidisciplinary review process that involved the funding agency and a department-level review group that considers the merits and possible research benefits and the potential to create, transfer, or use an enhanced potential pandemic pathogen (PPP). In January in the final days of the Obama administration, the White House Office of Science and Technology Policy (OSTP) released guidance the departments can use to follow through with the reviews.

There are eight criteria in the framework for guiding HHS funding decisions, which stipulate, for example, that the research has been evaluated by an independent expert review as scientifically sound, that the potential risks and benefits are justified, that there are no other equally effective but less risky options for answering the research question, and that the research team and facility have the capacity to do the work safety and securely and to respond rapidly if there are any accidents, protocol lapses, or security breaches.

Regarding issues surrounding publication, the criterion says that the research results are expected to be responsibly communicated, based on applicable laws, regulations, and policies, along with terms and conditions of funding.

Also, the framework stipulates that the work will be done with the support of funding mechanisms that allow appropriate risk management and ongoing institution and federal oversight of the research. And finally, the criteria state that the research must be ethically justifiable...

Marc Lipsitch, PhD, professor of epidemiology and director of the Center for Communicable Disease Dynamics at the Harvard T.H. Chan School of Public Health, has been deeply involved in the GOF discussions and has argued for a much more rigorous approach for evaluating the experiments. He has pushed for experts to consider safer ways to assess potential pandemic virus threats and for an international approach to tackling the issues.

"My overall take is that this is a small step forward," he said, adding that it includes a department-level review of the most concerning types of research, which have been defined appropriately after extensive time and debate. "The question is how such reviews will play out in practice."

However, Lipsitch said one problem is that the guidance specifies that research groups that propose work with enhanced pathogens will need to convince reviewers that there is no feasible, equally effective alternative way of addressing the scientific question with a less risky approach.

"If this means no alternative to answer with certainty the question of whether a specific strain that occurs in nature can very easily evolve to acquire a ferret-transmissible phenotype, then this criterion will always be satisfied," he said. "This is a scientific question that can uniquely be answered with dangerous experiments, and cannot be answered safely. But it is not a very useful one, because every strain in nature is different."

Michael Osterholm, PhD, MPH, who was a member of the NSABB during the controversy over the H5N1 papers, said he believes the GOF work can be done safely, but he doesn't agree that scientists doing the federally funded work should be unfettered.

Osterholm said his main concern regards the public health implications of the publicly available details about how the work is communicated, which the new framework doesn't spell out. "How we detail that information needs to be considered," such as more finely specifying when findings are open to the general public, when they're disseminated on a "need to know" basis, and when the information is classified.

"Until we have that part solved, I'm concerned about the work being done," he said.

Osterholm, director of the University of Minnesota's Center for Infectious Disease Research and Policy, which publishes CIDRAP News, added that some research is needed to answer key questions, such as what it would take for Ebola to become a respiratory virus, findings that would have implications for preparedness. "If it were the case, I don't want the public to have a blueprint on how to do it," he said.

Tom Inglesby, MD, director and chief executive officer at the Center for Health Security at Johns Hopkins Bloomberg School of Public Health, has also been deeply involved in discussions about issues related to the research pause. He said the requirements for the multidisciplinary, department-level pre-funding review and the involvement of the White House OSTP are excellent.

He added that the emphasis on enhanced potential pandemic pathogens is correct and focuses the framework on where it should be, such as on harmful consequences, immunity disruption, conferred resistance, and reconstructed extinct pathogens. "Though for the policy to be successful it needs to, at a minimum, be able to oversee the creation of novel strains that may be highly transmissible and highly virulent and should probably focus on that most intently to start."

A potentially serious weakness of the new framework is that surveillance activities involving potential pandemic pathogens (PPPs), including sampling and sequencing, aren't considered to be enhanced PPPs and would be exempt from reviews, Inglesby said, adding that surveillance as a rationale doesn't change potential risks of novel PPP strains. "There are serious debates about whether specific enhanced PPP projects are materially useful to on-the-ground surveillance programs," he said.

Inglesby's other concerns revolve around the lack of hard details of how the experiment reviews will work, such as the process for weighing the risks and benefits and the criteria for judging if researchers and institutions have the capacity to do the work safely. "I would have liked to see if this framework was working as intended before the moratorium was ended," he said, suggesting that agencies funding the work publish their experiences using the new framework to show how it functions.

-- Feds lift gain-of-function research pause, offer guidance, by Lisa Schnirring, December 19, 2017


Image

TABLE OF CONTENTS: [PDF HERE]

• INTRODUCTION TO ADDENDUM TO THE FINAL REPORT
• EXECUTIVE SUMMARY
• GLOSSARY OF TERMS
• KEY PEOPLE
• ADDENDUM TO THE FINAL REPORT
o I. The City of Wuhan: Epicenter of a Pandemic
o II. Evidence of a Lab Leak
o III. Evidence of Genetic Modification
o IV. Evidence of a Lab Leak Cover-Up
o V. Hypothesis: A Lab Leak That Caused a Pandemic
o VI. Recommendations
o VII. Conclusion
o VIII. Appendix
• Timeline of the WIV Lab Leak and the Start of the COVID-19 Pandemic
• China Center for Disease and Control Memo on Supplementary Regulations
• JPCM Confidential Notice on the Standardization of the Management of Publication of Novel Coronavirus Pneumonia Scientific Research
• February 6, 2020, Email at 12:43am from Peter Daszak to Ralph Baric, Linfa Wang, and Others Inviting Them to Sign the Statement
• February 6, 2020, Email at 3:16pm from Peter Daszak to Ralph Baric Relaying Wang’s Request Not to Sign the Statement
• February 8, 2020, Email at 8:52pm from Peter Daszak to Rita Colwell Alleging WIV Researchers Requested the Statement

Introduction

Five hundred and four days ago, on March 16, 2020, Committee Minority Staff began its investigation into the origins of SARS-CoV-2 and the COVID-19 global pandemic at the direction of Ranking Member Michael T. McCaul. The House Foreign Affairs Committee Minority Staff Final Report on The Origins of the COVID-19 Global Pandemic, Including the Roles of the Chinese Communist Party and the World Health Organization was published in late September 2020. At the time of its release, there were an estimated 30.8 million cases of COVID-19 around the world, and a death toll of approximately 958,000. Today, the cumulative count stands at more than 196.4 million cases and 4,194,061 dead.

The House Foreign Affairs Committee Minority Staff has continued to investigate the origins of COVID-19, examining new information as it became available, including through expert testimony. We have done so because approximately 48 million of our population are under the age of 12 and without access to a vaccination, while others remain unvaccinated due to underlying medical conditions, leaving a large portion of American citizens at risk of infection. We prepared this addendum as reports increase regarding various strains around the globe, and as PRC authorities continue to withhold critical information about the early months of the pandemic. We have strongly urged our Majority colleagues to take this investigation seriously and conduct a full bipartisan investigation into the origins of COVID-19, and will continue to do so. President Biden has said he wants to discover how the pandemic began, and it is our duty to the American people to use all the tools in our arsenal in pursuit of that goal. As always, we stand ready to address this and other foreign policy challenges together and in a bipartisan manner. We must not let up on pressing General Secretary Xi and CCP authorities for answers.

Here we share the result of these efforts in an addendum to our September 2020 Final Report. In particular, this update focuses on whether the virus may have leaked from a medical research laboratory in Wuhan, Hubei Province, PRC, and the efforts to conceal such a leak. The evidence used to inform this report is based upon open source information and includes published academic work, official PRC publications (both public and confidential), interviews, emails, and social media postings.

Since the publication of the September 21, 2020 Final Report new questions have been raised pertaining to the origins of COVID-19. The PRC’s continued lack of transparency resulted in President Joseph R. Biden, Jr.’s May 26, 2021, order to the United States Intelligence Community to prepare a report in 90 days on the origins of COVID-19, “including whether it emerged from human contact with an infected animal or from a laboratory accident.”1 [“Statement by President Joe Biden on the Investigation into the Origins of COVID-19.” The White House, 26 May 2021, http://www.whitehouse.gov/briefing-room ... -covid-19/.]

Based on the material collected and analyzed by the Committee Minority Staff, the preponderance of evidence suggests SARS-CoV-2 was accidentally released from a Wuhan Institute of Virology laboratory sometime prior to September 12, 2019. The virus, or the viral sequence that was genetically manipulated, was likely collected in a cave in Yunnan province, PRC, between 2012 and 2015. Researchers at the WIV, officials within the CCP, and potentially American citizens directly engaged in efforts to obfuscate information related to the origins of the virus and to suppress public debate of a possible lab leak.
It is incumbent on these parties to respond to the issues raised herein and provide clarity and any exonerating evidence as soon as possible. Until that time, it must be assumed General Secretary Xi and the Chinese Communist Party, prioritizes preserving the Party over the lives of its own people and those around the global suffering the effects of the COVID-19 pandemic.

Executive Summary

More than one year after the World Health Organization declared a pandemic, the world is still reeling from the emergence of the SARS-CoV-2 virus and the disease it causes, COVID-19. More than four million people have lost their lives worldwide, including more than 612,000 Americans, while economies around the world have been devastated by the fallout. This report investigates the origin of this virus and looks at how it became a deadly pandemic.

The Wuhan Institute of Virology

Last September, the House Foreign Affairs Committee Minority Staff, under the direction of Ranking Member Michael T. McCaul, released a report on the origins of the COVID-19 pandemic. That report highlighted the possibility SARS-CoV-2 could have leaked from the Wuhan Institute of Virology (WIV). However, as we continued our investigation and uncovered more information, we now believe it’s time to completely dismiss the wet market as the source of the outbreak. We also believe the preponderance of the evidence proves the virus did leak from the WIV and that it did so sometime before September 12, 2019.

This is based upon multiple pieces of evidence laid out in the report, including:

• The sudden removal of the WIV’s virus and sample database in the middle of the night on September 12, 2019 and without explanation;
• Safety concerns expressed by top PRC scientists in 2019 and unusually scheduled maintenance at the WIV;
• Athletes at the Military World Games held in Wuhan in October 2019 who became sick with symptoms similar to COVID-19 both while in Wuhan and also shortly after returning to their home countries;
• Satellite imagery of Wuhan in September and October 2019 that showed a significant uptick in the number of people at local hospitals surrounding the WIV’s headquarters, coupled with an unusually high number of patients with symptoms similar to COVID-19;
• The installation of a People’s Liberation Army’s bioweapons expert as the head of the WIV’s Biosafety Level 4 lab (BSL-4), possibly as early as late 2019; and
• Actions by the Chinese Communist Party and scientists working at or affiliated with the WIV to hide or coverup the type of research being conducted at there.


Genetic Modification

This report also lays out ample evidence that researchers at the WIV, in conjunction with U.S. scientists and funded by both the PRC government and the U.S. government, were conducting gain-of-function research on coronaviruses at the WIV, at times under BSL-2 conditions. Much of this research was focused on modifying the spike protein of coronaviruses that could not infect humans so they could bind to human immune systems. The stated purpose of this work was to identified viruses with pandemic potential and to create a broad-spectrum coronavirus vaccine. In many instances, the scientists were successful in creating “chimeric viruses” -– or viruses created from the pieces of other viruses –- that could infect human immune systems. With dangerous research like this conducted at safety levels similar to a dentist’s office, a natural or genetically modified virus could have easily escaped the lab and infected the community.

Committee Minority Staff has also identified scientists who are directly tied to the WIV, and who worked on gain-of-function research in the years prior to the start of the current pandemic, who had the ability to modify genetically modify coronaviruses without leaving any trace evidence. An American scientist, Dr. Ralph Baric, assisted in creating a method to leave no trace of genetic modification as early as 2005. And as early as 2016, scientists working at the WIV were able to do the same. This makes it clear that claims by the scientific community that SARS-CoV-2 could not be man-made because it has no genetic modification markers are disingenuous.

We conclude there is ample proof that the virus could have been genetically manipulated, and that it is vitally important we fully investigate this hypothesis to determine if that happened here.

The Cover-Up

In the original report, we laid out many of the ways the Chinese Communist Party (CCP) and the World Health Organization (WHO) went to great lengths to cover up the initial epidemic, and how their cover-up likely turned what could have been a local outbreak into a global pandemic. The CCP detained doctors in order to silence them, and disappeared journalists who attempted to expose the truth. They destroyed lab samples, and hid the fact there was clear evidence of human-to-human transmission. And they still refuse to allow a real investigation into the origins. At the same time, the WHO, under Director General Tedros, failed to warn the world of the impending pandemic. Instead, he parroted CCP talking points, acting as a puppet of General Secretary Xi.

In this addendum, we have uncovered further evidence of how top scientists at the WIV and Dr. Peter Daszak, an American scientist, furthered that cover-up. Their actions include bullying other scientists who questioned whether the virus could have leaked from a lab; misleading the world about how a virus can be modified without leaving a trace; and, in many, instances directly lying about the nature of the research they were conducting, as well as the low-level safety protocols they were using for that research.


These actions not only delayed an initial investigation into the possibility of a lab leak costing valuable time, but provide further proof the virus likely leaked from the WIV. These actions also call into question the way in which U.S. government grants are used in overseas labs and call for more oversight of those grants.

Next Steps

After this extensive investigation, we believe it is time to call Peter Daszak to testify before Congress. There are still many outstanding questions about the type of research he funded at the WIV that only he can answer. In addition, we believe there is legislation Congress can pass that would not only hold those responsible accountable but also help to prevent a future pandemic, including but not limited to:

• Institute a ban on conducting and funding any work that includes gain-of-function research until an international and legally binding standard is set, and only where that standard is verifiably being followed.
• Sanction the Chinese Academy of Sciences and affiliated entities.
• List the Wuhan Institute of Virology and its leadership on the Specially Designated Nationals and Blocked Persons List and apply additional, appropriate secondary sanctions.
• Authorize new sanctions for academic, governmental, and military bioresearch facilities that fail to ensure the appropriate levels of safety and information sharing.


GLOSSARY OF TERMS

Gain-of-Function Research: “Research that improves the ability of a pathogen to cause disease.” – U.S. Department of Health and Human Services

Spike Protein: A protein structure on the surface of an enveloped virus responsible for anchoring the virus to the host cell’s surface and enabling the injection of the virus’ genetic material into the host cell.

RBD: Receptor-Binding Domain. The specific short fragment in a spike protein of a virus that binds the virus to a specific receptor on the host cell.

Primary Author: The first listed author of an academic paper, usually the person who contributes the most to a paper.

Corresponding Author: The point of contact for editors and outside readers who have questions about an academic paper.

USAID Predict: An epidemiological research grant program funded by the United States Agency for International Development. PREDICT provided funding for biological sampling aimed at virus identification and collection. The program provided grant funding to EcoHealth Alliance.

SARS: Severe Acute Respiratory Syndrome. A viral respiratory disease caused by SARS-CoV, a betacoronavirus. First identified as the cause of a 2002-2003 epidemic.

MERS: Middle East Respiratory Syndrome. A viral respiratory disease caused by MERS-CoV, a betacoronavirus. First identified as the cause of a 2012 outbreak.

SARS-CoV-2: The betacoronavirus that causes COVID-19.

Coronavirus: An RNA virus that causes disease in mammals and birds. Range in severity from the common cold to SARS-CoV-2.

Betacoronavirus: One of the four subclassifications of coronaviruses. Found in bats and rodents, this is the genus includes SARS, MERS, and SARS-CoV-2.

Biosafety Level 1 (BSL1): Designed for work on microbes not known to cause disease in healthy adults and present minimal potential hazard to laboratorians and the environment. Work can be performed on an open lab bench or table.

Biosafety Level 2 (BSL2): For work with microbes that pose moderate hazards to laboratorians and the environment. The microbes are typically indigenous and associated with diseases of varying severity. Personal protective equipment includes lab coats and gloves. Work can be performed in the open or in a biological safety cabinet. Commonly compared to the level of safety observed in a dentist’s office.

Bio Safety Level 3 (BSL3): For work with microbes that are either indigenous or exotic, and that can cause serious or potentially lethal disease through respiratory transmission. Respiratory transmission is the inhalation route of exposure. Researchers should be under medical surveillance and potentially immunized for the microbes they work with. Respirators may be required, in addition to standard personal protective equipment. Work must be performed within a biological safety cabinet. Exhaust air cannot be recirculated, and the laboratory must have sustained directional airflow by drawing air into the laboratory from clean areas towards potentially contaminated areas.

Biosafety Level 4 (BSL4): This is the highest level of biological safety. The microbes in a BSL-4 lab are dangerous and exotic, posing a high risk of aerosol-transmitted infections. Infections caused by these microbes are frequently fatal and without treatment or vaccines. Researchers must change clothing prior to entering the lab, shower upon exiting, and decontaminate all materials before exiting. All work with microbes must be performed in a Class III biological safety cabinet or while wearing a full body, air-supplied, positive pressure suit. The lab must be in a separate building or in a restricted zone, and must have a dedicated supply and exhaust air, as well as vacuum lines and decontamination systems.

Wuhan Institute of Virology (WIV): A research institute in Wuhan, PRC focused on focused on virology, that consists of at least two facilities – the Wuhan National Biosafety Laboratory and the Wuhan Institute of Virology Headquarters.”

Wuhan National Biosafety Laboratory: The WIV’s new campus, located in the Zhengdian Scientific Park in Jiangxia District, Wuhan. The location of the WIV’s Biosafety Level 4 laboratory space.

WIV Headquarters: The older WIV facility, located in Wuchang District, Wuhan near the Wuhan Branch of the Chinese Academies of Science.

Chinese Academy of Sciences: The national academy for natural sciences in the PRC. Reports to the State Council of the People’s Republic of China.

WIV1: The first novel coronavirus isolated by WIV researchers. Isolated from bat fecal samples in 2013. A SARS like coronavirus.

WIV16: The second coronavirus isolated by WIV researchers. Isolated from a single bat fecal sample in 2016. A SARS like coronavirus.

Rs4874: The third coronavirus isolated by WIV researchers. Isolated from a single bat fecal sample in 2017. A SARS like coronavirus.

ID4491/RaTG13: A SARS like coronavirus collected in 2013 in a mining cave. 96.1% similar to SARS-CoV-2.

ACE2: Angiotensin-converting enzyme-2, found on the surface of certain cells in a variety of animals, including humans, mice, and civets. The entry point for coronaviruses.

hACE2: The human version of ACE2. Primarily found on the surface of cells and tissues throughout the human body, including the nose, mouth, and lungs. In the lungs, hACE2 is highly abundant on type 2 pneumocytes, an important cell type present in chambers within the lung called alveoli, where oxygen is absorbed, and waste carbon dioxide is released. The primary entry point for SARS-CoV-2 into human cells.

Chimeric Virus: An artificial, man-made virus. Created by joining two or more viral fragments.

Natural Virus: A virus found in nature; “wild type.”

Reverse Genetics System: A method in molecular genetics that is used to help understand the function(s) of a gene by analyzing the phenotypic effects caused by genetically engineering specific nucleic acid sequences within the gene. Can be used to create chimeric viruses indistinguishable from natural viruses.

Furin Cleavage Site: An enzyme in the spike protein of SARS-CoV-2 that increases how infectious the virus is in humans. SARS-CoV-2 is the only betacoronavirus to have this structure.

Phylogenetic Analysis: The study of the evolutionary development of a species or a group of organisms or a particular characteristic of an organism. Used to identify the relationship between different viruses in the same family.

CGG Double Codon: “CGG-CGG.” This group of six nucleotides (a group of three nucleotides is also know as a codon) is half of the 12 nucleotides that create the furin cleavage site. The CGG double codon is relatively rare in coronaviruses, and SARSCoV- 2 is the only coronavirus in its family to have one.

KEY PEOPLE

Dr. Wang Yanyi: Director General of the Wuhan Institute of Virology.

Dr. Yuan Zhiming: Director of the WNBL BSL-4 lab. General Secretary of the Chinese Communist Party Committee within the Wuhan Branch of the Chinese Academy of Sciences, to which the WIV belongs.

Dr. Shi Zheng-li: Senior scientist as the Wuhan Institute of Virology (WIV). Serves as Director, Research Center for Emerging Infectious Diseases; Director, Chinese Academy of Sciences Key Laboratory of Special Pathogens; Director, Biosafety Working Committee; and Deputy Director of the Wuhan National Biosafety Laboratory’s Biosafety-Level 4 lab.

Dr. Ben Hu: WIV researcher and former doctoral student of Shi Zheng-li. Deeply involved in the WIV’s coronavirus research.

Dr. Linfa Wang: PRC national, Director and Professor of the Program in Emerging Infectious Diseases at the Duke-NUS Graduate Medical School in Singapore. Chair of the Scientific Advisory Board for the Center for Emerging Diseases at the WIV.

Dr. Peter Daszak: CEO of EcoHealth Alliance. Longtime collaborator of Shi and others at the WIV. Provided subgrants to the WIV to help fund coronavirus research.

Dr. Ralph Baric: Researcher at the University of North Carolina at Chapel Hill who has collaborated with Shi and other WIV researchers on coronavirus research.

ADDENDUM TO THE REPORT

I. THE CITY OF WUHAN: EPICENTER OF A PANDEMIC


Wuhan is the epicenter of the coronavirus pandemic. Located in central PRC where the Yangtze River, the PRC’s longest river, and the Han River meet, Wuhan is the capital city of Hubei Province and boasts a population of about 11.1 million in about 3,280 square miles. [2] [“WHO-convened Global Study of Origins of SARS-CoV-2: China Part.” Joint WHO-China Study. 30 March 2021, https://www.who.int/health-topics/coron ... -the-virus] It is home to the PRC’s tallest skyscrapers, multiple colleges and universities, including the prominent Wuhan University, major historical and cultural sites, and an influential research laboratory, the Wuhan Institute of Virology (WIV). To put the scale of Wuhan in perspective, the city covers an area five times the size of Houston and has a larger population than New York City and Chicago combined.

Wuhan is home to the Hankou railway station, central PRC’s biggest European-style Railway station, and two other major train stations. Hankou Station connects directly to the Tianhe International Airport, the busiest airport in central PRC and the geographic center of the PRC’s airport network. From the Tianhe airport, travelers can fly direct to New York City, San Francisco, Paris, Milan, Rome, Hamburg, Bangkok, Tokyo, Seoul, and Dubai, among many other destinations around the world.

The PRC calls Wuhan one of its nine “National Central Cities,” an official state label that means it leads the way, along with the capital Beijing, Shanghai, and other major cities, in developing culture, politics, and the economy. [3] [Xu, Zongwei. “China Unveils National Central City Strategy.” China Watch, 29 Mar. 2018, http://www.chinawatch.cn/a/201803/29/WS ... 67c6c.html.] An August 2016 report by the Netherlands Enterprise Agency, a government agency that operates under the auspices of the Ministry of Economic Affairs and Climate Policy, identified Wuhan as a major hub not just within the PRC, but also globally within the Chinese “One Belt One Road” initiative due to its accessibility. [4] [Van de Bovenkamp, Judith and Yuan Fei. “Economic Overview of Hubei Province.” Neatherlands Business Support Office Wuhan, Aug. 2016, https://www.rvo.nl/sites/default/files/ ... -China.pdf] The city is also home to significant railway commerce. A 2018 report from Xinhua news expected an estimated 500 freight trains from Wuhan to Europe for the export of goods. [5] [“Central China-Europe Rail Freight to Surge in 2018.” Xinhua, 1 Feb. 2018. http://www.china.org.cn/china/Off_the_Wire/2018- 02/01/content_50372222.htm]

France, the U.S., the Republic of Korea, and the UK maintain Consulates in the city, which was selected to host the 7th International Military Sports Council (CISM) Military World Games. During the games, more than 9,000 military personnel from over 100 countries stayed in Wuhan in accommodations at an athletes’ village built specifically for the games.

II. EVIDENCE OF A LAB LEAK

As discussed in the previously issued report, the WIV continues to be a focal point of debate concerning the origins of SARS-CoV-2 and the COVID-19 pandemic. In recent months, new information about the WIV has come to light, enabling us to better understand the institute, the type of research conducted by scientists working there, and its ties to the CCP and their military, the People’s Liberation Army (PLA). We now believe the preponderance of evidence shows the virus accidentally leaked from one of the WIV’s facilities.

The Wuhan Institute of Virology

The WIV was founded in 1956 as the Wuhan Microbiology Laboratory and has operated under the administration of the Chinese Academy of Sciences since 1978. [6] [“History.” Wuhan Institute of Virology, http://english.whiov.cas.cn/About_Us2016/History2016/.] The institute currently occupies at least two campuses – the much-discussed Wuhan National Biosafety Laboratory (WNBL) in Zhengdian Scientific Park (see Figure 1), and the older facility (hereafter WIV Headquarters) located in the Xiaohongshan park in the Wuchang District of Wuhan (see Figure 2). The WNBL is a large complex with multiple buildings that house 20 Biosafety Level II (BSL-2) laboratories, two Biosafety Level III (BSL-3) laboratories, and 3000 square meters of Biosafety Level IV (BSL-4) space, “including four independent laboratories areas and two animal suites.” [7] [World Health Organization. “WHO Consultative Meeting on High/Maximum Containment (Biosafety Level 4) Laboratories Networking.” Meeting Report, Lyon, France, 13-15 Dec. 2018. https://apps.who.int/iris/bitstream/han ... HO-WHECPI- 2018.40-eng.pdf] Construction was completed in 2015, but due to delays the BSL-4 space did not become operational until early 2018. [8] [Zhiming, Yuan. “Current status and future challenges of high-level biosafety laboratories in China.” Journal of Biosafety and Biosecurity, 1 Sept. 2019, 1(2): 123-127. https://doi.org/10.1016/j.jobb.2019.09.005]

Image
Fig. 1: Wuhan National Biosafety Laboratory (WNBL)

Missing from the majority of public debates regarding the WIV is the research conducted at the WIV Headquarters, the older location in the Wuchang District of Wuhan. Located 12 miles northeast of the WNBL, in the Wuchang District, this facility remains the administrative headquarters of the WIV. In addition to the BSL-2 labs at this location, the WIV constructed a BSL-3 laboratory at the facility in 2003. [9] [Zheng Qianli, “Jiang Xia plays new essays and plays Yoko on the crane——The construction and research team of P4 laboratory of Wuhan Institute of Virology, Chinese Academy of Sciences.” Chinese Journal of Science, 1 Jan. 2018, https://archive.is/V3GHk#selection-517.35-517.202]

It was here, in the center of Wuhan, that Dr. Shi Zheng-li and her team conducted gain-of-function research on coronaviruses in the years leading up to the COVID-19 pandemic.

Image
Fig. 2: WIV Headquarters in Wuchang

According to the WIV’s website, Shi Zheng-li serves as the Director of the WIV’s Research Center for Emerging Infectious Diseases, the Deputy Director of the WNBL BSL-4 lab, the Director of the BSL-3 lab, and the Director of the Biosafety Working Committee. [10] [“Shi Zhingli.” Wuhan Institute of Virology, http://www.whiov.cas.cn/sourcedb_whiov_ ... 00074.html] Shi is also the Director of the Chinese Academy of Sciences (CAS) Key Laboratory of Special Pathogens and Biosafety, [11] [“Prof. SHI Zhengli elected a fellow of the American Academy of Microbiology.” Wuhan Institute of Virology, http://english.whiov.cas.cn/ne/201903/t ... 06697.html] which includes the majority of scientists who are conducting gain-of-function research on coronaviruses at the WIV.

It should be noted that the WIV has a Chinese Communist Party Committee within the institute, as well as a Commission for Discipline Inspection. The Party Committee is divided into four party branches, which are then divided into subbranches organized around the individual WIV departments, research centers, and offices. Each subbranch has its own Propaganda Committee. Committee Minority Staff were able to identify eight WIV researchers on these committees, including several who are affiliated with the Key Laboratory that Shi directs.

Table 1: WIV Researchers on CCP Propaganda Committees

WIV Researcher / Lab Affiliation / Propaganda Committee
[12] [“Party Branch.” Wuhan Institute of Virology, http://www.whiov.cas.cn/djkxwh/dqzz/dzb/]

Liu Qiaojiue / Key Laboratory of Special [13] [Wang Q, et. al. “Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase.” Cell, 23 July 2020, 182(2):417-428.e13, https://pubmed.ncbi.nlm.nih.gov/32526208/] Pathogens and Biosafety / Party Branch of Research Center for Emerging Infectious Diseases

Zhang Xiaowei / Key Laboratory of Special [14] [Zhang, Xiaowei et al. “Tick-borne encephalitis virus induces chemokine RANTES expression via activation of IRF-3 pathway.” Journal of Neuroinflammation, 30 Aug. 2016, 13(1):209. https://pubmed.ncbi.nlm.nih.gov/27576490/] Pathogens and Biosafety and Key Laboratory of Virology / Party Branch of the Research Center for Microbiology and Nanobiology

Shen Xurui / Key Laboratory of Special Pathogens and Biosafety [15] [Zhou, Peng et al. “A pneumonia outbreak associated with a new coronavirus of probable bat origin.” Nature March 2020, 579(7798): 270- 273. https://pubmed.ncbi.nlm.nih.gov/32015507/] / Graduate Party Branch of the Research Center for Emerging Infectious Diseases

Tang Shuang / State Key Laboratory of Virology [16] [Abudurexiti, Abulikemu, et al. “Taxonomy of the order Bunyavirales: update 2019.” Archives of Virology, July 2019, 164(7): 1949-1965. https://pubmed.ncbi.nlm.nih.gov/31065850/] / Party Branch of the Research Center for Microbial Resources and Bioinformatics

Wu Yan / State Key Laboratory of Virology [17] [Su, Hai-Xia et al. “Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.” Acta Pharmacologica Sinica, September 2020, 41(9): 1167-1177. https://pubmed.ncbi.nlm.nih.gov/32737471/] Party Branch of Molecular Virus and Pathology Research Center

He Lihong / State Key Laboratory of Virology [18] [Shao, Wei et al. “Functional Characterization of the Group I Alphabaculovirus Specific Gene ac73.” Virologica Sinica, Dec. 2019, 34(6): 701-711. https://pubmed.ncbi.nlm.nih.gov/31317397/] / Party Branch of the Research Center for Microbial Resources and Bioinformatics

Wang Qingxing / State Key Laboratory of Virology [19] [Su, Haixia et al. “Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease.” Nature Communications, 15 June 2021, (2(1): 3623. https://pubmed.ncbi.nlm.nih.gov/34131140/] / Graduate Party Branch of the Research Center for Molecular Viruses and Pathology

Yang Mengsi / State Key Laboratory of Virology [20] [Zhang, Juan, et. al. “Passive cancer targeting with a viral nanoparticle depends on the stage of tumorigenesis.” Nanoscale, 8 July 2021, 13(26):11334-11342, https://pubmed.ncbi.nlm.nih.gov/34165123/] / Graduate Party Branch of the Research Center of Microbiology and Nanobiology


The Committee for Discipline Inspection is charged with “the implementation of the party's line, policy, party discipline, relevant laws and regulations, and the institute's rules and regulations.” [21] [“Commission for Discipline Inspection.” Wuhan Institute of Virology, http://www.whiov.cas.cn/djkxwh/dqzz/jw/]

In addition to the researchers serving on propaganda committees, other key figures at the WIV also serve as CCP officials. Dr. Wang Yanyi serves as the Director of the WIV and joined the China Zhi Gong Party, a CCP controlled minority party, in 2010. In 2018, the same year she became the Director General of the WIV, she was elected the Deputy Director of the Wuhan Municipal Party Committee.

Until late 2019, the BSL-4 lab was managed by Dr. Yuan Zhiming. Yuan is the General Secretary of the Chinese Communist Party Committee within the Wuhan Branch of the Chinese Academy of Sciences, to which the WIV belongs. Local CCP leaders not only run the WIV itself but also directly managed the BSL-4 lab. [22] [Izambard, Antoine. “L'histoire Secrète Du Laboratoire P4 De Wuhan Vendu Par La France à La Chine.” Challenges, 30 Apr. 2020 http://www.challenges.fr/entreprise/san ... a-lachine_ 707425.]

Director Wang’s 2021 New Year’s speech makes reference to the Party Committee of Wuhan Institute of Virology, pledging that the party committee will “effectively play the role of a battle fortress of grassroots party organizations.” [23] [“New Year's Speech by the Director in 2021.” Wuhan Institute of Virology, http://www.whiov.cas.cn/gkjj/szzc_160220/] The WNBL also has its own party branch, the Zhengdian Laboratory Party Branch, which was “awarded the title of ‘Red Flag Party Branch’ by the Hubei Provincial Party Committee and Provincial Organization Working Committee, effectively playing an advanced and exemplary role.” [24] [“New Year’s Message from the Director in 2020.” Wuhan Institute of Virology, https://web.archive.org/web/20200701032 ... zc_160220/] Notably, in discussing the COVID-19 pandemic, Director Wang’s 2021 speech takes pains to address questions of lab safety – “The institute's high-level biosafety laboratory operates safely for more than 300 days throughout the year.” [25] [Ibid.] Her 2020 address, posted sometime after April 2020, makes no such mention.

The WNBL’s BSL-4 lab was constructed as a result of an agreement between the PRC and France that was signed after the 2003 SARS pandemic. [26] [“About WIV.” Wuhan Institute of Virology, http://english.whiov.cas.cn/About_Us201 ... ction2016/.] At the time, all BSL-3 labs in the PRC were controlled by the PRC’s People’s Liberation Army (PLA). Then-President of France, Jacques Chirac, and his Prime Minister, Jean-Pierre Raffarin, approved the project despite concerns from both the French Ministry of Defense and French intelligence services – Raffarin himself described it as “a political agreement.” [27] [Izambard, Antoine. “L'histoire Secrète Du Laboratoire P4 De Wuhan Vendu Par La France à La Chine.” Challenges, 30 Apr. 2020, http://www.challenges.fr/entreprise/san ... a-lachine_ 707425.] The PRC was suspected of having a biological warfare program, and the military and intelligence services were worried that the dual-use technology required to build a BSL- 4 lab could be misused by the PRC government. The uneasy compromise reached within the French government was that the agreement would require joint PRC-France research to be conducted in the lab, with French researchers present. [28] [Ibid.]

In 2016, the PRC requested dozens of the containment suits required to work in the lab. The French Dual-Use Commission, tasked with considering exports of sensitive equipment, rejected their request. According to French reporting, the request was “well above the needs of the Wuhan [lab].” [29] [Ibid.] This continued to fuel concerns within the French Ministry of Defense that the PRC was seeking to engage in military research or open a second BSL-4 lab for military means. Despite the agreement that the BSL-4 lab would be a site of joint research, and an announcement at the 2017 inauguration by then Prime Minister Bernard Cazeneuve of €5 million in funding, there has only been one French scientist assigned to the lab. His tour ended in 2020. [30] [Izambard.]

Safety Concerns and Unusual Maintenance

There have been several reports of safety concerns at PRC labs starting as early as 2004, when it was discovered SARS leaked from a lab in Beijing. Several other accidental releases have happened in the years since.

As discussed in our original report released last year, in 2018 U.S. State Department officials sent cables to Washington, D.C. highlighting concerns with safety issues at the WIV. The cables reported that scientists at the WIV noted “a serious shortage of appropriately trained technicians and investigators needed to safely operate this high-containment laboratory.” [31] [Rogin, Josh. “Opinion | State Department Cables Warned of Safety Issues at Wuhan Lab Studying Bat Coronaviruses.” The Washington Post, 14 Apr. 2020, http://www.washingtonpost.com/opinions/ ... -wuhanlab- studying-bat-coronaviruses/.] The cables also questioned the PRC’s commitment to prioritizing the important research for which the lab was designed.

Image
Fig. 4: Excerpt from January 19, 2018 Cable from the U.S. Embassy in Beijing to State Department Headquarters in Washington, D.C.

(b)(6) [DELETE] Thus, while the BSL-4 lab is ostensibly fully accredited, its utilization is limited by lack of access to specific organisms and by opaque government review and approval processes. As long as this situation continues, Beijing's commitment to prioritizing infectious disease control -- on the regional and international level, especially in relation to highly pathogenic viruses, remains in doubt.


One year later, in June 2019, George Gao, the Director of the Chinese Center for Disease Control and Prevention, expressed concerns about safety protocols at the WIV. In an almost prophetic statement published in Biosafety and Health, Gao wrote (emphasis added):

Advances in biomedical technologies, such as genome editing and synthetic biotechnology, have the potential to provide new avenues for biological intervention in human diseases. These advances may also have a positive impact by allowing us to address risks in new approaches. However, the proliferation of such technologies means they will also be available to the ambitious, careless, inept, and outright malcontents, who may misuse them in ways that endanger our safety. For example, while CRISPR-related techniques provide revolutionary solutions for targeted cellular genome editing, it can also lead to unexpected off-target mutations within genomes or the possibility of gene drive initiation in humans, animals, insects, and plants. Similarly, genetic modification of pathogens, which may expand host range as well as increase transmission and virulence, may result in new risks for epidemics. For example, in 2013, several groups showed that influenza H5N1 viruses with a few nucleotide mutations and H7N9 isolates reasserted with 2009 pandemic H1N1 virus could have the ability for airborne transmission between ferrets. Likewise, synthetic bat-origin SARS-like coronaviruses acquired an increased capability to infect human cells. Thus, modifying the genomes of animals (including humans), plants, and microbes (including pathogens) must be highly regulated. [32] [Gao, George F. “For a better world: Biosafety strategies to protect global health.” Biosafety and Health, June 2019, 1(1): 1-3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147920/]


Three months later, in September 2019, Yuan Zhiming, the Director of the BSL-4 lab at the WNBL and Shi’s superior, published an article in the Journal of Biosafety and Biosecurity.

Entitled, “Current status and future challenges of high-level biosafety laboratories in China,” [33] [Yuan Zhinming. “Current status and future challenges of high-level biosafety laboratories in China.” Journal of Biosafety and Biosecurity, Sept. 2019, 1(2): 123-127. https://www.sciencedirect.com/science/a ... 0391#b0080] the article discusses at length the construction of the WNBL. Yuan identifies multiple key issues, including inadequate biosafety management systems, insufficient resources for efficient laboratory operation, and deficiency of professional capacity. With a surprising level of transparency, Yuan admits that the enforcement of pathogen, waste, and laboratory animal management regulations “needs to be strengthened.” [34] [Ibid.] Discussing the insufficient level of resources being provided by the PRC government, he stated:

The maintenance cost is generally neglected; several high-level BSLs have insufficient operational funds for routine yet vital processes. Due to the limited resources, some BSL-3 laboratories run on extremely minimal operational costs or in some cases none at all. [35] [Ibid.]


Yuan also raised concerns about a lack of specialized biosafety managers and engineers to run the labs. [36] [Ibid.] It is important to note that researchers at the WIV had previously conducted gain-of-function research on coronaviruses at the BSL-2 and BSL-3 levels. This is important given that both the head of the China CDC and the head of the WIV’s BSL-4 labs had expressed concern about the safety of this research and the labs in which it was being conducted.

Interestingly, there appears to have been ongoing maintenance and repairs projects occurring at the WIV in 2019, before Yuan published his article raising these concerns. It is important to note that at the time of the hazardous waste treatment system renovation project, the WNBL had been operational for less than two years. Such a significant renovation so soon after the facility began operation appears unusual. Procurement announcements published on the PRC’s government procurement website provide evidence of ongoing work at what appears to be both WIV locations.

Table 2: WIV Procurement Projects in 2019

Project Name / Location / Date / Budget (USD)


Maintenance Project of P3 Laboratory and Laboratory Animal Center in Zhengdian Park [37] [“Announcement of Competitive Consultation on Maintenance Project of P3 Laboratory and Laboratory Animal Center in Zhengdian Park, Wuhan Institute of Virology, Chinese Academy of Sciences.” China Government Procurement Network, 1 March 2019, https://archive.is/7eCPU#selection-229.0-229.185] / WNBL / March 1, 2019 / $401,284.10

Procurement of Positive Pressure Protective Clothing [38] [“Announcement of a single source for the purchase of positive pressure protective clothing project by Wuhan Institute of Virology, Chinese Academy of Sciences.” China Government Procurement Network, 21 March 2019, https://archive.is/VUcNA#selection-229.0- 229.157] / WNBL / March 21, 2019 / $177,161.40

Hazardous Waste Treatment System Renovation Project [39] [ “Announcement on the transaction of the hazardous waste treatment system renovation project in Zhengdian Park, Wuhan Institute of Virology, Chinese Academy of Sciences.” China Government Procurement Network, 31 July 2019, https://archive.is/3CW03#selection- 229.0-229.166] / WNBL / July 31, 2019 / $1,521,279.28

Procurement Project of The Environmental Air Disinfection System and The Scalable Automated Sample Storage Management System [40] [“Announcement of winning the bid for the procurement project of the environmental air disinfection system and the scalable automated sample storage management system of the Wuhan Institute of Virology, Chinese Academy of Sciences.” China Government Procurement Network, 14 Aug. 2019, https://archive.is/1nXLD#selection-229.0-229.228] / Unclear / August 14, 2019 / $132,200,025.47

Security Service Procurement Project [41] [“Competitive consultation on the procurement project of security services in Zhengdian Science Park, Wuhan Institute of Virology, Chinese Academy of Sciences.” China Government Procurement Network, 12 Sept. 2019,https://archive.is/tUi75#selection-229.0- 229.156] / WNBL / September 12, 2019 / $1,281,022.33

Central Air Conditioning Renovation Project [42] [“Competitive Consultation on Central Air Conditioning Renovation Project of Wuhan Institute of Virology, Chinese Academy of Sciences.” China Government Procurement Network, 16 Sept. 2019, https://archive.is/bfoTD#selection-229.0-229.131] / Unclear / September 16, 2019 / $606,382,986.11

Procurement of Air Incinerator and Testing Service [43] [“The Wuhan Institute of Virology of the Chinese Academy of Sciences plans to use a single-source procurement method to publicize the procurement of air incineration devices and test service projects.” China Government Procurement Network, 3 Dec. 2019, https://archive.is/Jifqr#selection-229.0-229.197] / Unclear / December 3, 2019 / $49,388.81


The references to maintenance at the BSL-3 and animal center at the WNBL, the procurement of an environmental air disinfection system, and renovations to the hazardous waste treatment system and central air conditioning system all raise questions about how well these systems were functioning in the months prior to the outbreak of COVID-19.

The Disappearing Database

On September 12, 2019 the WIV’s online, public database of samples and virus sequences was taken offline in the middle of the night between 2:00AM and 3:00AM local time. [44] [“Status breakdown of the database of characteristic wild animals carrying virus pathogens (September 2019).” Scientific Database Service Monitoring & Statistics System. https://archive.is/AGtFv#selection-1553.0-1567.2] The database contained more than 22,000 entries consisting of sample and pathogen data collected from bats and mice. The database contained key information about each sample, including what type of animal it was collected from, where it was collected, whether the virus was successfully isolated, the type of virus collected, and its similarity to other known viruses.

Image
Fig. 6: Example Database Entry [45] [“Database of pathogens of bat and murine viruses.” Wikisource, https://zh.wikisource.org/zhhant/% E8%9D%99%E8%9D%A0%E6%BA%90%E5%92%8C%E9%BC%A0%E6%BA%90%E7%97%85%E6%AF%92%E7 %97%85%E5%8E%9F%E6%95%B0%E6%8D%AE%E5%BA%93]
Table 1: Virus data display of bat samples

Data element name / Example


Sample ID / 162387A
Sample tissue type / Anal
Animal type / bat
Source species / Rousettus leschenaultil
Species molecular identificatno / Rousettus sp.
Collection date / 2016-08-21
country / China
province / Yunnan
city / Miaoxin village, Mengna county, Sipsongpanna
GPS information: 101.51944.21.78127
Whether high-throughput sequencing / No
Whether the virus is isolated / No
publishing / Luo Y, Yi B. Jiang RD, et al. Virol. Sin. 2018;33(1):87-95. doi:10.1007/s12250-018-0017-2
Remarks / --
Detection Method / PCR-based
Virus name / Coronaviridae
Test results / Positive
blast result / btcov HKU9
Virus classification / HKU9
Virus sequence / See references for details
Similarity / 9436
Sequence length / 398bp
Sequence-encoded gene / Partial RdRp


To date, there has been no consistent answer provided as to why the database was removed or when or if it will be put back online.

Shi is listed as the data correspondence author for the project. When questioned about the database being taken offline, Shi has given several conflicting answers. During a December 2020 interview with BBC, Shi said the database was taken offline for “security reasons” after cyberattacks against the work and personal emails of WIV staff. She also insisted that WIV virus sequences were saved in the GenBank database, run by the National Center for Biotechnology Information. Shi stated, “It's completely transparent. We have nothing to hide." [46] [Sudworth, John. “Covid: Wuhan Scientist Would 'Welcome' Visit Probing Lab Leak Theory.” BBC News, 21 Dec. 2020, http://www.bbc.com/news/world-asia-china-55364445.]

In a January 26, 2021 email to someone inquiring about the database, however, Shi stated the database was taken down due to cyberattacks “during [the] COVID-19 pandemic.” [47] [Cleary, Tommy. “Prof Zheng-Li Shi Replied to Me, to CNRI,中⽂DOI运维 I Can Only Conclude @PeterDaszak &amp; the Rest of the @WHO Organisation Were given the Same Information Access Ultimatum:No Trust, No Conversation.@SciDiplomacyUSA Has Its Work Cut Out.Data Hostage? Pic.twitter.com/KhiFs42U7j.” Twitter, 10 Mar. 2021, https://twitter.com/tommy_cleary/status ... 25602?s=20.] She also claimed that researchers had “only entered a limit[ed] data in this database” despite it having more than 22,000 entries.

In an apparent contradiction of her BBC interview, Shi admitted that “access to the visitors is limited,” [48] [Sudworth.] but maintains:

…all our work regarding the different type of bat coronavirus (partial sequences or full-length genome sequences) have been published and the sequence and sample information have been submitted to GenBank. [49] [Ibid.]


At the end of her email, Shi writes, “I’ll not answer any of your questions if your curiosity is based on the conspiracy of ‘man made or lab leak of SARS-CoV-2’ or some non-sense questions based on your suspicion. No trust, no conversation” [50] [Ibid.] (emphasis added).

Re: U.S. government gave $3.7 million grant to Wuhan lab at

PostPosted: Wed Aug 18, 2021 4:50 am
by admin
Part 2 of 4

New Leadership and PLA Involvement

The WIV’s website indicates that Yuan Zhiming serves as the Dean of the Wuhan Branch of the Chinese Academy of Sciences and director of the WNBL BSL-4 lab. [51] [“Yuan Zhiming.” Wuhan Institute of Virology, http://www.whiov.cas.cn/sourcedb_whiov_ ... 00080.html] However, news posted on Weibo Douban, a PRC website, on February 7th, 2020 stated that PLA officials were dispatched to assume control of the response. The report says PLA Major General Chen Wei, an expert in biology and chemical weapon defenses, was deployed to Wuhan in January 2020 and took control of the WNBL BSL-4 lab. The posting of this information to Douban is significant given the website’s history of censoring posts critical of the CCP, including censoring words related to the Tiananmen Square Massacre. [52] [Gertz, Bill. “Chinese Maj. Gen. Chen Wei TAKES Leading Role in Coronavirus Fight.” The Washington Times, 16 Feb. 2020, http://www.washingtontimes.com/news/202 ... le-in-cor/.] [53] [Guli. “Major General Chen Wei, China's Chief Biochemical Weapons Expert, Takes Over Wuhan P4 Virus Laboratory.” Radio France Internationale, https://www.rfi.fr/cn/%E4%B8%AD%E5%9B%BD/20200208- %E4%B8%AD%E5%9B%BD%E9%A6%96%E5%B8%AD%E7%94%9F%E5%8C%96%E6%AD%A6%E5%99%A8%E 4%B8%93%E5%AE%B6%E9%99%88%E8%96%87%E5%B0%91%E5%B0%86%E6%8E%A5%E7%AE%A1%E6%AD %A6%E6%B1%89p4%E7%97%85%E6%AF%92%E5%AE%9E%E9%AA%8C%E5%AE%A4] [54] [Honorof, Marshall. “China Marks Tiananmen Massacre with 'Internet Maintenance Day.'” NBC News, 4 June 2013, https://www.nbcnews.com/id/wbna52096871] The post’s survival on a heavily CCP censored site confirms its legitimacy.

Image

Committee Minority Staff have also received testimony from a former senior U.S. official that Gen. Chen actually took control of the WNBL BSL-4 lab in late 2019, not January 2020 as was publicly reported. Gen. Chen taking over part of the WIV demonstrates the CCP was concerned about the activity happening there as news of the virus was spreading. If she took control in 2019, it would mean the CCP knew about the virus earlier, and that the outbreak began earlier – a topic discussed further in this section.

Gen. Chen is a researcher at the Academy of Military Medical Sciences in Beijing, and served as a delegate to the 12th National People’s Congress. [55] ["List of Deputies to the Twelfth National People’s Congress of the People’s Republic of China.” Sohu, http://news.sohu.com/20130227/n367313787.shtml] In January 2018, Gen. Chen was made a member of the 13th National Committee of the Chinese People’s Political Consultative Conference (CPPCC). According to the U.S.-China Economic Security Review Commission, the CPPCC is a “critical coordinating body that brings together representatives of China’s other interest groups and is led by a member of China’s highest-level decision-making authority, the CCP’s Politburo Standing Committee.” [56] [Bowe, Alexander. “China’s Overseas United Front Work: Background and Implications for the United States.” U.S.-China Economic and Security Review Commission, 24 Aug. 2018, https://www.uscc.gov/sites/default/file ... inal_0.pdf]

According to a January 15, 2021 fact sheet published by the State Department, in the years leading up to the pandemic, researchers at the WIV were engaged in classified research, including experiments on animals, on behalf of the PLA. [57] [United States, Department of State. “Fact Sheet: Activity at the Wuhan Institute of Virology.” 15 Jan. 2021, https://2017-2021.state.gov/fact-sheet- ... index.html] Dr. Shi has repeatedly denied any involvement of the PLA at the WIV. During a lecture hosted only by Rutgers Medical School, Shi stated:

We—our work, our research is open, and we have a lot of international collaboration. And from my knowledge, all our research work is open, is transparency. So, at the beginning of COVID-19, we heard the rumors that it’s claimed in our laboratory we have some project, blah blah, with army, blah blah, these kinds of rumors. But this is not correct because I am the lab’s director and responsible for research activity. I don’t know any kind of research work performed in this lab. This is incorrect information. [58] [Eban, Katherine. “The Lab-Leak Theory: Inside the Fight to Uncover COVID-19's Origins.” Vanity Fair, 3 June 2021, http://www.vanityfair.com/news/2021/06/ ... 9s-origins.]


This statement is demonstrably false. The WIV had multiple connections to PLA researchers prior to the COVID-19 pandemic; several were listed on the WIV’s English language website. The Academic Committee of State Key Laboratory of Virology at the WIV included a Deputy Director from the Second Military Medical University and a member from the 302 Military Hospital of China. The Scientific Advisory Committee for the Center for Emerging Infectious Diseases had among its members a researcher from the Institute of Military Veterinary at the Academy of Military Medical Sciences. [59] [“Committees.” Wuhan Institute of Virology, https://web.archive.org/web/20200527045 ... ommittees/] This website was scrubbed on May 28, 2020, and the lists of committee members removed. However, archived copies of the website are available online.

Fig. 3: Archived Versions of the WIV Committees Page
Academic Committee of State key laboratory of virology, WIV, CAS

Director:
Zihe RAO, Tsinghua University, China.
Deputy Directors:
Hongyang WANG, The Second Military Medical University, China.
Hongbin SHU, Wuhan University, China.
Members
Jianfang GUI, Institute of Hydrobiology, Chinese Academy of Sciences, China.
Fusheng WANG, 302 Military Hospital of China, China.
Hualan CHEN, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China.
Zhenghong YUAN, Fudan University, China.
Ningshao XIA, Xiamen University, China.
Linqi ZHANG, Tsinghua University, China.
Musheng ZENG, Sun Yat-sen University, China.
Jianguo WU, Wuhan University, China.
Xinwen CHEN, Wuhan Institute of Virology, Chinese Academy of Sciences, China.
Ke LAN, Wuhan University, China.


This raises the obvious question of why Shi, who served on one of the committees, would lie about military researchers working with the WIV. Her denial and the scrubbing of the website appear to be obvious attempts to obfuscate the PLA’s involvement with the WIV.

Geospatial Analysis of Traffic Patterns at Wuhan Hospitals Near the WIV

Around the time the WIV’s virus database went offline, car traffic at hospitals in downtown Wuhan began to increase. Researchers from Boston University School of Public Health, Boston Children’s Hospital, and Harvard Medical School used satellite imagery to examine parking lot volume of hospitals in Wuhan for the two and a half years prior to December 2019. They found that five of six hospitals analyzed had the highest relative daily volume of cars in the parking lot in September and October 2019, before the first reported cases of COVID-19.

Image
Fig. 7: Time-series of Different Influenza-like Illnesses, Symptoms and Surveillance signals [62] [Nsoesie]

This peak corresponded with an increase in searches for “cough” and “diarrhea” in Wuhan on Baidu, a Chinese search engine. [60] [Nsoesie, Elaine Okanyene, et. al. “Analysis of hospital traffic and search engine data in Wuhan China indicates early disease activity in the Fall of 2019 (2020).” Digital Access to Scholarship at Harvard, 2020. http://nrs.harvard.edu/urn-3:HUL.InstRepos:42669767] According to the CDC, both cough and diarrhea are symptoms of COVID- 19. [61] [“Symptoms of COVID-19.” Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-nc ... mstesting/ symptoms.html] This study suggests a virus with similar symptoms as COVID-19 was circulating in Wuhan in September and October.

The Initial Outbreak’s Proximity to the WIV

When people get sick, they are likely to seek healthcare near their home or work. Each of the hospitals that saw a rise in traffic with patients complaining of COVID-19 symptoms are located within 6.5 miles of the WIV Headquarters and are connected by public transit lines. The below map shows the location of the WIV Headquarters (in red) and the six hospitals (in blue) which experienced increase vehicle traffic in September and October 2019. When plotted on a map, these six hospitals are clustered around the WIV Headquarters in Wuchang, Wuhan, and are connected to that facility via the Wuhan Metro – various lines are shown in black, yellow, pink, and green on the map. The pink line represents Line 2, whose daily passenger volume exceeded one million trips in 2017. [63] [“Wuhan Metro is bursting with passengers, breaking records for two consecutive days.” 5 April 2017, https://web.archive.org/web/20170825184 ... 89625.html]

Image
Map 1: Harvard Study Hospitals in Relation to the WIV Headquarters

It is also important to note, according to an Australian scientist who worked in the BSL-4 lab, a daily shuttle bus transfers WIV researchers from the Wuhan Branch of the Chinese Academy of Sciences to the WNBL facility and back again. [64] [Cortez, Michelle Fay. “The Last—And Only—Foreign Scientist in the Wuhan Lab Speaks Out.” Bloomberg, 27 June 2021, http://www.bloomberg.com/news/features/ ... speaks-out.] According to public mapping data, the shuttle pick up and drop off point is less than 500 meters from the WIV Headquarters. As such, it is likely that researchers from both the WIV Headquarters, as well as the WNBL, used the Wuhan metro and/or the WNBL shuttle bus, as part of their daily work commute.

Therefore, it is reasonable to conclude, based on the WIV’s extensive sample library and history of genetically manipulating coronaviruses, that in early September, one or more researchers became infected with SARS-CoV-2 in the lab and carried it out into the city. Based on the WIV’s publications, researchers could have been exposed while experimenting with a natural virus collected from the wild or infected with a virus they genetically manipulated. Those researchers likely traveled to and from the WIV via the Wuhan metro or via the shuttle service, providing a vector for the virus to spread. This corresponds with the first signs of a growing wave of ill people in Wuhan centered around the WIV’s Wuchang facility.

The 2019 Military World Games and Sick Athletes

The 7th International Military Sports Council Military World Games (MWGs) opened in Wuhan on October 18, 2019. The games are similar to the Olympic games but consist of military athletes with some added military disciplines. The MWGs in Wuhan drew 9,308 athletes, representing 109 countries, to compete in 329 events across 27 sports. Twenty-five countries sent delegations of more than 100 athletes, including Russia, Brazil, France, Germany, and Poland. [65] ["Military Games to Open Friday in China.” China Daily, 17 Oct. 2019, http://www.china.org.cn/sports/2019- 10/17/content_75311946.htm.]

The PRC government recruited 236,000 volunteers for the games, which required 90 hotels, three railroad stations, and more than 2,000 drivers. [66] [“2019 Military World Games Kicks off in Central China's Wuhan.” CISION, 17 Oct. 2019, http://www.prnewswire.com/news-releases ... orldgames- kicks-off-in-central-chinas-wuhan-300940464.html.] An archived version of the competition’s website from October 20, 2019, lists the more than thirty venues that hosted events for the MWGs across Wuhan and the broader Hubei province. [67] [“Competition Venues.” Wuhan 2019 Military World Games, https://web.archive.org/web/20191020154 ... on_venues/.] The live website is no longer accessible – it is unclear why it was removed.

During the games, many of the international athletes became sick with what now appear to be symptoms of COVID-19. In one interview, an athlete from Luxembourg described Wuhan as a “ghost town,”[68] [Houston, Michael. “More athletes claim they contracted COVID-19 at Military World Games in Wuhan.” Inside the Games, 17 May 2020, https://www.insidethegames.biz/articles ... s-covid-19] and recalls having his temperature taken upon arriving at the city’s airport. In an interview with The Financial Post, a Canadian newspaper, one member of the Canadian Armed Forces who participated in the games said (emphasis added):

This was a city of 15 million people that was in lockdown. It was strange, but we were told this was to make it easy for the Games’ participants to get around. [I got] very sick 12 days after we arrived, with fever, chills, vomiting, insomnia.… On our flight to come home, 60 Canadian athletes on the flight were put in isolation [at the back of the plane] for the 12-hour flight. We were sick with symptoms ranging from coughs to diarrhea and in between. [69] [Francis, Diane. “Diane Francis: Canadian Forces Have Right to Know If They Got COVID at the 2019 Military World Games in Wuhan.” Financial Post, 25 June 2021, https://financialpost.com/diane-francis ... taryworld- games-in-wuhan.]


The service member also revealed his family members became ill as his symptoms increased, [70] [Ibid.] a development that is consistent with both human-to-human transmission of a viral infection and COVID-19. Similar claims about COVID-19 like symptoms have been made by athletes from Germany, France, Italy, [71] [Houston.] and Sweden. [72] [Liao, George. “Coronavirus May Have Been Spreading since Wuhan Military Games Last October.” Taiwan News, 13 May 2020, http://www.taiwannews.com.tw/en/news/3932712.]

By cross referencing the listed MWG venues with publicly available mapping data, it is possible to visualize the venues (in black) in relation to the WIV Headquarters (in red) and the abovementioned hospitals (in blue). The green figures represent athletes who have publicly expressed their belief they contracted COVID-19 while in Wuhan and are mapped at the venues which hosted the events in which they competed. Some of these athletes resided in the military athletes’ village.

[I got] very sick 12 days after we arrived, with fever, chills, vomiting, insomnia.… On our flight to come home, 60 Canadian athletes on the flight were put in isolation [at the back of the plane] for the 12-hour flight. We were sick with symptoms ranging from coughs to diarrhea and in between.

-- Canadian Athlete


Image
Map 2: WIV Headquarters, Hospitals, MWG Venues, and Sick Athletes

At least four countries who sent delegations to the MWGs have now confirmed the presence of SARS-CoV-2 or COVID-19 cases within their borders in November and December 2019, before the news of an outbreak first became public.

1. Italy. In February 2021, researchers from Italy published a research letter in the CDC’s Emerging Infectious Diseases journal describing a case involving a 4-year-old boy from Milan. A retrospective analysis of samples taken in 2019 identified the boy, who developed a cough on November 21, 2019, as having been infected with SARS-CoV-2 three months before Italy’s first reported case. The boy had no reported travel history. [73] [Amendola, Antonella¸ et. al. “Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019.” Emerging Infectious Diseases, Feb. 2021, 27(2). https://doi.org/10.3201/eid2702.204632]

2. Brazil. A March 2021 article by researchers in Brazil examined wastewater samples from October to December 2019. Previous studies have confirmed that humans infected with the virus can experience prolonged viral shedding via their gastrointestinal tract. A sample from November 27th tested positive for SARS-CoV-2 RNA, confirming the virus was circulating in Santa Catarina, Brazil months before January 21, 2020, when the first case in the Americas was reported. [74] [Fongaro, Gislaine et al. “The presence of SARS-CoV-2 RNA in human sewage in Santa Catarina, Brazil, November 2019.” The Science of the Total Environment, 8 March 2021, 778: 146198. https://dx.doi.org/10.1016%2Fj.scitotenv.2021.146198]

3. Sweden. Sweden’s Public Health Agency said it is likely that individuals in the country were infected with SARS-CoV-2 as early as November 2019. [75] [“Coronavirus May Have Arrived in Sweden in November: Public Health Agency.” The Local, 5 May 2020, http://www.thelocal.se/20200505/the-cor ... -november/.]

4. France. Researchers in France also re-tested samples from late 2019 in an effort to identify early COVID-19 cases. They identified a 42-year-old male who presented to the emergency room on December 27th with an influenza-like illness. He had no connection to the PRC and no recent travel history. Upon re-testing, the patient’s samples were positive for SARS-CoV-2. It should be noted that one of his children also had similar symptoms before the man became sick, suggesting that the first case in France was likely earlier than December 27th. [76] [Deslandes, A et al. “SARS-CoV-2 was already spreading in France in late December 2019.” International Journal of Antimicrobial Agents, 3 May 2020, 55(6): 106006. https://dx.doi.org/10.1016%2Fj.ijantimicag.2020.106006]

As stated above, athletes from France, Italy, and Sweden also complained of illnesses with symptoms similar to COVID-19 while at the MWGs in Wuhan. The presence of SARS-CoV-2 in four countries, on two separate continents, suggests a common source. If, as presumed, SARS-CoV-2 first infected humans in Wuhan before spreading to the rest of the world, the 2019 Military World Games in Wuhan appears to be a key vector in the global spread – in other words, potentially one of the first “super spreader” events.

Conclusion

While much of the public debate was initially focused on the Huanan seafood market in Wuhan as the origin of the pandemic, the preponderance of evidence now suggests that the virus leaked from the Wuhan Institute of Virology. Given the WIV’s demonstrated history of conducting gain-of-function experiments on coronaviruses, including genetically manipulating viruses specifically to make them infectious to humans in BSL-2 labs, as well as their possession of one of the world’s largest collections of coronaviruses, it is completely plausible that one or more researcher(s) was accidentally infected and carried the virus out of the lab. The evidence outlined above, combined the cover-up conducted CCP authorities, strongly suggest the Wuhan Institute of Virology as the source of the current pandemic. [77] [Stahl, Lesley. “What Happened In WUHAN? Why Questions Still Linger on the Origin of the Coronavirus.” CBS News, 28 Mar. 2021, http://www.cbsnews.com/news/covid-19-wu ... 021-03-28/.]

III. EVIDENCE OF GENETIC MODIFICATION

The other topic of debate is whether the virus could have been genetically modified. The WIV was conducting gain-of-function research on coronaviruses and testing them against human immune systems in the months leading up to the emergence of SARS-CoV-2, however the scientific community has claimed it is not possible it was anything but a naturally occurring virus. But, as this report lays out, we believe it is a viable hypothesis that the virus could have been modified.

“You can engineer a virus without leaving any trace. The answers you are looking for, however, can only be found in the archives of the Wuhan laboratory.”

– Dr. Ralph Baric


Research Regarding SARS Like Coronaviruses from 2004-2017

The WIV’s work on bat coronaviruses dates back to the aftermath of SARS in the early 2000s. Shi met Peter Daszak, an American citizen, in 2004 during an effort to find the origins of the 2002 SARS pandemic. Daszak is the CEO of EcoHealth Alliance, a New York-based NGO that funds scientific research around the world. [78] [Zaugg, Julie. “In Wuhan with Bat Woman, at the origins of the Covid-19.” L’Illustre, 22 Jan. 2021, https://www.illustre.ch/magazine/a-wuhanavec- bat-woman-aux-origines-du-covid-19] For the last year and a half, questions have been raised about how and why EcoHealth Alliance provided the WIV with U.S. taxpayer dollars. Those funds were provided to EcoHealth Alliance in the form of grants from the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Science Foundation (NSF), and the United States Agency for International Development (USAID).

Image

Beginning in 2005, and continuing over the next 16 years, Shi and Daszak have collaborated on coronavirus research. Together, they “led dozens of expeditions to caves full of bats, to collect samples and analyze them.” [79] [Ibid.] They have identified more than 500 novel coronaviruses, including roughly 50 related to SARS or MERS, and they have repeatedly engaged in gain-of-function research on coronaviruses designed to make them more infectious in humans. [80] [Ibid.] As discussed below, the vast majority of the most relevant scientific publications that have emerged from the WIV regarding coronaviruses was conducted with funding provided by Peter Daszak through EcoHealth Alliance.

Article and Publication: “Bats Are Natural Reservoirs of SARS-Like Coronaviruses,” in Science (2005).

Participants: Li Wendog, primary author; Shi, second author and one of three corresponding authors; Peter Daszag; additional scientists from Australia and China.

Funding: The paper was supported in part by funding from the PRC government, who provided a special grant for Animal Reservoirs of SARS-CoV from the State Key Program for Basic Research (grant no. 2005CB523004) and the State High Technology Development Program (grant no. 2005AA219070) from the Ministry of Science and Technology.

It was also funded by the U.S. government, through the NIH and NSF, who provided funding in the form of an ‘Ecology of Infectious Diseases’’ award (no. R01-TW05869) from the John E. Fogarty International Center and the V. Kann Rasmussen Foundation.

Purpose: The scientists hoped to identify the origins of SARS by identifying species of bats which are a natural host for SARS-like coronaviruses.

Conclusion: “These findings on coronaviruses, together with data on henipaviruses (23–25, 28), suggest that genetic diversity exists among zoonotic viruses in bats, increasing the possibility of variants crossing the species barrier and causing outbreaks of disease in human populations. It is therefore essential that we enhance our knowledge and understanding of reservoir host distribution, animal-animal and human-animal interaction (particularly within the wet-market system), and the genetic diversity of bat-borne viruses to prevent future outbreaks.” [81] [Ibid.]

Relevance: This conclusion would drive the next fifteen years of collaboration between the WIV and Peter Daszak, with Shi directing the laboratory work.


In 2006, Shi and Daszak collaborated with a researcher in Australia to publish “Review of bats and SARS” in Emerging Infectious Diseases, a peer-reviewed journal published monthly by the U.S. Centers for Disease Control and Prevention. Shi was again listed as the second author, and the work was funded by the same PRC and NIH/NSF grants referenced above. [82] [Wang L-F, Shi Z, Zhang S, Field H, Daszak P, Eaton BT. “Review of bats and SARS.” Emerg Infect Dis, Dec. 2006; 12(12): 1834-1840., http://dx.doi.org/10.3201/eid1212.060401] The following year, these grants supported the publication of “Evolutionary Relationships between Bat Coronaviruses and Their Hosts” in Emerging Infectious Diseases. Shi is listed as the sixth author, followed by another WIV researcher, and Peter Daszak is listed as one of two corresponding authors. [83] [Cui J, et. al. “Evolutionary relationships between bat coronaviruses and their hosts.” Emerg Infect Dis., Oct. 2007; 13(10):1526-32. https://wwwnc.cdc.gov/eid/article/13/10/07-0448_article]

In 2007, Shi and several other WIV researchers joined additional scientists in publishing another paper on coronaviruses.

Article and Publication: “Difference in Receptor Usage between Severe Acute Respiratory Syndrome (SARS) Coronavirus and SARS-Like Coronavirus of Bat Origin” in Journal of Virology.

Participants: WIV researchers and Linfa Wang. Shi is listed as the corresponding author.

Funding: This work was funded by the PRC government and grants from Australia and the European Commission.

Purpose: This study focused on the receptors used by the spike protein of SARS-like coronaviruses, which are the major surface structures that enable coronaviruses to bind to receptors on cells. To test this, researchers created multiple chimeric viruses by inserting different sequences of the SARS-CoV spike protein into the spike protein of the SARS-like virus being examined, and tested them against bat, civet, and human ACE2 expressing cells.

Conclusion:

One of these chimeric viruses was able to enter cells through the human ACE2 receptor. ACE2 is an abbreviation for angiotensin converting enzyme-2, which is a protein found on the surface of cells and tissues throughout the human body, including the nose, mouth, and lungs. “In the lungs, ACE2 is highly abundant on type 2 pneumocytes, an important cell type present in chambers within the lung called alveoli, where oxygen is absorbed and waste carbon dioxide is released.” [84] [Sriram, Krishna, et al. “What Is the ACE2 Receptor, How Is It Connected to Coronavirus and Why Might It Be Key to Treating COVID-19? The Experts Explain.” The Conversation, 25 May 2021, https://theconversation.com/what-is-the ... ing-covid- 19-the-experts-explain-136928.] ACE2 is also the location where SARS-CoV-2’s spike protein binds to human cells. Researchers concluded that “a minimal insert region” is “sufficient to convert the SL-COV S [SARS-like coronavirus spike protein] from non- ACE2 binding to human ACE2 binding.” [85] [Ren.]

Relevance: In other words, WIV researchers were able to take a SARS-like coronavirus that does not infect humans and modify it so it was able to do so. Also importantly, this work was done under BSL-2 conditions.


Shi and Daszak do not appear as coauthors on a paper again until 2013.

Article and Publication: “Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor” in Nature. [86] [Ge, Xing-Yi et al. “Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.” Nature, 30 Oct. 2013, 503(7477): 535-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389864/]

Participants: WIV and EcoHealth researchers, including Hu,. Shi, Daszak, and Wang who are credited for designing the experiments. Shi and Daszak listed as corresponding authors.

Funding: The study was funded by grants from the PRC government (including grant no. 2013FY113500), as well as the National Institute of Allergy and Infectious Diseases (NIAID) (no. R01AI079231), a NIH/NSF “Ecology and Evolution of Infectious Diseases” award (no. R01TW005869), an award from the NIH Fogarty International Center supported by International Influenza Funds from the Office of the Secretary of the Department of Health and Human Services (no. R56TW009502), and USAID’s Emerging Pandemic Threats PREDICT program. [87] [Ibid.]

Purpose: This work marked “the first recorded isolation of a live SL-CoV” [88] [Ibid.] [SARS-live coronavirus], which researchers isolated from bat fecal samples and named WIV1. Additionally, they identified two novel bat coronaviruses (SCH014 and Rs3367) and reported “the first identification of a wild-type bat SL-CoV capable of using ACE2 as an entry receptor.” [89] [Ibid.]

Conclusion: “Finally, this study demonstrates the public health importance of pathogen discovery programs targeting wildlife that aim to identify the ‘known unknowns’—previously unknown viral strains closely related to known pathogens. These programs, focused on specific high-risk wildlife groups and hotspots of disease emergence, may be a critical part of future global strategies to predict, prepare for, and prevent pandemic emergence.” [90] [Ibid.]

Relevance: By isolating a wild-type (common strain in nature) SARS-like coronavirus that binds to ACE2, and testing it in human lung tissue, the authors proved that bat coronaviruses are capable of infecting humans directly, without having to pass through an intermediate host.


In 2014, Shi and Daszak coauthored two more joint WIV-EcoHealth Alliance papers. The lead author for one of the papers, entitled “Detection of diverse novel astroviruses from small mammals in China,” was Ben Hu, a WIV researcher who was a coauthor of earlier Shi/Daszak papers. Shi is listed as the corresponding author, and the paper was again jointly funded by the PRC government (including grant no. 2013FY113500) and USAID’s PREDICT program. [91] [Hu, Ben, et. al. “Detection of diverse novel astroviruses from small mammals in China.” J Gen Virol. Nov 2014, 95(Pt 11): 2442-2449. https://pubmed.ncbi.nlm.nih.gov/25034867/]

The next year, in 2015, Shi provided Ralph Baric and other researchers at the University of North Carolina at Chapel Hill with spike protein sequences and plasmids of SCH014, one of the viruses Shi, Daszak, and WIV researchers identified in bat feces samples in 2013. American researchers used those samples to create “a chimeric virus expressing the spike of bat coronavirus SHC014 in a mouse-adapted SARS-CoV backbone.” [92] [Menachery, Vineet, et. al. “A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.” Nat Med, 9 Nov. 2015, 21:1508–1513. https://doi.org/10.1038/nm.3985] In other words, they removed the spike protein from SHC014 and inserted it into a SARS coronavirus that was genetically manipulated to better infect mice. This work was done under BSL-3 conditions. The newly created virus was then shown to bind to ACE2 in humans, replicate “efficiently” [93] [Menachery.] in primary human airways cells, and withstand antibodies and vaccines. Researchers concluded that the work “suggests a potential risk of SARSCoV re-emergence from viruses currently circulating in bat populations.” [94] [Ibid.] This research was funded by NIAID and the NIH under multiple awards (nos. U19AI109761, U19AI107810, AI085524, F32AI102561, K99AG049092, DK065988), USAID’s PREDICT program via EcoHealth Alliance, and the PRC government. Baric was the corresponding author. [95] [Ibid.]

2015 also saw the publication of another Shi/Hu/Wang/Daszak paper. Entitled “Isolation and Characterization of a Novel Bat Coronavirus Closely Related to the Direct Progenitor of Severe Acute Respiratory Syndrome Coronavirus,” it was published in the Journal of Virology. Nine of the twelve authors were WIV researchers, including Hu and Shi, who was the corresponding author. Here the WIV reported the successful isolation of a second novel coronavirus, WIV16. The SARS-like coronavirus was isolated from a single sample of bat fecal matter collected in Kunming, Yunnan Province of the PRC in July 2013. Like previous papers, this work was supported by a NIAID grant (no. R01AI110964) and by grants from the PRC government (including grant no. 2013FY113500). [96] [Yang, Xing-Lou et al. “Isolation and Characterization of a Novel Bat Coronavirus Closely Related to the Direct Progenitor of Severe Acute Respiratory Syndrome Coronavirus.” Journal of Virology, 30 Dec. 2015, 90(6): 3253-6. https://dx.doi.org/10.1128%2FJVI.02582-15]

In addition to her aforementioned work with researchers at UNC Chapel Hill, Shi also provided them with additional bat coronavirus sequences and plasmid of WIV1’s spike protein. The resulting paper, “SARS-like WIV1-CoV poised for human emergence,” was published in the Proceedings of the National Academy of Sciences of the United States of America in March 2016. While neither Shi nor Daszak (nor any WIV researcher) are listed as coauthors, Baric was the corresponding author.

This paper is significant because the authors discuss moving from disease surveillance to creating chimeric viruses as a means of pandemic preparedness; “this manuscript describes efforts to extend surveillance beyond sequence analysis, constructing chimeric and full-length zoonotic coronaviruses to evaluate emergence potential.” [97] [Menachery, Vineet, et al. “SARS-like WIV1-CoV poised for human emergence.” Proceedings of the National Academy of Sciences of the United States of America, 14 March 2016, 113(11): 3048-53. https://dx.doi.org/10.1073%2Fpnas.1517719113]

During this work, researchers produced chimeric viruses created by inserting the spike protein from WIV1 into a strain of SARS-CoV adapted to infecting mice. They subsequently tested this chimeric virus in human airway epithelial cells as well as in mice. [98] [Ibid.] In addition to standard BALB/c mice (a strain of albino, lab-breed house mice used in experimentation [99] [“Inbred Strains: BALB.” MGI, http://www.informatics.jax.org/inbred_s ... BALB.shtml.]), researchers genetically manipulated the mice to create a strain of mice expressing the human ACE2 (hACE2) receptor. While hACE2 was found primarily in the lungs of the mice, it was also present in the brain, liver, kidneys, and gastrointestinal tract. The WIV1 chimeric virus was then tested in these hACE2 expressing mice, proving that the chimeric virus could infect humans. This work was funded by NIAID and NIH awards (nos. U19AI109761, U19AI107810, AI1085524, F32AI102561, K99AG049092, DK065988, AI076159, and AI079521). [100] [Menachery 2016.]

In 2016, Shi and Daszak also coauthored two additional papers focused on infectious diseases that year. One, entitled “Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response,” was coauthored by Wang and represents a major step forward in the WIV’s work. While working on this project, WIV researchers created a reverse genetics system and used it to genetically modify WIV1, the live coronavirus that was successfully isolated in 2013 and that UNC researchers manipulated months earlier. WIV researchers created multiple versions of this virus by deleting or adding genetic information to the virus’ RNA. According to the paper, all experiments with live virus for this paper were done under BSL-2 conditions, which does not require respirators or biological safety cabinets. Nine of the eleven authors are WIV researchers, and Shi is the corresponding author. The experimentation for the paper was supported by a grant from NIAID (no. R01AI110964) and funding from the PRC government. [101] [Zeng, Lei-Ping et al. “Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response.” Journal of Virology, 24 June 2016, 90(14): 6573-6582. https://dx.doi.org/10.1128%2FJVI.03079-15]

The following year, Ben Hu was the lead author of a paper entitled “Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus.” As with previous papers, the overwhelming majority (14 out of 17) of the authors worked at the WIV. Daszak, Shi, and Wang are all listed as coauthors. Hu is the lead author and Shi is one of two corresponding authors. Daszak is credited for “funding acquisition.” [102] [Hu, Ben et al. “Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus.” PLOS Pathogens, 30 Nov. 2017, 13(11). https://dx.doi.org/10.1371%2Fjournal.ppat.1006698]

Additionally, using the reverse genetics system they debuted the previous year, WIV researchers created eight separate chimeric viruses by inserting the spike protein of various SARS-like coronaviruses into WIV1. Two of these chimeric viruses (WIV1-Rs4231S and WIV1-Rs7327S), and one natural virus, Rs4874, all replicated within hACE2 expressing cells. [103] [Hu, 2017.]

To reiterate, WIV researchers created chimeric coronaviruses able to infect humans in 2017, before the WNBL BSL-4 lab became operational. This work was jointly funded by NIAID (no. R01AI110964), USAID’s PREDICT program, and the PRC government (including grant no. 2013FY113500).

Research Regarding SARS-Like Coronaviruses at the WIV or in Conjunction with WIV Scientists from 2018-2019

While Shi and Daszak coauthored several additional papers in 2018 and 2019 regarding coronaviruses, none include gain-of-function research on SARS-like coronaviruses designed to make them more infectious to humans. This is especially odd given that in 2018 the Chinese Academy of Science launched a new special project titled “Pathogen Host Adaption and Immune Intervention.” [104] [“Guidelines for the application of the ‘Pathogen Host Adaptation and Immune Intervention’ project of the Chinese Academy of Sciences Strategic Leading Technology.” Chinese Academy of Sciences, 6 Sept. 2018, https://archive.is/spmNg#selection-3389.0-3389.160] One of the five subprojects was titled “Research on Virus Traceability, Cross-Species Transmission, and Pathogenic Mechanism,” – Shi is listed as one of the two scientists in charge. [105] [Ibid.] This subproject had three areas of focus: 1) the traceability, evolution and transmission mechanism of new pathogens; 2) molecular mechanisms of viral cross-species infection and pathogenicity, and 3) the interaction mechanism between virus and host.

A second WIV scientist, Cui Zongqiang, was one of two researchers in charge of another subproject entitled, “New methods and new technologies for infection and immune research.” [106] [Ibid.] This project focused on, among other things, evaluating new vaccines and establishing “humanized small animal models” [107] [Ibid.] for in vitro pathogen testing. [108] [Ibid.]

In January 2018, Shi was appointed Principal Investigator for a new Strategic Priority Research Program of the Chinese Academy of Sciences (grant no. XBD29010101, $1.35 million USD), investigating “genetic evolution and transmission mechanism of important bat-borne viruses.” [109] [Shi, Zheng-li. “Curriculum Vitae.” https://www.ws-virology.org/wp-content/ ... li-Shi.pdf “Study on the evolutionary mechanism of bat SARS-like coronavirus adapted to host receptor molecules and the risk of cross-species infection.”] This project, especially with its focus on transmission mechanisms, aligns with the first focus area mentioned above. That same month, Shi began work on a project titled “Study on the evolutionary mechanism of bat SARS-like coronavirus adapted to host receptor molecules and the risk of crossspecies infection.” [110] [MedSci, https://archive.is/g35C6#selection-1425.0-1425.139] The project was funded at a value of roughly $850,000 USD (grant no. 31770175) and is slated to run until December 2021. [111] [Ibid.] This grant aligns with the second focus area, the description of which specifically mentions replicating and modifying coronaviruses (emphasis added):

For important emerging emergencies and virulent viruses (influenza virus, Ebola virus, coronavirus, Marburg virus, arenavirus, etc.), by studying their ability to invade different host cells and their ability to replicate in different host cells, analyze the key molecules affecting their cross-species infections and their pathogenic mechanisms. Including: virus invasion, virus replication and assembly, and infection model. [112] [“Guidelines for the application of the ‘Pathogen Host Adaptation and Immune Intervention’ project of the Chinese Academy of Sciences Strategic Leading Technology.” Chinese Academy of Sciences, 6 Sept. 2018, https://archive.is/spmNg#selection-3389.0-3389.160]


Shi did not publish any papers funded by this grant before the start of the pandemic. As such, it is impossible to know what experiments she was conducting in the months prior to the pandemic.

Further evidence expands on Shi’s work in 2018 and 2019. In January 2019, Shi and several other scientists were awarded a National Natural Science Award Second Prize for a project entitled, “Research on Important Viruses Carried by Chinese Bats.” [113] [“Catalogue and introduction of the 2018 National Natural Science Award winning projects.” Ministry of Science and Technology, 8 Jan. 2019, https://archive.is/jKq7B#selection-187.0-187.86] Five out of the six researchers on the award were coauthors of the previously discussed 2013 paper entitled, “Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.”

In January 2019, Ben Hu, was awarded $385,850 in grant money (grant no. 31800142) by the Youth Science Fund Project (YSFP) of the National Natural Science Foundation of China. [114] [“Pathogenicity of two new bat SARS-related coronaviruses to transgenic mice expressing human ACE2.” MedSci, https://archive.is/shrM2#selection- 1545.0-1558.0] The YSFP “supports the young researchers to independently select topics within the scope of the scientific funding and carry out basic research.” [115] [“[Good News] 100% winning bid! All applications of the National Natural Science Foundation of China(NSFC) were approved.” Faculty of Economics and Management, ECNU Academy of Statistics and Interdisciplinary Sciences, 11 May 2020, http://asis.ecnu.edu.cn/asisenglish/64/ ... 0/page.htm] This project, selected by Ben Hu, was titled, “Pathogenicity of two new bat SARS-related coronaviruses to transgenic mice expressing human ACE2.” [116] [“Pathogenicity of two new bat SARS-related coronaviruses to transgenic mice expressing human ACE2.” MedSci, https://archive.is/shrM2#selection- 1545.0-1558.0] To date, the two novel SARS-related coronaviruses have not been identified, and the grant money has only been cited in papers published about SARS-CoV-2.

WIV researchers confirmed to the WHO investigative team that they were conducting experimentations testing chimeric coronaviruses in 2018 and 2019. [117] [Joint Report – ANNEXES.] According to an interview with Shi published by Science, all coronavirus experimentation, including infecting hACE2 mice and civets, was done at the BSL-2 and BSL-3 levels – “the coronavirus research in our laboratory is conducted in BSL-2 or BSL-3 laboratories.” [118] [Shi, Zheng-li. “Reply to Science Magazine.” Science Magazine, https://www.sciencemag.org/sites/defaul ... 0Q%26A.pdf]

This ongoing work appears to coincide with Peter Daszak’s stated goal of developing a broadspectrum coronavirus vaccine. In a May 19, 2020, interview with “This Week in Virology,” Daszak discussed the goal of the gain-of-function work he funded on coronaviruses with the WIV (emphasis added):

Coronaviruses are pretty good – I mean you’re a virologist, you know all this stuff – but the… you can... um manipulate them in the lab pretty easily. The spike protein drives a lot of what happens with the coronavirus – zoonotic risk. So, you can get the sequence, you can build the protein, and we work with Ralph Baric at UNC to do this, insert it into a backbone of another virus, and do some work in the lab. So, you can get more predictive when you find a sequence – you’ve got this diversity. Now, the logical progression for vaccines is, if you’re going to develop a vaccine for SARS, people are going to use pandemic SARS, but let’s try to insert some of these other related [viruses] and get a better vaccine. [119] [Racaniello, Vincent. “TWiV 615: Peter Daszak of EcoHealth Alliance.” YouTube, interview by Vincent Racaniello,19 May 2020, https://www.youtube.com/watch?v=IdYDL_RK--w]


Shi, Hu, and others at the WIV were the ones collecting, identifying, genetically modifying, and testing these novel coronaviruses against human immune systems for Peter Daszak.

In sum, in the years leading up to the emergence of SARS-CoV-2, there was:

• Research by Shi and others at the WIV on how to alter the spike protein of non-infectious
SARS-like coronaviruses so that they can bind to human ACE2 receptors;
• Repeated collaboration between Shi, Hu, Daszak, Wang, and other researchers on
genetically manipulating coronaviruses to increase their infectiousness in humans;
• A new PRC Strategic Priority Research Program, run by Shi, that was actively
manufacturing chimeric viruses in BSL-2 and BSL-3 conditions and seeking out novel
viruses;
• Evidence of ongoing collaboration between Shi and the other scientists who first isolated
a live coronavirus in 2013;
• A second grant awarded to Hu to test novel coronaviruses against human immune
systems in BSL-2 and BSL-3 conditions;
• A stated effort to develop a broad-spectrum coronavirus vaccine.

Given the above, it is self-evident that Shi and her colleagues, with funding and support from Daszak, were actively genetically manipulating coronaviruses and testing them against human immune systems in 2018 and 2019, before the beginning of the pandemic.


Unusual Features of SARS-CoV-2

Committee Minority Staff interviews with scientists and current and former U.S. government officials raised several questions about the natural origins of SARS-CoV-2, including:

1. The highly infectious nature of SARS-CoV-2, which they consider as infectious as measles;

2. The lack of an identified intermediate host (found 4 months after the outbreak of SARS and 9 months after MERS); and

3. The highly efficient binding to human ACE2.

The highly contagious nature of SARS-CoV-2 has been a hot topic of conversation since the virus began to spread around the world. Some scientists and other experts point to the incredibly high case numbers as evidence that SARS-CoV-2 is inherently different from known natural betacoronaviruses. For example, MERS first appeared in 2012 and has infected less than 4,000 people. SARS first appeared in 2002 and infected less than 10,000. At the time of writing, less than two years from when it has first appeared, SARS-CoV-2 has infected more than 196.4 million people.

SARS-CoV-2 also has a highly unusual affinity for binding to human ACE2 receptors over other hosts. In February 2020, American researchers examined this issue closely. They found that SARSCoV- 2’s spike protein “binds at least 10 times more tightly than the corresponding spike protein of severe acute respiratory syndrome (SARS)–CoV to their common host cell receptor.” [120] [Wrapp, Daniel et al. “Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.” Science, 13 March 2020, 367(6483): 1260-1263. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164637/] In other words, SARS-CoV-2 binds more than 10 times more tightly to human ACE2 than the virus that causes SARS. The researchers found this likely explains why the virus is so contagious. [121] [Ibid.]

Australian and British researchers also examined how SARS-CoV-2 binds to the ACE2 of various animals, publishing their research in Scientific Reports on June 24, 2021. The scientists found that SARS-CoV-2’s spike protein binds the strongest to human ACE2. They reported (emphasis added):

This finding was surprising as a zoonotic virus typically exhibits the highest affinity initially for its original host species, with lower initial affinity to receptors of new host species until it adapts. As the virus adapts to its new host, mutations are acquired that increase the binding affinity for the new host receptor. Since our binding calculations were based on SARS-CoV-2 samples isolated in China from December 2019, at the very onset of the outbreak, the extremely high affinity of S protein for human ACE2 was unexpected. [122] [Piplani, S., et. al. “In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.” Scientific Reports, 24 June 2021, 11(13063) https://www.nature.com/articles/s41598-021-92388-5]


The first preprint version of this paper went further, concluding, “the data indicates that SARS-CoV- 2 is uniquely adapted to infect humans, raising important questions as to whether it arose in nature by a rare chance event or whether its origins might lie elsewhere” emphasis added. [123] [Piplani, S., et. al. Preprint of “In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.” ArXiv, 13 May 2020, https://arxiv.org/abs/2005.06199v1] This research provides evidence that SARS-CoV-2 is uniquely well adapted to humans, suggesting a non-zoonotic source of the outbreak.

The Furin Cleavage Site

One of the most discussed questions centers around the furin cleavage site (FCS) of SARS-CoV-2. The FCS is part of the virus’ spike protein, which enables it to bind to and enter human cells. In February 2020, French and Canadian scientists reported SARS-CoV-2 contains an FCS that is absent in other coronaviruses of the same clade, or branch of viruses believed to have a similar common ancestor. The scientists also reported that when a bronchitis virus was modified by inserting a similar cleavage site, the virus’ pathogenicity was increased. [124] [Coutard, B et al. “The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade.” Antiviral Research, Feb. 2020, 176: 104742 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114094/] While some scientists have noted that other coronaviruses contain furin cleavage sites, phylogenetic analysis shows that SARS-CoV-2 is the only identified sarbecovirus (a subsection of betacoronaviruses) with this feature. [125] [Wu, Yiran, and Suwen Zhao. “Furin cleavage sites naturally occur in coronaviruses.” Stem Cell Research, 9 Dec. 2020, 50:102115. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836551/]

In January 2021 a group of American researchers published “Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis” in Nature. In the article, researchers reported the FCS “may have facilitated the emergence of SARS-CoV-2 in humans.” [126] [Johnson, B.A., et. al. “Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.” Nature, 25 Jan. 2021, 591: 293-299. https://www.nature.com/articles/s41586-021-03237-4] Using a reverse genetic system, they created a mutant strain of SARS-CoV-2 which lacked the FCS. The result was a virus that was weakened in human respiratory cells and that exhibited reduced development in hACE2 expressing mice. This demonstrates the importance of the FCS in the rapid spread of COVID-19.

In other words, did the FCS develop naturally, or was it added in via genetic manipulation? Part of the genetic sequence for the FCS includes a CGG double codon (CGG-CGG). This group of six nucleotides (a group of three nucleotides is also known as a codon) is half of the 12 nucleotides that create the FCS. SARS-CoV-2 is the only identified coronavirus within its class to feature this combination. Some believe this is evidence of genetic manipulation, arguing this double codon is a telltale sign of the FCS being artificially inserted into the virus. [127] [Quay, Steven, and Richard Muller. “The Science Suggests a Wuhan Lab Leak.” The Wall Street Journal, 6 June 2021, http://www.wsj.com/articles/the-science ... 1622995184.]

The “No-See-Um” Method

Critics of the theory that the virus was genetically modified or man-made have repeatedly pointed to the apparent lack of telltale signs of genetic manipulation in the SARS-CoV-2 genome. They claim this is “proof” the virus was not only naturally occurring, but that the COVID-19 pandemic could only be the result of a zoonotic spillover event. Such arguments ignore key pieces of evidence to the contrary.

Molecularly cloned viruses were indistinguishable from wild type.

– Dr. Ralph Baric


In 2005, Ralph Baric, one of the researchers at UNC Chapel Hill with whom Shi would later collaborate with between 2014 and 2016, published a paper entitled, “Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs.” [128] [Baric R.S., Sims A.C. “Development of Mouse Hepatitis Virus and SARS-CoV Infectious cDNA Constructs.” Curr Top Microbiol Immunol, 2005; 287:229-52. https://doi.org/10.1007/3-540-26765-4_8] In this paper, Baric references using a novel genetic engineering system he developed with other UNC colleagues to engineer full-length SARSCoV genomes via a “no-see-um” method. This method allows for the assembly of various partial genomic sequences into a full-length genome, creating a new and infectious coronavirus. [129] [Ibid.] The publication includes the below figure, which is titled, “Systemic Assembly Strategy for the SARS-CoV infectious clone.” It clearly shows the various SARS fragments and how they were used to create a full-length, custom genomic sequence.

Image
Fig. 5: Baric’s “No-See-Um” System

The paper stated these viruses were “indistinguishable from wild type,” [130] [Ibid.] meaning that it is impossible to tell they were synthetically created.

Baric himself confirmed this interpretation in a September 2020 interview, where he stated, “You can engineer a virus without leaving any trace. The answers you are looking for, however, can only be found in the archives of the Wuhan laboratory.” [131] [Renda, Silvia. “Possibile Creare Un Virus in Laboratorio Senza Lasciare Traccia? La Risposta Dell'autore Della Chimera Del 2015 Di Cui Parlò Tg Leonardo.” L'HuffPost, 14 Sept. 2020, http://www.huffingtonpost.it/entry/e-po ... alasciare- traccia-la-risposta-dellesperto_it_5f5f3993c5b62874bc1f7339.] Referring to chimeric viruses he generated in 2015 with WIV researchers, Baric said his team intentionally left signature mutations to show that it was genetically engineered. “Otherwise there is no way to distinguish a natural virus from one made in the laboratory.” [132] [Ibid.]

Shi and Baric have collaborated on multiple papers regarding coronaviruses. The most recent of which was in May 2020, when they joined other researchers in publishing “Pathogenesis of SARSCoV- 2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.” [133] [Jiang, Ren-Di et al. “Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.” Cell, 21 May 202, 182(1): 50-58.e8. https://dx.doi.org/10.1016%2Fj.cell.2020.05.027] One year later, Baric signed onto a May 14, 2021, letter published in Science which argued that the lab leak theory must be taken seriously and should be fully evaluated. [134] [Bloom, Jesse D., et. al. “Investigate the origins of COVID-19.” Science, 14 May 2021; 372(6543): 694. https://science.sciencemag.org/content/372/6543/694.1]

In 2017, a dissertation was submitted to the University of Chinese Academy of Sciences by Zeng Leiping, a doctoral student working at the WIV, entitled “Reverse Genetic System of Bat SARS-like Coronaviruses and Function of ORFX.” [135] [Leiping, Zeng. Reverse Genetic System of Bat SARS-like Coronaviruses and Function of ORFX. 2017. The University of Chinese Academy of Sciences, PhD dissertation. English translation first made available by @TheSeeker268 on Twitter, https://twitter.com/TheSeeker268/status ... 07776?s=20] The referenced reverse genetic system is the same that was used by the WIV in 2016 to create genetically modified viruses and conduct experiments with live viruses under BSL-2 conditions. In his dissertation, Zeng stated the he and other WIV researchers used this system to "construct an S gene chimeric recombinant viral infectious BAC clone with WIV1 as the backbone and without leaving any trace sequences (e.g. incorporated enzymatic sites) in the recombinant viral genome” (emphasis added).

In an end-of-chapter discussion in the dissertation, Zeng reiterates this lack of evidence of genetic manipulation, stating:

We established a reverse genetics system for coronaviruses, and based on the genomic backbone of WIV1, we established a scheme to replace the S gene without traces, constructed infectious BAC clones of 12 S-gene chimeric recombinant viruses, and successfully rescued. Four of these recombinant viral strains (including Rs4231, Rs4874, Rs7327, and SHC014) were tested for ACE2 utilization by these strains in humans, civets, and bats.


Zeng was employed at the WIV when he submitted his dissertation, and Shi was his advisor. As such, it is clear that Shi and others at the WIV not only possessed the capability to genetically modify coronaviruses “without traces,” but were actively doing so in the years leading up to the current pandemic. It appears Zeng Leiping is currently a postdoctoral research fellow in bioengineering at Stanford University.

Re: U.S. government gave $3.7 million grant to Wuhan lab at

PostPosted: Thu Aug 19, 2021 1:57 am
by admin
Part 3 of 4

IV. EVIDENCE OF A LAB LEAK COVER-UP

In addition to the events previously discussed (sequence database taken offline, road closures during the MWG, etc.), there are several additional incidents that suggest the PRC, WIV researchers, and others were actively working to suppress and discredit early conversations that the virus could have been man-made or that it could have leaked from a WIV facility.

In April 2012, six miners working in a copper mine located in Yunnan province of the PRC fell ill. Between the ages of 30 and 63, the workers presented to a hospital in Kunming with “persistent coughs, fevers, head and chest pains and breathing difficulties.” [139] [Stanway, David. “Explainer: China's Mojiang Mine and Its Role in the Origins of COVID-19.” Reuters, 9 June 2021, http://www.reuters.com/business/healthc ... 021-06-09/.] Three of the six eventually died. Researchers from the WIV were asked to investigate and test samples from the sick miners. They also began collecting samples from bats in the cave that housed the mine, which led to the discovery of several new coronaviruses. As a result, the WIV began a long-term study of the mine, collecting samples each year. Despite this, Shi maintains the miners were killed by a fungus growing on bat feces not from a virus. [140] [Qiu, Jane. “How China's 'Bat Woman' Hunted Down Viruses from SARS to the New Coronavirus.” Scientific American, 1 June 2020, http://www.scientificamerican.com/artic ... onavirus1/]

ID4991 vs. RaTG13: SARS-CoV-2’s “Closest Relative”

A 2016 paper published by PRC researchers (most of whom are affiliated with the WIV) describes these efforts as researchers conducting “surveillance of coronaviruses in bats in an abandoned mineshaft in Mojiang County, Yunnan Province, China, from 2012–2013.” [141] [Ge, Xing-Yi et al. “Coexistence of multiple coronaviruses in several bat colonies in an abandoned mineshaft.” Virologica Sinica, 3 Feb. 2016; 31(1): 31-40. https://dx.doi.org/10.1007%2Fs12250-016-3713-9] Shi and Hu are listed as coauthors. WIV researchers identified two new betacoronaviruses – HiBtCoV/3740-2 and RaBtCoV/4991. The study concluded, “RaBtCoV/4991 showed more divergence from human SARSCoV than other bat SL-CoVs and could be considered as a new strain of this virus lineage.” [142] [Ibid.] Shi designed and coordinated the study, drafted the manuscript, and is listed as the corresponding author.

Four years later and after the initial reports of an unknown SARS-like coronavirus in Wuhan, Shi and 28 other PRC scientists submitted an article to Nature for publication entitled, “A pneumonia outbreak associated with a new coronavirus of probably bat origin,” [143] [Zhou, P., et al. “A pneumonia outbreak associated with a new coronavirus of probable bat origin.” Nature, 3 Feb 2020, 579: 270–273. https://doi.org/10.1038/s41586-020-2012-7] on January 20, 2020. It was published in early February. It should be noted that this manuscript was submitted on the same day the PRC’s National Health Commission first issued a statement confirming human-to-human transmission – one month after local health officials warned the CCP human-to-human transmissions were occurring. [144] [Wang, Yanan. “Human-to-Human Transmission Confirmed in China Coronavirus.” AP NEWS, 20 Jan. 2020. https://apnews.com/14d7dcffa205d9022fa9ea593bb2a8c5] It is highly unlikely Shi and her coauthors would have written this paper the same day they submitted it, meaning they were aware for days or perhaps weeks that the virus was spreading via from human-to-human transmission and did not alert the world. According to a study by researchers at the University of Southampton, implementing appropriate restrictions based on human-to-human transmission just one week before this paper was published would have reduced the number of cases in Wuhan by 66%. [145] [Lai, Shengjie, et al. “Effect of Non-Pharmaceutical Interventions for Containing the COVID-19 Outbreak in China.” MedRxiv, 2020, https://www.medrxiv.org/content/10.1101 ... 20029843v3.] This would have made a significant difference in the spread of the virus, especially in conjunction with the significant travel that occurred during the Spring Festival, which ran from January 10 to January 23, 2020, when the city of Wuhan was locked down.

Shi is listed as the corresponding author for the article, which states that COVID-19 “has now progressed to be transmitted by human-to-human contact.” [146] [Zhou (2020).] The researchers conclude that RaTG13, an allegedly naturally occurring bat coronavirus, is the closest relative to SARS-CoV-2 (emphasis added):
We then found that a short region of RNA-dependent RNA polymerase (RdRp) from a bat coronavirus (BatCoV RaTG13)—which was previously detected in Rhinolophus affinis from Yunnan province—showed high sequence identity to 2019- nCoV. We carried out full-length sequencing on this RNA sample (GISAID accession number EPI_ISL_402131). Simplot analysis showed that 2019-nCoV was highly similar throughout the genome to RaTG13 (Fig. 1c), with an overall genome sequence identity of 96.2%. Using the aligned genome sequences of 2019-nCoV, RaTG13, SARS-CoV and previously reported bat SARSr-CoVs, no evidence for recombination events was detected in the genome of 2019-nCoV. Phylogenetic analysis of the full-length genome and the gene sequences of RdRp and spike (S) showed that—for all sequences—RaTG13 is the closest relative of 2019-nCoV and they form a distinct lineage from other SARSr- CoVs (Fig. 1d and Extended Data Fig. 2)…The close phylogenetic relationship to RaTG13 provides evidence that 2019-nCoV may have originated in bats. [147] [Ibid.]

A close examination of the paper, and the corrections published months later, reveal inconsistences in the researchers’ claims. Several of the statements made in the above quotation are simply false. After months of criticism and questioning about RaTG13, Shi and the other researchers were forced to publish an addendum on November 17, 2020. That addendum reveals that RaTG13 was actually ID4991, the sample collected years prior in 2012 or 2013, and that the full-length genomic sequence was obtained in 2018, not in January 2020 as the paper originally stated. [148] [Zhou, P., et. al. “Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin.” Nature, 17 Nov. 2020, 588: E6. https://doi.org/10.1038/s41586-020-2951-z]

Unfortunately, no other labs can confirm the genomic sequence of RaTG13 – Shi said in an interview published in Science Magazine that the entire sample was used up after genomic sequencing. [149] [Shi, Zheng-li. “Reply to Science Magazine.” Science Magazine, https://www.sciencemag.org/sites/defaul ... 0Q%26A.pdf] The inability of outside researchers to verify the genome of RaTG13, and the above efforts to obfuscate when the WIV collected and sequenced RaTG13, raises multiple questions:

• Why leave out of the February 2020 article that the virus sequence was renamed?

• Why lie about when the full-length sequence was obtained?

• Why only issue a correction almost ten months later?

• Why was this sample destroyed via testing when others weren’t?

In December 2020, reporters from BBC News attempted to visit the cave in Yunnan where RaTG13 was collected. They found themselves followed by plain-clothes police officers and stopped at checkpoints where they were told to stay out of the area. [150] [Sudworth, John. “Covid: Wuhan Scientist Would 'Welcome' Visit Probing Lab Leak Theory.” BBC News, 21 Dec. 2020, http://www.bbc.com/news/world-asia-china-55364445.] A French publication, Envoye Special, produced a video in which they reported conversations with villagers who lived near the mine. According to one of those villagers, the mine was closed and monitored via surveillance cameras. That villager also alleged several people were arrested for venturing too close to the mine. [151] [Asis, Francisco de. “Quite Important the Conversation with Danaoshan Inhabitant.- He Pointed towards the Location We Already Knew for the Mine.- The Roadblocks Are Probably the Diverted Traffic We Already Observed Too.Rest of the Story Is Just Incredible! Pic.twitter.com/kzHz7v5rSg.” Twitter, Twitter, 12 Mar. 2021, https://twitter.com/franciscodeasis/sta ... 88641?s=20.]

It is important to note that in March 2020, American, British, and Australian researchers published “The proximal origin of SARS-CoV-2” in Nature Magazine. [152] [Andersen, Kristian G et al. “The proximal origin of SARS-CoV-2.” Nature Medicine, 17 March 2002, 26(4):450-452. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095063/] Regarding RaTG13, they found, “Although RaTG13, sampled from a Rhinolophus affinis bat, is ~96% identical overall to SARSCoV- 2, its spike diverges in the RBD, which suggests that it may not bind efficiently to human ACE2.” [153] [Ibid.] “RBD” is an abbreviation for receptor-binding domain, part of the virus’ spike protein. This is the same part of the virus’ genome that Shi, Hu, and other WIV researchers were genetically modifying and replacing as far back as 2015.

If SARS-CoV-2 was genetically modified, this could represent a viable model for how. RaTG13’s RBD, or full spike protein, could be replaced using the WIV’s reverse genetic system. If one of the many unpublished coronaviruses in the WIV’s possession was modified, and the resulting chimeric virus was then exposed to hACE2 expressing mice or civets, the resulting virus could become better adapted to infecting humans – just like SARS-CoV-2.

According to scientists – including those working at the WIV – ID4991/RaTG13 is more closely related to SARS-CoV-2 than any other publicly identified virus. It’s now clear WIV researchers had this virus as early as 2013, several years before the WIV began genetically modifying other coronaviruses found in the wild. Given the largest difference between RaTG13 and SARS-CoV-2 is at the spike protein – precisely where the WIV modified various coronaviruses for years – and that WIV researchers renamed the virus and lied about when they sequenced, ID4991/RaTG13 could be a source of genetic material if SARS-CoV-2 was indeed genetically modified.

According to emails obtained by Buzzfeed News, it appears Kristian G. Andersen, the lead and corresponding author of the abovementioned article, initially considered this a viable theory. In a January 31, 2020 email to Dr. Anthony Fauci, the director of NIAID, Andersen stated that parts of the virus were possibly engineered and inconsistent with evolutionary theory:

Image
Fig. 8: Andersen Email Suggesting SARS-CoV-2 was Genetically Modified [154] [Andersen, Kristian G. Email to Anthony Facui and Jeremy Farrar. 31 Jan. 2020. https://s3.documentcloud.org/documents/ ... emails.pdf]
From: Kristian G. Andersen [DELETE]
Sent: Friday, January 31, 2020 10:32 PM
To: Fauci, Anthony (NIH/NIAID) [E] [DELETE]
Cc: Jeremy Farrar [DELETE]
Subject: Re: FW: Science: Mining coronavirus genomes for clues to the outbreak's origins

Hi Tony,

Thanks for sharing. Yes, I saw this earlier today and both Eddie and myself are actually quoted in it. It's a great article, but the problem is that our phylogenetic analyses aren't able to answer whether the sequences are unusual at individual residues, except if they are completely off. On a phylogenetic tree the virus looks totally normal and the close clustering with bats suggest that bats serve as the reservoir. The unusual features of the virus make up a really small part of the genome (<9,1%) so one has to look really closely at all the sequences to see that some of the features (potentially) look engineered.

We have a good team lined up to look very critically at this, so we should know much more at the end of the weekend. I should mention that after discussions earlier today, Eddie, Bob, Mike, and myself all find the genome inconsistent with expectations from evolutionary theory. But we have to look at this much more closely and there are still further analyses to be done, so those opinions could still change.

Best,
Kristian

The WIV’s intentionally misleading February 2020 paper regarding RaTG13 was uploaded as a preprint on January 23rd. [155] [Zhou, Peng, et. al. Preprint of “Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin.” 23 Jan. 2020, bioRxiv, https://www.biorxiv.org/content/10.1101 ... 2.914952v2] Given that Andersen and his coauthors cited it in their March 2020 paper, it is all but certain that Andersen, Dr. Fauci, and the others would have seen it before Andersen sent this email. The day after Anderson emailed Dr. Fauci on February 1, 2020, Dr. Fauci, Andersen, and others debated this issue via teleconference. Previously, they had agreed to keep the debate confidential. Following this discussion, Andersen abandoned his claims that the virus was genetically modified. [156] [Young, Alison. “'I Remember It Very Well': Dr. Fauci Describes a Secret 2020 Meeting to Talk about COVID Origins.” USA Today, 18 June 2021, http://www.usatoday.com/story/opinion/2 ... 737494002/.] It is unclear what was said on this call that led to Anderson doing so.

Additional Cover-Up Activities by Scientists at the WIV

As more investigative work continues on the type of research being conducted at the WIV, CCP censors and WIV researchers have been deleting or scrubbing references to coronavirus research that could be related to the origins of the COVID-19 pandemic. As previously discussed, Ben Hu received a Youth Science Fund Project award to test the pathogenicity of two novel SARS-related coronaviruses beginning in 2019. In some publicly facing PRC websites, Hu’s name has now been struck from the grant.

Image
Fig. 9: Ben Hu’s Name Removed From 2019 Grant [157] [2019 Natural Science Foundation Query and Analysis System. https://journal.medsci.cn/m/nsfc.do? u=%E4%B8%AD%E5%9B%BD%E7%A7%91%E5%AD%A6%E9%99%A2%E6%AD%A6%E6%B1%89%E7%97%85%E6%AF%9 2%E7%A0%94%E7%A9%B6%E6%89%80]
CO10802 / To study the mechanism of baculovirus Ac34 protein inhibiting the nuclear pathway of mammalian CRM1 / Mu Jingfang / Wuhand Institute of Virology, Chinese Academy of Sciences

C010802 / Pathogenicity of two new bat SARS-related coronaviruses to transgenic mic expressing human ACE2 / -- / Wuhan Institute of Virology, Chinese Academy of Sciences

H1904 / Study on the mechanism of enterovirus 71 type 3A protein antagonizing RNAI antiviral immunity / Qiu Yang / Wuhan Institute of Virology, Chinese Academy of Sciences

Of the almost 80 WIV grants listed in the database, the one awarded to Ben Hu is the only one that does not identify the principal investigator.

A December 12, 2017, interview with Hu was pulled offline after it began circulating on Twitter. In the article, Hu discusses monitoring and collecting samples from the bat cave in Yunnan and his work using the reverse genetic system to insert spike proteins into live coronaviruses. Interestingly, he discusses how Shi Zheng-li “often personally leads the team to take samples.” [158] [“Hunting bat viruses, tracking the origin of SARS, an interview with Dr. Hu Ben, Wuhan Institute of Virology, Chinese Academy of Sciences.” First Author, 12 Dec. 2017, https://archive.vn/sVHmq#selection-45.79-45.215] It is likely that this article was pulled down for drawing attention to the cave where RaTG13 was collected.

Similarly, a 2018 article written by Hu and published on the website for the Wuhan Branch of the Chinese Academy of Sciences has also been removed. [159] [Hu, Ben. “The Wuhan Institute of Virology's "Research on Chinese Bats Carrying Important Viruses" won the first prize of the 2018 Hubei Provincial Natural Science Award.” Wuhan Branch, Chinese Academy of Sciences, 13 April 2018, archived: https://web.archive.org/web/20210107222 ... 91050.html] While the article broadly discusses the work of Shi and other researchers at the WIV, it does not offer any unique insight or evidence of dangerous research. So why was it removed?

Perhaps most incriminating are Shi’s repeated lies about activities taking place at the WIV. In August 2020, after the publication of the Committee Minority Staff’s interim report, the China Global Television Network interviewed Shi about our work. In the resulting article, Shi denied that Major General Chen Wei took over the BSL-4 lab:
Liu Xin: The report actually went further and said that the lab has been taken over by the Chinese military. It says that Major General Chen Wei has succeeded Yuan Zhiming as the Director of the WIV and Chen Wei is a Chinese military medical sciences expert.

Shi Zhengli: This is a rumor; there is no such thing.

Liu Xin: You absolutely deny that the Chinese military has taken over the WIV.

Shi Zhengli: Yes, it is a rumor. [160] [Xin, Liu. “Exclusive Interview: CGTN's Liu Xin Talks to China's 'Bat Woman'.” CGTN, 26 Aug. 2020, https://news.cgtn.com/news/2020-08-22/C ... index.html.]

This is demonstrably false. As previously discussed, posts made on CCP-controlled forums announcing Chen’s arrival acknowledged her takeover of the lab. The report stated, “PLA Maj. Gen. Chen Wei has been in Wuhan for more than 10 days. She took over the P4 lab as if it were a ‘reassurance pill.’” [161] [Guli.]

During the same interview, and in response to Committee Minority Staff raising questions about a possible lab leak, Shi again lied, claiming that all of the WIV’s research has been published and their samples available for review:
Another piece of evidence that I can give you is that our lab has been doing research for 15 years, and all our work has been published. We also have a library of our own genetic sequences, and we have experimental records of all our work related to the virus, which are accessible for people to check. [162] [Xin.]

This, again, is demonstrably false. The WIV’s sequence library was taken offline in September 2019 and is not “accessible for people to check.” Given the previously discussed undisclosed coronavirus research and military activities at the WIV, it is obvious that not “all” of the WIV’s work has been published. Daszak confirmed this in an interview with Nature: “we have data that we’ve gathered over 15 years of working in China — 5 years under a previous grant from the NIH — which haven’t been published yet.” [163] [Subbaraman, Nidhi. “'Heinous!': Coronavirus Researcher Shut down for Wuhan-Lab Link Slams New Funding Restrictions.” Nature News, 21 Aug. 2020, http://www.nature.com/articles/d41586-020-02473-4.]

In a June 2021 interview, Shi told the New York Times, “my lab has never conducted or cooperated in conducting GOF experiments that enhance the virulence of viruses.” [164] [Qin, Amy, and Chris Buckley. “A Top Virologist in China, at Center of a Pandemic Storm, Speaks Out.” The New York Times, 14 June 2021, http://www.nytimes.com/2021/06/14/world ... -leak.html] This is a bizarre claim given the years of published research, often designed and led by Shi, that explicitly sought to make coronaviruses more infectious to humans. In the same interview, Shi lied about WIV researchers falling ill in the fall of 2019 – “The Wuhan Institute of Virology has not come across such cases.” This is despite the State Department’s January 15th 2021 fact sheet and confirmation from a Dutch virologist on the WHO’s investigative team that several researchers were sick. [165] [Gordon, Michael R., et al. “WSJ News Exclusive | Intelligence on Sick Staff at Wuhan Lab Fuels Debate on Covid-19 Origin.” The Wall Street Journal, 23 May 2021, http://www.wsj.com/articles/intelligenc ... 19-origin- 11621796228.]

Cover-Up Activities by the Chinese Communist Party

According to a WHO internal document from August 2020, the PRC put little effort into determining the source of the SARS-CoV-2 after January 2020:
Following extensive discussions with and presentation from Chinese counterparts, it appears that little had been done in terms of epidemiological investigations around Wuhan since January 2020. The data presented orally gave a few more details than what was presented at the emergency committee meetings in January 2020. No PowerPoint presentations were made and no documents were shared. [166] [Kirchgaessner, Stephanie. “China Did 'Little' to Hunt for Covid Origins in Early Months, Says WHO Document.” The Guardian, 23 Feb. 2021, http://www.theguardian.com/world/2021/f ... o-document]

Given the large amount of financial resources devoted by the PRC in the years prior for locating, sampling, identifying, and experimenting with coronaviruses, it is odd that little effort would be put into determining the source of the virus, if the source was unknown. In mid-February 2020, the PRC’s Ministry of Science and Technology issued new guidelines for laboratory research in the PRC. Official PRC sources stressed:
The mention of biosafety at labs by the ministry has nothing to do with some saying that the coronavirus leaked from the Wuhan Institute of Virology of the Chinese Academy of Sciences. [167] [Caiyu, Liu, and Leng Shumei. “Biosafety Guideline Issued to Fix Chronic Management Loopholes at Virus Labs.” Global Times, 16 Feb. 2020, http://www.globaltimes.cn/content/1179747.shtml.]

Experts interviewed in February 2020 by The Global Times stated that PRC labs paid “insufficient attention to biological disposal.” [168] [Ibid.] This included disposing of lab materials into sewage systems. [169] [Ibid.] Given that these new guidelines were issued after the PRC stopped searching for the source of the outbreak, it raises questions as to what prompted the PRC to stop its search.
Shortly thereafter, on February 25, 2020, the Chinese Center for Disease Control and Prevention issued supplementary regulations affecting how PRC scientists work on research related to COVID- 19. The guidelines prohibit researchers from sharing data or samples and requires them to receive permission prior to conducting research or publishing the results.

Image
Fig. 10: Excerpt from China CDC Regulations Issued on February 25th [170] [Chinese Center for Disease Control and Prevention. “On the Supplementary Regulations on Strengthening the Management of Science and Technology During the Emergency Response to the Novel Coronavirus.” 25 Feb. 2020. https://www.documentcloud.org/documents ... -Regs.html]
3. No one can, under their own name or in the name of their research team, provide other institutions and individuals with information related to the COVID-19 epidemic on their own, including data, biological specimens, pathogens, culture, etc.

4. Before publishing papers and research results related to the COVID-19 epidemic, you must first report them to the Science and Technology Group/Department for preliminary review, and if necessary, submit it to the Emergency Leading Group or the Department of Science and Education of the National Health Commission for approval.

Papers that have been submitted but not yet reviewed by the Science and Technology Group/Department should be withdrawn as soon as possible and redone according to these regulations.

A full copy of the regulations is included in the Appendix.

On February 27, 2020, Health Times, published remarks from an interview with Yu Chuanhua, who referenced health data from February 25th. Yu is the Vice President of the Hubei Health Statistics and Information Society and Professor of Epidemiology and Health Statistics at Wuhan University, and was running a database of confirmed COVID-19 cases in early 2020. In the interview, Yu stated he had evidence of COVID-19 cases as early as September 2019:
Professor Yu Chuanhua said, “For example, there is data on a patient who became ill on September 29. The data shows that the patient has not undergone nucleic acid testing. The clinical diagnosis (CT diagnosis) is a suspected case. The patient has died. This data has not been confirmed and there is no time to death. It may also be wrong data." With the research of the database, Professor Yu Chuanhua found more and more case data before December 8. There were two cases in November, and the onset time was November 14 and November 21, 2019. Before December 8, there were also five or six cases. Among them, one patient who became ill at the end of November was hospitalized on December 2 and was clinically diagnosed with pneumonia. [171] [Wang, Zhenya. “Experts Judge the Source of the New Crown: December 8 Last Year May Not Be the Earliest Time of Onset.” Health Times, 27 Feb. 2020, http://www.jksb.com.cn/index.php?m=wap& ... &id=160018.]

Before the interview was published on February 27th, Yu called the reporter and tried to retract the information regarding the two sick patients in November. [172] [Ibid.] It is likely that this was done to comply with the China CDC gag order that was issued two days prior.

Nine days later, on March 5, 2020, the Joint Prevention and Control Mechanism (JPCM) of the State Council Novel Coronavirus Pneumonia Scientific Research Group issued a confidential memo, obtained by the Associated Press, entitled, “Notice on the Standardization of the Management and Publication of Novel Coronavirus Scientific Research.” [173] [Joint Prevention and Control Mechanism of the State Council Novel Coronavirus Pneumonia Scientific Research Group. “Notice on the Standardization of the Management and Publication of Novel Coronavirus Scientific Research.” 3 Mar. 2020. https://www.documentcloud.org/documents ... tions.html] The notice announced the research group was taking control of all publication work related to the pandemic for “coordinated deployment.” [174] [Ibid.] It also required units publishing research to notify the JPCM’s propaganda team, which was tasked to work with a special public opinion team to coordinate publication of research with public opinion and “social concerns.” [175] [Ibid.]

Image
Fig. 11: Excerpt from JPCM Memo
Each member work unit of the scientific research team will gather scientific research information within their own unit and systems, review and check the content and form of its publication, and report it to the scientific research team for approval in a timely manner. The scientific research group's dedicated teams of professionals and various experts are responsible for reviewing the publication's content and format and giving expert opinions, and when necessary, arranging expert assessment. Aft the scientific research group approves, the publishing work unit should, according to work requirements, arrange publication via press conferences, official websites, state social media, news media and other platforms, and notify the propaganda and scientific research teams of the Joint Prevention and Control Mechanism of the State Council. In principle, COVID-19 scientific research should be published first in the form of an official authoritative publication. The special group on public opinion should strengthen communication with the propaganda team, take into account the trend of public opinion and social concerns, and strengthen guidance of the publication of scientific research and information.

The memo concludes with a warning: “Those who fail to apply for approval in accordance with the prescribed procedures and publish unconfirmed false information on scientific research, thereby causing serious adverse social impacts, shall be held accountable.” [176] [Ibid.] A full copy of the memo is included in the Appendix. These documents are clear evidence of the CCP’s effort to restrict research on SARS-CoV-2, so that the only research published supports the Party’s official story on the origins and emergence of COVID-19.

After the release of the Committee Minority Staff’s interim report on the origins of COVID-19, China Global Television Network, a PRC state-owned media outlet, released a propaganda video aimed at undermining this investigation. Entitled, “Clearing up confusion in McCaul report on COVID-19,” the approximately 45-minute video labels the report “misinformation.” [177] [“The Point: Clearing up Confusion in the McCaul Report On Covid-19.” CCTV News, 25 July 2020, https://www.youtube.com/watch? v=n5qYogMTZOw.] It also discusses what they call the “tired old theory that the virus could have leaked from a lab” [178] [Ibid.] and reveals that Shi Zheng-li was interviewed about our report. [179] [Ibid.] The piece also claims the BSL-4 lab space at the WIV was never taken over by Maj. Gen. Chen Wei. [180] [Ibid.] As discussed earlier, this statement is demonstrably untrue.

In June 2021, Jesse Bloom published a preprint entitled, “Recovery of deleted deep sequencing data sheds more light on the early Wuhan SARS-CoV-2 epidemic.” Bloom is a Principal Investigator and Associate Professor for Basic Sciences and the Herbold Computational Biology Program at Fred Hutch, a cancer research center. Bloom was able to recover multiple deleted viral sequences collected from patients in Wuhan in early December 2020. These sequences were originally uploaded to the NIH’s Sequence Read Archive by researchers in Wuhan, but later deleted at their request.

Oddly, these samples more greatly diverge from SARS-CoV-2’s bat coronavirus ancestor – “the earliest SARSCoV-2 sequences were collected in Wuhan in December, but these sequences are more distant from RaTG13 than sequences collected in January from other locations in China or even other countries.” [181] [Bloom, Jesse D. Preprint: “Recovery of deleted deep sequencing data sheds more light on the early Wuhan SARS-CoV-2 epidemic.” bioRxiv, 29 June 2021, https://www.biorxiv.org/content/10.1101 ... 8.449051v2] Bloom concludes (emphasis added):
The fact that this informative data set was deleted suggests implications beyond those gleaned directly from the recovered sequences. Samples from early outpatients in Wuhan are a gold mine for anyone seeking to understand spread of the virus. Even my analysis of 13 partial sequences is revealing, and it clearly would have been more scientifically informative to fully sequence all 34 samples rather than delete the partial sequence data. There is no obvious scientific reason for the deletion: the sequences are concordant with the samples described in Wang et al. (2020a,b), there are no corrections to the paper, the paper states human subjects approval was obtained, and the sequencing shows no evidence of plasmid or sample-to-sample contamination…. Even though the sequencing data were on the Google Cloud (as described above) and the mutations were listed in a table in the Small paper by Wang et al. (2020b), the practical consequence of removing the data from the SRA was that nobody was aware these sequences existed. Particularly in light of the directive that labs destroy early samples (Pingui 2020) and multiple orders requiring approval of publications on COVID-19 (China CDC 2020; Kang et al. 2020a), this suggests a less than wholehearted effort to maximize information about viral sequences from early in the Wuhan epidemic. [182] [Ibid.]
 
The PRC’s efforts to obfuscate the origins of COVID-19 were not limited to destroying samples and silencing doctors, but featured a sustained disinformation campaign as well. As discussed in our previous report, Lijian Zhao, an official within the PRC’s Foreign Ministry, shared an article on Twitter that claimed the virus was brought to the PRC by the U.S. military. [183] [Zhao, Lijian. “This Article Is Very Much Important to Each and Every One of Us. Please Read and Retweet It. COVID-19: Further Evidence That the Virus Originated in the US. Https://T.co/LPanIo40MR.” Twitter, 13 Mar. 2020, http://www.twitter.com/zlj517/status/12 ... 3427906560] The article was from the Global Times research.ca, a website that pushes pro-Putin propaganda and has reported ties to Russian state media. [184] [Thomas, Elise, and Aspi. “Chinese Diplomats and Western Fringe Media Outlets Push the Same Coronavirus Conspiracies.” The Strategist, 30 Mar. 2020, http://www.aspistrategist.org.au/chines ... spiracies/.] His tweet was amplified by the Chinese Embassy in South Africa. [185] [Chinese Embassy in South Africa. “More Evidence Suggests That the Virus Was Not Originated at the Seafood Market in Wuhan at All, Not to Mention the so Called ‘Made in China’. Https://T.co/8cRxkSZB3z.” Twitter, 16 Mar. 2020, http://www.twitter.com/ChineseEmbSA/sta ... 3689587712]

Image
Fig. 12: PRC Spokesman Tweet Suggesting COVID-19 Arrived in Wuhan via the Military World Games
Lijian Zhao @zlj517 Mar 12, 2020
China government official
2/2 CDC was caught on the spot. When did patient zero being in US? How many people are infected? What are the names of the hospitals? It might be US army who brought the epidemic to Wuhan. Be transparent! Make public your data! US owe us an explanation!
1:03
From Global Times
Get the facts about COVID-19

To further drive this narrative, CCP-controlled media outlets accused Maatje Benassi, a member of the U.S. Army Reserve, as being “patient zero.” Benassi competed at the Military World Games without becoming ill, yet has been repeatedly targeted for harassment. Videos pushing the theory have been uploaded to WeChat, Weibo, and Xigua – PRC based sites. Two weeks after Zhao tweeted that the U.S. army brought the virus to Wuhan, the Global Times amplified the narrative, urging the U.S. government to release athletes’ health info and repeated the claim about Benassi. [186] [Shumei, Leng, and Wan Lin. “US Urged to Release Health Info of Military Athletes Who Came to Wuhan in October 2019.” Global Times, 25 Mar. 2020, http://www.globaltimes.cn/content/1183658.shtml.]

Another tweet by Zhao actually suggests the pandemic did start in September, as is suggested in this addendum, but that it began in the United States. [187] [Zhao, Lijian. US CDC Admitted Some #COVID19 Patients Were Misdiagnosed as Flu during 2019 Flu Season. 34 Million Infected & 20000 Died. If #COVID19 Began Last September, & US Has Been Lack of Testing Ability, How Many Would Have Been Infected? US Should Find out When Patient Zero Appeared. Twitter, 22 Mar. 2020, https://twitter.com/zlj517/status/12417 ... 39168?s=20.]

Image
Fig. 13: PRC Spokesman Tweet Suggesting the COVID-19 Pandemic Started in September 2019.
Lijian Zhao @zlj517 Mar 22, 2020
China government official
US CDC admitted some #COVID19 patients were misdiagnosed as flu during 2019 flu season. 34 million infected & 20000 died. If #COVID19 began last September, & US has been lack of testing ability, how many would have been infected? US should find out when patient zero appeared.

It is important to note that this tweet was sent in March 2020. The previously discussed Harvard study suggesting the pandemic began in September was not published until the second half of 2020. This accusation came ten days after Zhao repeated his theory that the U.S. military brought COVID- 19 to Wuhan. If the CCP realized an investigation would show an uptick in visits of patients with symptoms similar to COVID-19 in September, October, and November of 2019, this would likely be the actions they would take to coverup the source of those illnesses.

WIV Disinformation Campaign Involving Peter Daszak

As we have previously explained, Peter Daszak was heavily involved in the gain-of-function research taking place at the WIV, including research that was done at BSL-2 levels and that was done while the United States had a moratorium in place on funding gain-of-function research. In addition, we have uncovered strong evidence that suggests Peter Daszak is the public face of a CCP disinformation campaign designed to suppress public discussion about a potential lab leak. Emails obtained by a third-party organization show that Daszak organized a February 19, 2020, statement in the Lancet “condemn[ing] conspiracy theories suggesting that COVID-19 does not have a natural origin.” [188] [Calisher, Charles et al. “Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19.” Lancet, 7 Mar. 2020, 395(10226): e42-e43. https://pubmed.ncbi.nlm.nih.gov/32087122/] The statement continued, “Conspiracy theories do nothing but create fear, rumours, and prejudice that jeopardise our global collaboration in the fight against this virus.” [189] [Ibid.] The emails show Daszak’s effort to organize a large group of scientists to sign onto a statement that he personally drafted. One email concludes with Daszak stating, “Please note that this statement will not have EcoHealth Alliance logo on it and will not be identifiable as coming from any one organization or person, the idea is to have this as a community supporting our colleagues.” [190] [Daszak, Peter. Email to Linda Saif, Hume Field, JM Hughe, Rita Colweel, Alison Andrew, Aleksei Chmura, Hongying Li, William B. Karesh, and Robert Kessler. 6 Feb. 2020. https://usrtk.org/wp-content/uploads/20 ... 2.6.20.pdf]

The emails, sent from Daszak’s EcoHealth Alliance email account, also reveal the statement was drafted in response to a request by WIV researchers with whom Daszak had worked (emphasis added):
You should know that the conspiracy theorists have been very active, targeting our collaborators with some extremely unpleasant web pages in China, and some have now received death threats to themselves and their families. They have asked for any show of support we can give them. [191] [Daszak, Peter. Email to Rita Colwell. 8 Feb. 2020. https://usrtk.org/wp-content/uploads/20 ... ls_Daszak- 2.8.20.pdf]

In a separate email, Daszak states that Linfa Wang (who did not sign the statement) pushed for Daszak and Baric to not sign the statement, effectively hiding their involvement. As previously discussed, Linfa Wang, who is copied on several other emails about the statement, was a coauthor of multiple Daszak/Shi/Hu papers. Wang is currently the Director and Professor of the Program in Emerging Infectious Diseases at the Duke-NUS Graduate Medical School in Singapore. He is a PRC national who received his B.S. in biochemistry from the East China Normal University in Shanghai, PRC [192] [Wang, Linfa. “Curicullum Vitae.” https://globalhealth.duke.edu/sites/def ... an2017.pdf] before completing a Ph.D. in molecular biology at the University of California, Davis in the United States.

In January 2020, Wang was at the WIV in Wuhan, visiting researchers he worked with. Given his previous publications, this likely included a vsiit with Hu and Shi, with whom he has authored dozens of papers. He departed the city on January 18th, [192] [Kupferschmidt, Kai. “This Biologist Helped Trace SARS to Bats. Now, He's Working to Uncover the Origins of COVID-19.” Science, 9 Sept. 2020, http://www.sciencemag.org/news/2020/09/ ... s-covid-19.] less than three weeks before Daszak externally circulated his draft Lancet statement. Wang is included on the email soliciting cosigners. [193] [Daszak (6 Feb.)]

In the email, Daszak states, (emphasis added):
I spoke with Linfa last night about the statement we sent round. He thinks, and I agree with him, that you, me and him should not sign this statement, so it has some distance from us and therefore doesn't work in a counterproductive way... We'll then put it out in a way that doesn't link it back to our collaboration so we maximize an independent voice. [194] [Daszak, Peter. Email to Ralph Baric, Toni Baric, Alison Andre, and Aleksei Chmura. 6 Feb. 2020. https://usrtk.org/wpcontent/ uploads/2021/02/Baric_Daszak_email.pdf]

Copies of these emails are included in the Appendix.

While pushing for Daszak and Baric, the WIV’s most prominent American collaborators, to hide their efforts to organize this statement, Wang was serving as the Chair of the Scientific Advisory Board for the Center for Emerging Diseases at the Wuhan Institute of Virology, of which Shi Zheng-li is the Director. [195] [Wang.]

Baric agreed and chose not to sign. It is unclear why Daszak ultimately changed his mind and signed the statement. Despite Daszak’s role as the organizer of the Lancet statement, Charles Calisher is listed as the corresponding author. Oddly, the email address listed for Calisher is a generic one (COVID19statement@gmail.com [196] [Calisher.]) that appears to have been created specifically for this statement, an unusual practice for scientific publications.

The February 2021 Lancet statement declared the authors had “no competing interest,” despite Daszak organizing the letter on behalf of WIV researchers who he funded and with whom he collaborated. In June 2020, after public concerns regarding Daszak’s connection to the WIV, “the Lancet invited the 27 authors of the letter to re-evaluate their competing interests.” [197] [Editors of The Lancet. “Addendum: competing interests and the origins of SARS-CoV-2.” The Lancet, 26 June 2021, 397: 2449-50. https://www.thelancet.com/action/showPd ... %2901377-5] Daszak submitted a revised disclosure statement which, while transparent about his prior work with PRC researchers, fails to reference the WIV or disclose that he drafted the statement at the request of PRC researchers. [198] [Ibid.]

The emails also reveal that Daszak helped edit a letter sent on February 6, 2020 by the Presidents of the U.S. National Academies of Sciences, Engineering, and Medicine to the White House Office of Science and Technology Policy regarding the origins of COVID-19.

While not included in the final version, the last draft edited by Daszak and the other experts who were consulted included a line stating, “The initial views of the experts is that the available genomic data are consistent with natural evolution and that there is currently no evidence that the virus was engineered to spread more quickly among humans.” Daszak actually pushed for broader language, as he believed “this is a bit too specific, because there are other conspiracy theories out there.” It is unclear why the sentence was removed by the Presidents of the U.S. National Academies before the letter was sent to the White House. Daszak specifically sought to time the publication of his statement in The Lancet for after this letter was released. And the statement references the letter as proof of the virus’ natural origin, without disclosing that Daszak helped edit it. It is highly likely that senior government officials, including Dr. Fauci, would have seen both the letter from the U.S. National Academies of Sciences, Engineering, and Medicine and the statement published in The Lancet, shaping their opinion and stifling debate within the U.S. federal government regarding the origins of COVID-19.

Sixteen months after sending this initial letter, the Presidents of the U.S. National Academies of Sciences, Engineering, and Medicine released an updated statement on June 15, 2021, titled, “Let Scientific Evidence Determine Origin of SARS-CoV-2, Urge Presidents of the National Academies.” [199] [McNutt, Marcia, et al. “NASEM Response to OSTP Re Coronavirus_February 6, 2020.” Received by Kelvin Droegemeier , National Academies of Science, Engineering, and Medicine, 6 Feb. 2020, Washington, District of Columbia. https://www.nationalacademies.org/docum ... 5521A660F4 0FD8D752FFB82A8E21FA8D3C29976D/NASEM%20Response%20to%20OSTP%20re%20Coronavirus_February%206%2C%202020.pdf? hide=thumbs+breadcrumbs+favs+props+nextprev+sidebar+pin+actions&scheme=light&fitwidth] This updated statement acknowledges there are scenarios that the origin of the pandemic could have resulted from a lab leak, stating (emphasis added):
However, misinformation, unsubstantiated claims, and personal attacks on scientists surrounding the different theories of how the virus emerged are unacceptable, and are sowing public confusion and risk undermining the public’s trust in science and scientists, including those still leading efforts to bring the pandemic under control… In the case of SARS-CoV-2, there are multiple scenarios that could, in principle, explain its origin with varying degrees of plausibility based on our current understanding. These scenarios range from natural zoonotic spillover (when a virus spreads from non-human animals to humans) to those that are associated with laboratory work. [200] [Ibid.]

Unlike the letter to the White House, this statement does not state which, if any, outside experts were consulted when drafting the statement.

Interestingly, three weeks later, in July 2021, Daszak and his colleagues released an update to their February 2020 statement with a very similar title: “Science, not speculation, is essential to determine how SARS-CoV-2 reached humans.” The second statement was signed by 24 of the original 27 authors and reflects a major step back from those authors’ original position (emphasis added):
The second intent of our original Correspondence was to express our working view that SARS-CoV-2 most likely originated in nature and not in a laboratory, on the basis of early genetic analysis of the new virus and well-established evidence from previous emerging infectious diseases, including the coronaviruses that cause the common cold as well as the original SARS-CoV and MERS-CoV. Opinions, however, are neither data nor conclusions. Evidence obtained using the scientific method must inform our understanding and be the basis for interpretation of the available information. [201] [Calisher, Charles H et al. “Science, not speculation, is essential to determine how SARS-CoV-2 reached humans.” Lancet, 5 July 2021, 398:209-211. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257054/]

This is quite different from Daszak’s words in the first border-line propaganda statement “condemn[ing] conspiracy theories suggesting that COVID-19 does not have a natural origin.” [202] [Calisher (Feb.)] Despite this softening, the authors continue to accuse those who seek to investigate the lab leak hypothesis of being the source of the PRC’s unwillingness to cooperate with an international investigation:
Allegations and conjecture are of no help, as they do not facilitate access to information and objective assessment of the pathway from a bat virus to a human pathogen that might help to prevent a future pandemic. Recrimination has not, and will not, encourage international cooperation and collaboration. [203] [Calisher (July)]

Whereas the first statement cited the letter from the Presidents of the U.S. National Academies of Sciences, Engineering, and Medicine (which Daszak helped edit), the second cites the Presidents’ statement released just weeks prior. This raises the question of whether Daszak, or any of the authors, assisted in drafting or editing the June 15th statement issues by the National Academies.

It should also be noted that Daszak was the only representative of the United States on the WHO-China Joint Study team in early 2021. The United States put forth a list of experts to be considered, none of whom were chosen. Daszak was not on that list but was nevertheless selected and approved by the CCP. [204] [Testimony from former senior U.S. official received by Committee Minority Staff.] The annexes of the WHO’s report on the origins of COVID-19, issued in March 2021, include multiple examples of CCP disinformation that have been repeated by Daszak. This include a discussion of “conspiracy theories,” [205] [Joint Report - ANNEXES.] which include the lab leak hypothesis and questions regarding the possible genetically modified nature of SARS-CoV-2. It also refers to the WIV’s sequence database that was taken offline as a “rumour about missing data.” [206] [Ibid.] This is similar language to that which Daszak used during his Chatham House interview – despite the database remaining offline. [207] [Ibid.] Committee Minority Staff was unable to determine whether Daszak assisted in the drafting or editing of the WHO report.

Peter Daszak has taken several additional concerning actions in regard to the origins of COVID-19, including inexplicably lying about the work conducted by EcoHealth Alliance in the months following the emergence of SARS-CoV-2. In an August 21, 2020, interview with Nature, after the NIH suspended the grants he was using to fund research at the WIV, Daszak claimed “The grant isn’t used to fund work on SARS-CoV-2. Our organization has not actually published any data on SARSCoV- 2.” [208] [Subbaraman.] This is despite the fact that four days later Nature Communications published “Origin and cross-species transmission of bat coronaviruses in China.” [209] [Latinne, Alice et al. “Origin and cross-species transmission of bat coronaviruses in China.” Nature Communications, 25 Aug. 2020, 11(1):4235, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447761/] Daszak, Shi, Hu, and Wang are all listed as authors, with Shi and Daszak both being listed as corresponding authors. The preprint for the article was uploaded on May 31, 2020, almost three months before Daszak’s interview with Nature. The paper includes a phylogenetic analysis “suggesting a likely origin for SARS-CoV-2 in Rhinolophus spp. bats.” [210] [Ibid.] Daszak, Shi, three EcoHealth Alliance affiliated researchers, and Linfa Wang are credited with designing the study, conducting fieldwork, and establishing collection and testing protocols.

The research was funded by the NIH (grant no. R01AI110964) and USAID’s PREDICT project (cooperative agreement number GHN-A-OO-09-00010-00), as well as the Strategic Priority Research Program of the Chinese Academy of Sciences (grant no. XDB29010101) that Shi was directing. It also received support from the National Natural Science Foundation of China (grants no. 31770175 and 31830096). The paper notes:
All work conducted by EcoHealth Alliance staff after April 24th 2020 was supported by generous funding from The Samuel Freeman Charitable Trust, Pamela Thye, The Wallace Fund, & an Anonymous Donor c/o Schwab Charitable. [211] [Ibid.]

April 24th was the day the NIH terminated the project Understanding the Risk of Bat Coronavirus Emergence, which was funded under grant R01AI110964, [212] [Lauer, Michael. Email to Peter Daszak. 24 April 2020. https://www.sciencemag.org/sites/defaul ... 202020.pdf] which is cited in the paper as funding this work. [213] [Latinne.] The grant Daszak told Nature was not being used to fund work on SARS-CoV-2 is cited in a paper presenting research on SARS-CoV-2.

Earlier, in March 2020, Peter Daszak and two other EcoHealth Alliance affiliated researchers published “A strategy to prevent future epidemics similar to the 2019-nCoV outbreak.” [214] [Daszak, Peter et al. “A strategy to prevent future epidemics similar to the 2019-nCoV outbreak.” Biosafety and Health, March 2020, 2(1): 6-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144510/] While the paper lacked lab experimentation, it discussed SARS-CoV-2 and claimed that “wildlife trade has clearly played a role in the emergence of” [215] [Ibid.] the virus. This work was also funded by the same NIH grant (grant no. R01AI110964), as well as the same cooperative agreement with USAID’s PREDICT Project.

In December 2020, Daszak stated in a tweet that the suspension of the aforementioned NIH grant directly prevented him from accessing samples at the WIV. If the grant did not support EcoHealth Alliance’s work on SARS-CoV-2, how could it be related to their inability to access SARS-CoV-2 samples?

Why did Daszak claim the NIH grant “isn’t used to fund work on SARS-CoV-2” [216] [Subbaraman.] when his own published research and statements show that it was?

Another concerning example of Daszak’s behavior comes from a March 10, 2021 discussion with Chatham House. In response to a question about the WIV taking down its viral sequence and sample database in September 2019 and whether the WHO investigative team requested to see the data, Peter Daszak stated (emphasis added):
I asked the question in front of the whole team, both sides, while we were at the Wuhan Institute of Virology, about the so-called missing database. And what we were told, by Shi Zheng-li, was that there had been hacking attempts on it, about 3,000 hacking attempts, and they took down this excel spreadsheet-based database. Absolutely reasonable. We did not ask to see the data, and as you know, a lot of this work is work that has been conducted with EcoHealth Alliance, and I’m also part of those data, and we do basically know what’s in those databanks. And I shared, I gave a talk to both sides about the work we’ve done with the Wuhan Institute of Virology and explained what’s there. There is no evidence of viruses closer to SARS-CoV-2 than RaTG13 in those databases. It’s as simple as that. [217] [“Sustaining the Response: Inside the WHO-China Mission.” Chatham House, 10 March 2021, https://www.youtube.com/watch? v=GMllEF58944&t=3249s.]

This is a stunning claim given the database contained more than 22,000 samples and was inaccessible by anyone outside of the WIV after September 2019. It was physically impossible for Daszak to remotely access the database after the SARS-CoV-2 genome was released in January 2020 in order to compare the genome to samples in the database. If not, given that no one outside of the WIV knew RaTG13 was closely related to SARS-CoV-2 prior to publication in February 2020, how could Daszak claim to know there is not a closer match in one of the 22,000 plus samples when he could not access the data? This raises the question of whether he has copy of the database.

Daszak has also been, at best, incorrect about how the WIV handed RaTG13. In an April 21, 2020 interview with the New York Times, he stated (emphasis added):
We found the closest relative to the current SARS-CoV-2 in a bat in China in 2013. We sequenced a bit of the genome, and then it went in the freezer; because it didn’t look like SARS, we thought it was at a lower risk of emerging. With the Virome project, we could have sequenced the whole genome, discovered that it binds to human cells and upgraded the risk. And maybe then when we were designing vaccines for SARS, those could have targeted this one too, and we would have had something in the freezer ready to go if it emerged. [218] [Kahn, Jennifer. “How Scientists Could Stop the Next Pandemic Before It Starts.” The New York Times, 21 Apr. 2020, http://www.nytimes.com/2020/04/21/magaz ... ccine.html.]

This is, of course, untrue. Researchers at the WIV fully sequenced RaTG13’s genome in 2018. [219] [Zhou, (Nov. 2020).] Either Daszak knew this was untrue, and lied to the New York Times, or he was being kept in the dark about the work being conducted at the WIV. If the later is true, it raises more questions about Daszak’s March 2021 claim to know everything in the WIV’s database that was taken offline.

Re: U.S. government gave $3.7 million grant to Wuhan lab at

PostPosted: Thu Aug 19, 2021 4:31 am
by admin
Part 4 of 4

V. HYPOTHESIS: A LAB LEAK THAT CAUSED A PANDEMIC

Having examined the evidenced discussed in this addendum, Committee Minority Staff has put together the following hypothesis that could reasonably represent what could have occurred in the early months of the COVID-19 pandemic.

In the months leading up to an accidental release of SARS-CoV-2, the hazardous waste treatment system at the WNBL was undergoing renovation. The central air conditioning system at one of the facilities needed to be renovated, which likely resulted in lower than ideal air circulation and enabling viral particles to remain suspended in the air longer. After the July 4, 2019 notice from the Ministry of Science and Technology, and prior to the September 30th deadline, researchers at the WIV were reviewing samples collected under grant 2013FY113500, held by Yuan Zhiming, the Director of the WNBL BSL-4. [220] [“Notice of the Resource Allocation and Management Department of the Basic Research Department of the Ministry of Science and Technology on the Comprehensive Performance Evaluation of Special Projects of Basic Science and Technology Work.” Ministry of Science and Technology, 4 July 2019. https://archive.is/pIwh4#selection-703.7-711.34]

This is the same grant which funded:

• The 2013 paper reporting the first isolation of a live SARS-like coronavirus after sampling at the cave in Kunming. [221] [Ge.]

• The 2014 paper, which was the result of collecting 986 samples from 39 species of small mammals in Guangxi and Yunnan provinces.

• The 2016 paper, where a second live coronavirus was successfully isolated.

• The 2017 paper, where a third live SARS-like coronavirus was isolated and WIV researchers created eight chimeric coronaviruses with altered spike proteins.

Hu, Shi, and others at the WIV were actively testing novel and genetically manipulated coronaviruses against hACE2 expressing mice and civets at BSL-2 and BSL-3 conditions, including viruses collected from the cave in Yunnan where the miners fell ill. A defective hazardous waste treatment system and central air conditioning system would increase the likelihood of a lab employee (or several) becoming infected with SARS-CoV-2, as viral particles would be more likely to remain in the air for longer periods of time. As previously discussed, the WIV provides a shuttle for employees, transporting individuals from near the old WIV facility in Wuchang to the WNBL and back. The infected employees (whether from the WNBL or the WIV Headquarters) then traveled throughout central Wuhan, likely by the metro, spreading the virus.

In early September, it became known that an accidental release occurred. Initially, not knowing SARS-CoV-2 spreads via human-to-human transmission or that asymptotic people are responsible for a large number of new cases, concern was low. Concern was additionally tempered by the knowledge that previous accidental releases from labs resulted in only a small number of infections. Still, measures are ordered in response. At midnight local time on the morning of September 12th, the Wuhan University, which sits less than a mile from the WIV Headquarters and whose medical school houses a BSL-3 lab accredited to experiment on animals, [222] [“About Wuhan University School of Medicine (WUSM).” Wuhan University School of Medicine, 23 Apr. 2013, https://wsm70.whu.edu.cn/English_Site/About.htm] issues a notice for laboratory inspections in late September. [223] [“Notice on the implementation of laboratory safety inspections in 2019.” Wuhan University, http://simlab.whu.edu.cn/info/1107/1018.htm] It is likely that officials issued similar orders to other labs in the area. Between two and three hours later, the WIV’s viral sequence database is taken offline in the middle of the night. [224] [“Status breakdown of the database of characteristic wild animals carrying virus pathogens (September 2019).” Scientific Database Service Monitoring & Statistics System.
https://archive.is/AGtFv#selection-1553.0-1567.2] Roughly 17 hours later, at 7:09 p.m. local time, the WIV publishes a procurement announcement for “security services” at the WNBL, to include gatekeepers, guards, video surveillance, security patrols, and people to handle the “registration and reception of foreign personnel.” [225] [“Competitive consultation on the procurement project of security services in Zhengdian Science Park, Wuhan Institute of Virology, Chinese Academy of Sciences.” China Government Procurement Network, 12 Sept. 2019, https://web.archive.org/web/20210716170 ... 900712.htm] The budget provided was in excess of $1.2 million. [226] [Ibid.]

In order to prevent national embarrassment, the decision was made to allow the 2019 Military World Games to continue. No spectators were allowed to attend the games, but international athletes and some of the 236,000 volunteers still become infected, spreading the virus in the city. Dozens of athletes fall ill with symptoms. Since COVID-19 can infect humans without causing symptoms, an untold number of athletes and volunteers become infected, but are asymptomatic and unaware they are infectious.

The athletes return to their home countries in late October, carrying SARS-CoV-2 across the world. Just as was the case in 2002 with SARS, [227] [Epstein, Gady A. “Chinese Admit to SARS Mistakes.” Baltimoresun.com, Baltimore Sun, 1 Apr. 2003, http://www.baltimoresun.com/balte. sars21apr21-story.html.] the CCP sought to hide the outbreak, wasting precious time that could have been used to prevent the global pandemic. By the time the world was alerted to the virus spreading in Wuhan, it had already begun to spread around the world.

In December, as cases begin to overload local hospitals, it became impossible to hide the outbreak. At some point in late 2019, Major General Chen Wei is brought in to take over the BSL-4 lab at the WNBL and lead the response efforts. The Wuhan Branch of the China CDC set a case definition for COVID-19 that only included those who have visited the Huanan Seafood Market, meaning that only people who had a link to the market were identified as having COVID-19. This further obscured the true origins of the virus.

Linfa Wang, a scientist with ties to the WIV and who has worked with Shi, Hu, and Daszak on the genetic modification of coronaviruses, was in Wuhan in early January 2020. While there he visited the WIV and likely met with Shi, Hu, and others. Sometime after his departure on January 18th and before February 6th, WIV researchers asked Peter Daszak to organize a public statement suppressing debate regarding the lab as the origin of SARS-CoV-2. On January 20th, WIV researchers submitted the February 2020 article where ID4991 was renamed as RaTG13 and which contained false information about when the genomic sequence for the virus was obtained.

At 12:43am on February 6th, Daszak sent the draft statement to Wang, Baric, and others asking them to join as cosigners. Sometime before Daszak went to bed that night, Wang called him and requested that he, Daszak, and Baric not sign the statement in order to obfuscate their connections to the WIV. Baric agreed, and neither him nor Wang signed the statement. The statement was published on February 19th, declaring discussion of a lab leak a conspiracy theory, and suppressing public debate on the origins of COVID-19.

VI. RECOMMENDATIONS

In the previously issued report, Committee Minority Staff provided several recommendations for actions to be taken by the United States in response to COVID-19, including seeking new leadership at the WHO, pursuing Taiwan’s re-admittance to the WHO as an observer, engaging in an international investigation with likeminded WHO Member States regarding the early stages of COVID-19, and supporting concrete reforms to the International Health Regulations. These recommendations remain relevant.

In response to the new information laid out in this addendum, there are additional steps that can be taken by the Committee, Congress more broadly, and the Executive Branch on this issue. Given the previously detailed inconsistencies and CCP disinformation campaign regarding a possible lab leak, Peter Daszak must be subpoenaed to appear before the House Foreign Affairs Committee and Senate Foreign Relations Committee as material witness to this investigation. Committee Minority Staff attempted, on multiple occasions, to contact Daszak with a list of questions relevant to this report. He never responded. In contrast, Ralph Baric provided answers to a list of questions from Committee Minority Staff. His assistance was appreciated, and we believe his testimony would also be useful. Daszak and Baric should provide expert testimony, including but not limited to the following questions:

• What was the extent of genetic manipulation of coronaviruses and their testing against human immune systems at the WIV in 2018 and 2019?

• Who requested the statement of support published in the Lancet?

• Did this request include labeling discussion of a possible lab leak as a conspiracy theory?

• What was the nature and content of Wang’s call to Daszak in the early hours of February 6th, 2020?

• Why did Daszak make conflicting, and apparently false, statements regarding the NIH grant terminated in 2020?

• How could Daszak confirm RaTG13 is the closet match to SARS-CoV-2 in the WIV’s database if it was taken offline in September 2019?

• Does Daszak have a copy of the WIV’s database that was taken offline?

• Who put forth Daszak’s name to join the joint WHO-China investigative team?

• Was Daszak aware the funding he was providing directly supported gain-of-function research by paying for the collection of viruses the WIV later experimented with, even though the federal government had a moratorium on such research from 2014 through 2017?

• Do they believe SARS-CoV-2 could possibly be a genetically modified virus created via a system similar to Baric’s “no-see-um” method and the system used by WIV researchers in 2016, thus leaving no evidence of manipulation?

Committee Minority Staff also recommends Congress pursue legislation to implement the following restrictions and sanctions in response to the pandemic:

• Institute a ban on conducting and funding any work that includes gain-of-function research until an international and legally binding standard is set, and only where that standard is verifiably being followed.

• Authorize and fund a public-private partnership for pandemic prevention, warning, and early detection.

• Sanction the Chinese Academy of Sciences and affiliated entities.

• List the Wuhan Institute of Virology and its leadership on the Specially Designated Nationals and Blocked Persons List and apply additional, appropriate secondary sanctions.

• Expand statutory and administrative sanctions regimes to curb the abuse of dual-use technology.

• Authorize new sanctions for academic, governmental, and military bioresearch facilities that fail to ensure the appropriate levels of safety and information sharing.

• Review all H-2B visas of Chinese nationals engaged in biological, chemical, or related research in the United States for possible revocation.

• Review all student visas of Chinese nationals studying at U.S. academic institutions for possible revocation.

Additionally, the Executive Branch should engage in international negotiations to establish a legally binding international standard for laboratory biosafety, to include certification and inspections by an international organization similar to the International Atomic Energy Agency.

Foreign governments facing economic contraction that have entered into agreements under the PRC’s Belt and Road Initiative are encouraged to examine bilateral agreement terms. In particular, agreements or memoranda of understanding that promote joint scientific and academic research wherein the Chinese government has access to natural resources, minerals, plant life, and animals unique to the nation state. Agreements that promote adaptation of governing structures that centralize control over all local, municipal, or provincial levels increase the risk of creating national governing structures that manipulate, misinform, misdirect and gaslight their own citizens to protect centralized governing structures.

Foreign governments considering entering into bilateral agreements with the PRC are advised to be aware that based on the information presented within this report, the PRC conducts scientific research without regard for adequate safety protocols in place, in a manner that does not comport with international safety standards, and without adequate assessment of the risks scientific research may pose to the environment, test subjects, or humanity. It is the recommendation of the Committee Minority Staff that such agreements be avoided.

VII. CONCLUSION

The Intelligence Community 90-day review report on the origins of COVID-19, ordered by President Biden, is due no later than August 24, 2021. While based on open source information, it is the hope of Committee Minority Staff that the collection and analysis contained within this addendum, produced at the direction of Ranking Member Michael T. McCaul, will help inform the public debate about the viability of a laboratory accident being the source of SARS-CoV-2. It is vital the public discourse surround the Wuhan Institute of Virology is transparent, honest, and detailed.

It is the opinion of Committee Minority Staff, based on the preponderance of available information; the documented efforts to obfuscate, hide, and destroy evidence; and the lack of physical evidence to the contrary; that SARS-CoV-2 was accidentally released from a Wuhan Institute of Virology laboratory sometime prior to September 12, 2019. The virus, which may be natural in origin or the result of genetic manipulation, was likely collected in the identified cave in Yunnan province, PRC, sometime between 2012 and 2015. Its release was due to poor lab safety standards and practices, exacerbated by dangerous gain-of-function research being conducted at inadequate biosafety levels, including BSL-2. The virus was then spread throughout central Wuhan, likely via the Wuhan Metro, in the weeks prior to the Military World Games. Those games became an international vector, spreading the virus to multiple continents around the world.

It is incumbent on the parties identified in this report to respond to the issues raised herein and provide clarity and any new or additional evidence as soon as possible. As always, Committee Minority Staff stands ready to receive such evidence or testimony that supports or contradicts this report. Until such time as the Chinese Communist Party lifts its self-imposed veil of secrecy, explains its lies regarding the early stages of the pandemic, and provides access to the WIV’s archives and sample database, questions will remain as to the origins of SARS-CoV-2 and the COVID-19 pandemic. Until that day, it is incumbent upon the United States and likeminded countries around the world to ensure accountability, and implement the reforms necessary to prevent the CCP’s malfeasance from giving rise to a third pandemic during the 21st century.

VII. APPENDIX

Timeline of the WIV Lab Leak and the Start of the COVID-19 Pandemic


April 2012: Six miners working in a copper mine located in a cave in Yunnan province of the PRC fall ill. Between the ages of 30 and 63, the workers presented to a hospital in Kunming with persistent coughs, fevers, head and chest pains, and breathing difficulties.” Three of the six died.

Late 2012 – 2015: Researchers from the WIV collect samples from bats in the cave.

2015 - 2017: Shi Zheng-li, Ben Hu, Peter Daszak, and Linfa Wang jointly publish research on the isolation of novel coronaviruses. They conduct gain-on-function research, testing novel and genetically manipulated coronaviruses against mice and other animals expressing human immune systems. At times they collaborate with Ralph Baric.

2018 – 2019: Shi, Hu, and other researchers at the WIV infect transgenic mice and civets expressing human immune systems with unpublished novel and genetically modified coronaviruses.

July 4, 2019: The PRC’s Ministry of Science and Technology orders a review of several grants, including grant no. 2013FY113500. This is the grant which funded the collection of hundreds of coronaviruses and bat samples from the cave in Yunnan province.

July 16, 2019: The WIV publishes a tender requesting bids to conduct renovation on the hazardous waste treatment system at the Wuhan National Biosafety Lab (WNBL). The closing date was July 31st.

Late August/Early September 2019: One or more researchers become accidently infected with SARS-CoV-2, which was either collected in the Yunnan cave, or the result of gain-of-function research at the WIV. They travel by metro in central Wuhan, spreading the virus.

September 12, 2019: At 12:00am local time, the Wuhan University issues a statement announcing lab inspections. Between 2:00am and 3:00am, the WIV’s viral sequence and sample database is taken offline. At 7:09pm, the WIV publishes a tender requesting bids to provide security services at the WNBL.

September – October 2019: Car traffic at hospitals surrounding the WIV Headquarters, as well as the shuttle stop for the WNBL, show a stead increase before hitting its highest levels in 2.5 years. Baidu search terms for COVID-19 related symptoms increase in a corresponding manner.

Late October – Early November 2019: The international athletes return home, carrying SARS-CoV-2 around the world.

November 21, 2019: A 4-year-old boy from Milan, Italy develops a cough. His samples will later test positive for COVID-19.

November 27, 2019: Samples of wastewater are collected in Brazil that will later test positive for the presence of SARS-CoV-2 RNA.

December 1, 2019: The CCP’s first “official” case of COVID-19 become infected.

Late 2019: Major General Chen Wei arrives in Wuhan, taking over the WNBL BSL-4 lab.

Dec. 27, 2019: A Chinese genomic company reportedly sequenced most of the virus in Wuhan and results showed a similarity to SARS. Zhang Jixian, a doctor from Hubei Provincial Hospital of Integrated Chinese and Western Medicine, tells PRC health authorities that a novel disease affecting some 180 patients was caused by a new coronavirus.

Dec. 29, 2019: Wuhan Municipal CDC organized an expert team to investigate after the Hubei Provincial Hospital of Integrated Chinese and Western Medicine and other hospitals find additional cases.

Dec. 30, 2019: Doctors in Wuhan report positive tests for “SARS Coronavirus” to local health officials. Under the 2005 International Health Regulations, the PRC is required to report these results to the WHO within 24 hours. They do not.

Dec. 31, 2019: WHO officials in Geneva become aware of media reports regarding an outbreak in Wuhan and direct the WHO China Country Office to investigate.

Jan. 2020: Linfa Wang meets with collaborators at the WIV, likely including Shi and Hu.

Jan. 1, 2020: Hubei Provincial Health Commission official orders gene sequencing companies and labs who had already determined the novel virus was similar to SARS to stop testing and to destroy existing samples. Dr. Li Wenliang is detained for “rumor mongering.”

Jan. 2, 2020: The Wuhan Institute of Virology (WIV) completes gene sequencing of the virus, but the CCP does not share the sequence or inform the WHO. PRC aggressively highlights the detentions of the Wuhan doctors.

Jan. 3, 2020: China’s National Health Commission ordered institutions not to publish any information related to the “unknown disease” and ordered labs to transfer samples to CCP controlled national institutions or destroy them.

Jan. 11-12, 2020: After a researcher in Shanghai leaks the gene sequence online, the CCP transmits the WIV’s gene sequencing information to the WHO that was completed 10 days earlier. The Shanghai lab where the researcher works is ordered to close.

Jan. 14, 2020: Xi Jinping is warned by a top Chinese health official that a pandemic is occurring.

Jan. 18, 2020: Linfa Wang departs Wuhan.

Jan. 20, 2020: WIV researchers submitted an article claiming that SARS-CoV-2 is natural in origin. The article renames ID4991 as RaTG13 and contained false information about when the genomic sequence for the virus was obtained.

Jan. 23, 2020: The CCP institutes a city-wide lockdown of Wuhan. However, before the lockdown goes into effect, an estimated 5 million people leave the city.

Last Week of January 2020: Daszak and other outside experts edit a letter to be sent by the Presidents of the National Academies of Sciences, Engineering, and Medicine to the White House Office of Science and Technology Policy. Daszak pushes for language to address “conspiracy theories.”

Jan. 30, 2020: One week after declining to do so, Tedros declares a Public Health Emergency of International Concern.

Late Jan. – Early Feb. 2020: PRC researchers, likely those at the WIV, request Peter Daszak’s assistance in responding to suggestions of a lab leak or genetic manipulation of SARS-CoV-2. Daszak helps edit the National Academies of Sciences, Engineering, and Medicine’s response to the White House Office of Science and Technology Policy on the origins of COVID-19.

Feb. 3, 2020: The WIV researchers’ paper submitted on January 20th is published by Nature online.

Feb. 6, 2020 at 12:43:40 am: Daszak sends the draft Lancet statement, which cites the Feb. 3 WIV paper, to Wang, Baric, and others asking them to join as cosigners. Within hours, Wang calls him, informs Daszak that he will not sign, and requests that neither Daszak or Baric sign.

Feb. 6, 2020 (Afternoon): At 3:16pm, Daszak send a High Important email to Baric, forwarding Wang’s request, and informing Baric the statement will be “put out in a way that doesn’t link it back to our collaboration.” At 4:01:22 pm, Baric agrees to not sign the statement.

Feb. 7, 2020: Dr. Li, who first shared the positive SARS test results with his classmates via WeChat, dies from COVID-19.

Feb. 9, 2020: The death toll for COVID-19 surpasses that of SARS.

Feb. 15, 2020: First death from COVID-19 outside of Asia occurs, in France.

Feb. 16, 2020: WHO and PRC officials begin a nine-day “WHO-China Joint Mission on Coronavirus Disease 2019” and travel to the PRC to examine the outbreak and origin of COVID-19. Many team members, including at least one American, were not allowed to visit Wuhan.

Feb. 18, 2020: Daszak statement is published by the Lancet online, which references the letter from the U.S. National Academies of Sciences, Engineering, and Medicine he helped write and the WIV’s February 3rd paper on the origins of COVID-19. Despite drafting the letter, Daszak is not listed as the corresponding author.

Feb. 25, 2020: For the first time, more new cases are reported outside of PRC than within.

Feb. 26, 2020: The WHO-China Joint Mission issues its findings, praising the PRC for its handling of the outbreak.

Feb. 29, 2020: The first reported COVID-19 death in the United States occurs.

March 11, 2020: The WHO officially declares the COVID-19 outbreak a pandemic after 114 countries had already reported 118,000 cases including more than 1,000 in the United States.

Nov. 17, 2020: As a result of public pressure, Shi, Hu, and other WIV researchers publish an addendum to their February 3rd paper, confirming that RaTG13 was ID4991 collected from the cave in Yunnan, and revealing they collected 293 coronaviruses from the cave between 2012 and 2015.

June 15, 2021: The Presidents of the U.S. National Academies of Sciences, Engineering, and Medicine release a statement saying, “let scientific evidence determine origin of SARS-CoV-2.”

June 21, 2021: After public pressure, Daszak updates his public disclosure form for the Lancet statement. He does not mention the WIV or that the statement was drafted at the request of PRC researchers.

July 5, 2021: Daszak and 23 of the original 27 authors release an update to their February 2021 statement, walking back their labeling of public debate around the source of the virus as “conspiracy theories.”

**********

Image

Image

Image

Image

Memo to the Offices of the Chinese Center for Disease Control and Prevention

Memo (2020) No. 16 of the Science and Technology Department

On the Supplementary Regulations on Strengthening the Management of Science and Technology During the Emergency Response to the Novel Coronavirus Pneumonia

All units and offices directly under the center:

In order to further strengthen scientific research management in our center during the emergency response to the novel coronavirus pneumonia, and in accordance with the spirit of relevant documents issued by the higher authorities, the "Supplementary Regulations on Strengthening the Management of Science and Technology During the Emergency Response to the Novel Coronavirus Pneumonia" has been formulated. Every unit and office, please attach great importance to it and spread it through all levels -- everyone must be notified. In case of any violation of relevant regulations, the offender and their unit will be held accountable.

Attachment: Supplementary Regulations on Strengthening the Management of Science and Technology During the Emergency Response to the Novel Coronavirus Pneumonia

Chinese Center for Disease Control and Prevention
February 25, 2020

cc: Gao Fu, Li Xinhua, Liu Jianjun, Feng Zijian.

Image

Annex: Supplementary Regulations on Strengthening the Management of Science and Technology During the Emergency Response to the Novel Coronavirus Pneumonia

According to the spirit of the "Notice of the General Office of the National Health Commission on Strengthening the Management of Biological Sample Resources and Related Scientific Research Activities during the Prevention and Control of Major Infectious Diseases" (National Health Commission Science and Technology Memo [2020] No. 3), the "Notice of the General Office of the Ministry of Science and Technology on Strengthening the Management of New Coronavirus Pneumonia Science and Technology Research Projects" and other documents, and in order to effectively combat the new coronavirus pneumonia ("COVID-19") epidemic, to strictly standardize scientific research management, and to further strengthen the implementation of scientific research management systems, these supplementary "Regulations on Strengthening the Management of Science and Technology During the Emergency Response to the Novel Coronavirus Pneumonia" (Chinese Center for Disease Control Science and Technology Memo [2020] No. 128) have been formulated.

1. Prioritize the interests of the country and the people and take the prevention and control of the COVID-19 epidemic as the primary task. During the emergency response against the epidemic, we must concentrate our forces, distinguish our priorities, focus our main energies on controlling the epidemic, write papers "on the land of the motherland", apply research results to the fight against the epidemic, and not focus on publishing papers until the epidemic is under control.

2. The launch of scientific research projects related to the COVID-19 epidemic must undergo preliminary review by the Science and Technology Group/Department. According to the research subject, experts should be organized to conduct scientific and ethical reviews, and, if necessary, the project must be submitted to the emergency leading group or the Department of Science and Education of the National Health Commission for approval. The research projects authorized by higher authorities must be examined and approved by the emergency leading group via the Science and Technology Group/Department and be kept on record.

Image

3. No one can, under their own name or in the name of their research team, provide other institutions and individuals with information related to the COVID-19 epidemic on their own, including data, biological specimens, pathogens, culture, etc.

4. Before publishing papers and research results related to the COVID-19 epidemic, you must first report them to the Science and Technology Group/Department for preliminary review, and if necessary, submit it to the Emergency Leading Group or the Department of Science and Education of the National Health Commission for approval.

Papers that have been submitted but not yet reviewed by the Science and Technology Group/Department should be withdrawn as soon as possible and redone according to these regulations.

5. In principle, progress reports on scientific research projects should be reported to the Science and Technology Group/Department on a monthly basis, or according to the time period stipulated by higher authorities.

6. Strictly follow relevant regulations on medical ethics, scientific research integrity and academic spirit.

7. Anyone who violates the above regulations shall be dealt with severely in accordance with discipline, laws and regulations.

8. The date of the implementation of this regulation will be explained by the Science and Technology Group/Department.

Chinese Center for Disease Control and Prevention
February 25, 2020

**********

Image

Image

Image

Image

Joint Prevention and Control Mechanism of the State Council in Response to the Novel Coronavirus Pneumonia Scientific Research Group

Notice on the Standardization of the Management of Publication of Novel Coronavirus Pneumonia Scientific Research


To the Joint Prevention and Control Mechanism of the State Council in Response to the Novel Coronavirus Pneumonia member work units and offices, and other relevant work units:

In order to thoroughly implement relevant requirements from the meeting of the Joint Prevention and Control Mechanism of the State Council in Response to the Novel Coronavirus Pneumonia (hereinafter referred to as the "Joint Prevention and Control Mechanism of the State Council"), and to effectively standardize the management of the publication of scientific research, the following is issued below.

1. Comprehensively strengthen the management of publication of scientific research

In accordance with the principles of "following laws and regulations, being scientific and objective, centralized management, and precise publications", all publication work on epidemic prevention research and information related to COVID-19, including medication, vaccines, virus origins, virus transmission routes, testing reagents, etc. will be taken over by the Joint Prevention and Control Mechanism of the State Council's scientific research group (hereinafter referred to as "the scientific research group") for coordinated deployment. The scientific research group will coordinate the publication of information on emergency scientific research by all work units in all locations.

Image

2. Establish a standardized publication mechanism for scientific research

Each member work unit of the scientific research team will gather scientific research information within their own unit and systems, review and check the content and form of its publication, and report it to the scientific research team for approval in a timely manner. The scientific research group's dedicated teams of professionals and various experts are responsible for reviewing the publication's content and format and giving expert opinions, and when necessary, arranging expert assessment. Aft the scientific research group approves, the publishing work unit should, according to work requirements, arrange publication via press conferences, official websites, state social media, news media and other platforms, and notify the propaganda and scientific research teams of the Joint Prevention and Control Mechanism of the State Council. In principle, COVID-19 scientific research should be published first in the form of an official authoritative publication. The special group on public opinion should strengthen communication with the propaganda team, take into account the trend of public opinion and social concerns, and strengthen guidance of the publication of scientific research and information.

3. Strictly require all scientific research units to do a good job on the publication of scientific research

The member work units of the scientific research team of the Joint Prevention and Control Mechanism shall follow the principle of centralized management, strictly enforce their own system's publication approval procedures for relevant scientific research, strengthen the management of universities, research institutions, and enterprises under the centralized management of their work unit systems, and communicate the requirements of this notice to all relevant units engaged in research on COVID-19. The publishing work unit is the one primarily responsible for the research content they publish, and they must consider, in a comprehensive manner, the research progress, the epidemic prevention and control situation, societal concerns, the consequences of publication, and various other issues. They must ensure the accuracy of the published content and guide societal expectations in a reasonable manner. During the period of epidemic prevention and control, all universities, research institutions, medical institutions, enterprises and their staff shall not publish information on scientific research related to epidemic prevention and control without approval. Papers exchanged on the Chinese Medical Association ...

**********

Image

http://rapeutation.com/acovidsarslableak2z6.jpg

February 6, 2020, Email at 12:43 am from Peter Daszak to Ralph Baric, Linfa Wang, and Others Inviting Them to Sign the Statement

A Statement in support of the scientists, public health and medical professionals of China

Feb. 6, 2020 12:43:40 AM EST

A Statement in support of the scientists, public health and medical professionals of China

Subject: A Statement in support of the scientists, public health and medical professionals of China
From: Peter Daszak [DELETE]
To: Ralph Baric [DELETE]
Cc: [DELETE]
Sent: February 6, 2020 12:43:40 AM EST
Attachments: Statement of support, 2019nCoV China Final.docx

**********

Image

A Statement in support of the scientists, public health and medical professionals of China

Feb. 6, 2020 12:43:40 AM EST

Dear Ralph, Linda, Jim, Rita, Linfa and Hume,

I’ve been following the events around the novel coronavirus emergence in China very closely and have been dismayed by the recent spreading of rumors, misinformation and conspiracy theories on its origins. These are now specifically targeting scientists with whom we’ve collaborated for many years, and who have been working heroically to fight this outbreak and share data with unprecedented speed, openness and transparency. These conspiracy theories threaten to undermine the very global collaborations that we need to deal with a disease that has already spread across continents.

We have drafted a simple statement of solidarity and support for scientists, public health and medical professionals of China, and would like to invite you to join us as the first signatories. If you agree, we will send this letter to a group of around half-a-dozen other leaders in the field and then disseminate this widely with a sign-up webpage for others to show their support by signing up to its language. I will then personally present this at my plenary during the ICID 2020 conference in Malaysia in two weeks, with the goal of also getting widespread attention in SE Asia to our support for the work that our colleagues in China are undertaking.

I sincerely hope you can join us. Please review the letter, and let me know if you are willing to join Billy Karesh and myself as co-signatories. Also, please confirm your title and affiliation that will be shown in the letter. We plan to make circulate this widely to coincide with a letter from the Presidents of the US National Academies of Science, Engineering, and Medicine, which will likely be released tomorrow or Friday.

Thank you for your consideration and support of the scientific and public health community around the world!

Cheers,

Peter

Peter Daszak
President
EcoHealth Alliance
460 West 34th Street – 17th Floor
New York, NY 10001
Tel. +1 212-380-4474
Website: http://www.ecohealthalliance.org
Twitter: @PeterDaszak

EcoHealth Alliance leads cutting-edge research into the critical connections between human and wildlife health and delicate ecosystems. With this science we develop solutions that prevent pandemics and promote conservation.

**********

Image

A Statement in support of the scientists, public health and medical professionals of China

Feb 6, 2020 12:43:40 AM EST

Statement in Support of the Scientists, Public Health, and Medical Professionals of China Combating the Novel Coronavirus Outbreak

We, the undersigned, are scientists who have followed the emergence of 2019-nCoV, and are deeply concerned about its global impact on people’s health and well-being. We have watched as the scientists, public health and medical professionals of China have worked heroically to rapidly identify the pathogen behind this outbreak, put in place significant measures to reduce its impact, and share their results transparently with the global health community. We sign this statement in solidarity with all scientists, public health, and medical professionals in China who continue to save lives and protect global health during the challenge of this novel coronavirus outbreak. We want you to know that we are all in this together, with you in front of us on the battlefield against the novel coronavirus.

The rapid, open and transparent sharing of data on 2019-nCoV is now being threatened by rumors and misinformation around the origins of this outbreak. We stand together to strongly condemn conspiracy theories suggesting that 2019-nCoV does not have a natural origin. Scientific evidence overwhelmingly suggests that this virus originated in wildlife, as have so many other emerging diseases (1-4). This is further supported by a letter from the Presidents of the US National Academies of Science, Engineering, and Medicine, and by the scientific communities they represent (INSERT REF). Conspiracy theories will do nothing but create fear, rumors, and prejudice that jeopardize our global collaboration in the fight against this virus. We need to prioritize scientific evidence and unity over misinformation and conjecture now. We want you all to know that we stand with you, the science and health professionals of China, in your fight against this virus.

We invite others to join us in supporting the scientists, public health, and medical professionals of Wuhan and across China. Stand with our colleagues on the front-line!

Please add your name in an act of support by going to [INSERT LINK HERE].

Image

A Statement in support of the scientists, public health and medical professionals of China

Feb 6, 2020 12:43:40 AM EST

Signatories

Dr. Peter Daszak, President, EcoHealth Alliance
Dr. Jim Hughes, Professor Emeritus, Emory University
Dr. Rita Colwell, former Director of National Science Foundation
Dr. Ralph Baric, Professor, The University of North Carolina, Chapel Hill
Dr. Linda Saif, Distinguished University Professor, The Ohio State University
Dr. Billy Karesh, Executive Vice President, EcoHealth Alliance
Dr. Linfa Wang, Professor, Duke-NUS Medical School
Dr. Hume Field, Honorary Professor, The University of Queensland

References

1. P. Zhou et al., A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, (2020).

2. R. Lu et al., Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, (2020).

3. N. Zhu et al., A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, (2020).

4. L. Ren et al., Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J. Epub ahead of print, (2020).

**********

Image

February 6, 2020, Email at 3:16pm from Peter Daszak to Ralph Baric Relaying Wang's Request Not to Sign the Statement

To: Peter Daszak [DELETE]
Cc: [DELETE]
From: Baric, Ralph [DELETE]
Sent: Thur 2/6/2020 4:01:22 PM (UTC-05:00)
Subject: RE: No need for you to sign the "Statement" Ralph!

I also think this is a good decision. Otherwise it looks self-serving and we lost impact. ralph

From: Peter Daszak [DELETE]
Sent: Thursday, February 6, 2020 3:16 PM
To: Baric, Ralph S. [DELETE]
Cc: [DELETE]
Subject: No need for you to sign the "Statement" Ralph!!
Importance: High

I spoke with Linfa last night about the statement we sent round. He thinks, and I agree with him, that you, me and him should not sign this statement, so it has some distance from us and therefore doesn't work in a counterproductive way.

Jim Hughes, Linda Saif, Hume Field, and I believe Rita Colwell will sign it, then I'll send it round some other key people tonight. We'll then put it out in a way that doesn't link it back to our collaboration so we maximize an independent voice.

Cheers,

Peter

Peter Daszak
President
EcoHealth Alliance
460 West 34th Street – 17th Floor
New York, NY 10001
Tel. +1 212-380-4474
Website: http://www.ecohealthalliance.org
Twitter: @PeterDaszak

EcoHealth Alliance leads cutting-edge research into the critical connections between human and wildlife health and delicate ecosystems. With this science we develop solutions that prevent pandemics and promote conservation.

**********

Image

February 8, 2020, Email at 8:52pm from Peter Daszak to Rita Colwell Alleging WIV Researchers Requested the Statement

From: Peter Daszak [DELETE]
Sent: Saturday, February 08, 2020 8:52 PM
To: Rita Colwell [DELETE]
Cc: Rita Colwell [DELETE]
Subject: RE: coronavirus statement
Importance: High

Hi Rita,

I appreciate your comments and I think at this point, that work has already been done, with >50 genomes published from 12 countries, and phylogenetic analyses published by authors from multiple countries. I’ve tried to make this a bit more clear, and have edited the letter as follows, so it hopefully addresses your comments:

1) I’ve inserted a reference to the GISAID webpage where 57 (to date) full genome sequences of 2019-nCoV from 12 countries are published and analyzed

2) I’ve inserted a reference to the CDC webpage on 2019-nCoV which makes the following statement, completely in concurrence with our letter:

"2019-nCoV is a betacoronavirus, like MERS and SARs, both of which have their origins in bats. The sequences from U.S. patients are similar to the one that China initially posted, suggesting a likely single, recent emergence of this virus from an animal reservoir."

In addition, please note that we will not be referring to this as a ‘petition’ but as a ‘statement in support of’ – This is in the title and will be in all materials we send out. This is to avoid the appearance of a political statement – this is simply a letter from leading scientists in support of other scientists and health professionals who are under serious pressure right now.

I hope you are willing to sign on to this -- your voice will be very influential, particularly in keeping these critical bridges open between the USA and China. You should know that the conspiracy theorists have been very active, targeting our collaborators with some extremely unpleasant web pages in China, and some have now received death threats to themselves and their families. They have asked for any show of support we can give them. As soon as we hear back from you we’ll get ready to send this to our larger list (attached), but of course if you don’t feel comfortable, I’ll make sure your name is not associated with this.

Cheers,

Peter

Peter Daszak
President
EcoHealth Alliance
460 West 34th Street – 17th Floor
New York, NY 10001

Re: U.S. government gave $3.7 million grant to Wuhan lab at

PostPosted: Sat Aug 21, 2021 3:21 am
by admin
Genetic susceptibility for COVID-19–associated sudden cardiac death in African Americans
by John R. Giudicessi, MD, PhD,∗† Dan M. Roden, MD,‡§‖ Arthur A.M. Wilde, MD, PhD,¶# and Michael J. Ackerman, MD, PhD†∗∗††∗
ncbi.hlm.nih.gov
Heart Rhythm. 2020 Sep; 17(9): 1487–1492.
Published online 2020 May 5. doi: 10.1016/j.hrthm.2020.04.045
PMCID: PMC7198426
John R. Giudicessi
∗Clinician-Investigator Training Program, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota
†Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota

Dan M. Roden
‡Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
§Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee
‖Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee

Arthur A.M. Wilde
¶Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Heart Center, Amsterdam, The Netherlands
#European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-Heart)

Michael J. Ackerman
†Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota
∗∗Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
††Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota

Image Image

"In 2000 Dutch researchers, for instance, earned the gratitude of rodents everywhere by genetically engineering the spike protein of a mouse coronavirus so that it would attack only cats."

-- The origin of COVID: Did people or nature open Pandora’s box at Wuhan?, by Nicholas Wade

HIGHLIGHTS:

African Americans account for 26% of confirmed COVID-19 cases but 43% of COVID-19 deaths....COVID-19 mortality rates in predominantly black counties are 6-fold higher than that in predominantly white counties....

Current evidence supports the notion that the common ion channel variants p.Asp85Asn-KCNE1 and p.Ser1103Tyr-SCN5A confer an increased risk of DI-LQTS and DI-SCD (Table 1 ).13 Importantly, p.Ser1103Tyr-SCN5A is seen almost exclusively in individuals of African descent and its frequency in that population (∼8%) is higher than that of p.Asp85Asn-KCNE1 (0.2%–2.5% depending on ancestry; 0.2% in individuals of African origin)...
Heterozygous and homozygous carriers of SCN5A-p.Ser1103Tyr, a common genetic variant with functional effects among African-Americans, have an increased risk of sudden death.

-- SCN5Aallelic expression imbalance in African-Americans heterozygous for the common variant p.Ser1103Tyr, by Stacy AS Killen, Jennifer Kunic, Lily Wang, Adele Lewis, Bruce P Levy, Michael J Ackerman & Alfred L George Jr.

In individuals of African descent, the common SCN5A-encoded Nav1.5 sodium channel variant p.Ser1103Tyr-SCN5A has been associated with an increased risk of VA/SCD.14 , 15 , 17 Of note, this proarrhythmic potential has been reported to be enhanced by nongenetic risk factors known to reduce cardiac repolarization reserve (eg, hypokalemia and QTc-prolonging medication exposure....p.Ser1103Tyr-SCN5A is overrepresented in African American sudden infant death syndrome decedents...p.Ser1103Tyr-SCN5A confers an increased risk of sudden death in African Americans regardless of age....

Direct and/or indirect myocardial injury/stress, as assessed by cardiac biomarkers such as troponin I and brain-type natriuretic peptide, has emerged as both a prominent and a prognostic feature in COVID-19. Of note, in an adjusted Cox regression model, the mortality risk associated with elevated cardiac biomarkers/acute cardiac injury was more significant than age and high-risk comorbid conditions such as chronic obstructive/fibrotic pulmonary disease, diabetes, and a history of cardiovascular disease....

p.Ser1103Tyr-SCN5A could produce a similar African American–specific susceptibility to hypoxia-induced VA/SCD in the setting of SARS-CoV-2 infection/COVID-19....

Unfortunately, the increased risk of VA/SCD linked to the potentially proarrhythmic p.Ser1103Tyr-SCN5A common variant is likely not limited to the possibility of hypoxia-induced VA/SCD. As succinctly outlined in recent work by Lazzerini et al,27 the exaggerated immune response triggered by SARS-CoV-2 infection, specifically elevation of IL-6, likely increases arrhythmia risk via (1) modulation of cardiac ion channel expression/function leading to APD prolongation (eg, direct IL-6–mediated blockade of hERG/Kv11.1 potassium channels), (2) cardiac sympathetic nervous system hyperactivity, and (3) inhibition of cytochrome P450 enzymes involved in the metabolism of some QTc-prolonging drugs (eg, IL-6 and CYP3A4) (Figure 1). The latter effect of IL-6 is particularly important given that a number of COVID-19 pharmacotherapies (eg, hydroxychloroquine ± azithromycin and lopinavir/ritonavir) under investigation and/or in use clinically are known to prolong the QTc interval and predispose to DI-TdP/DI-SCD ...

these data suggest that 1 in 13 African Americans may be at a substantially increased risk of potentially lethal VAs, most notably DI-TdP, during the COVID-19 pandemic because of the perfect storm of (1) intrinsic genetic susceptibility (i.e., p.Ser1103Tyr-SCN5A), (2) modifiable environmental risk factors (eg, electrolyte abnormalities and concurrent QTc-prolonging drug use), and (3) COVID-19–specific risk factors (eg, profound hypoxemia and cytokine storm) (Figure 1). Whether population-specific genetic risk factors such as p.Ser1103Tyr-SCN5A are contributing to the spike in sudden deaths and racial health disparities observed in COVID-19 epicenters remains to be proven, and given the lack of banked DNA in these epicenters, this speculation may not even be testable.


Nevertheless, given the potential for COVID-19 to exacerbate known gene-environment interactions pertaining to the potentially proarrhythmic p.Ser1103Tyr-SCN5A common variant, it seems reasonable (1) to avoid using COVID-19–directed QTc-prolonging drugs (eg, hydroxychloroquine ± azithromycin and lopinavir/ritonavir)...

A potentially pro-arrhythmic common variant, p.Ser1103Tyr-SCN5A, present in 1 out of 13 individuals of African descent has the potential to increase the risk of drug- and hypoxia-induced ventricular arrhythmias/sudden cardiac death and contribute to observed racial health disparities in the COVID-19 pandemic. As such, the use of unproven, QTc-prolonging COVID-19-directed therapies, most notably the combination of hydroxychloroquine and azithromycin, should be limited.

-- Genetic susceptibility for COVID-19–associated sudden cardiac death in African Americans
by John R. Giudicessi, MD, PhD, Dan M. Roden, MD, Arthur A.M. Wilde, MD, PhD, and Michael J. Ackerman, MD, PhD


Introduction

Since emerging from Wuhan, China, in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), has infected >3.2 million individuals worldwide and ∼1 million in the United States (as of April 29, 2020).1 , 2 Despite the institution of measures designed to “flatten the curve,” COVID-19 has claimed the lives of >225,000 individuals worldwide and >60,000 individuals in the United States alone (as of April 29, 2020).2 Of note, mortality estimates in some of the hardest hit regions have already or may need to be revised to account for a spike in sudden deaths occurring at home.3 , 4

Although most of these deaths are likely directly attributable to COVID-19 (eg, pulseless electrical activity/respiratory arrests), many of the same regions within the United States have also seen the outpatient prescription volume of COVID-19–directed heart rate–corrected QT interval (QTc)–prolonging drug(s), specifically hydroxychloroquine, rise by as much as 22,700% compared to the same time period (March 15–31) in 2019.5 Importantly, recent studies have shown that between 11% and 25% of hospitalized patients with COVID-19 treated with chloroquine or hydroxychloroquine and azithromycin had QTc values rise above the critical 500 ms threshold.6 , 7

As a result, a substantial number of patients with COVID-19, prescribed these so-called corona cocktails, may be at an increased risk of developing drug-induced long QT syndrome (DI-LQTS), which could deteriorate into drug-induced torsades de pointes (DI-TdP) or worse drug-induced sudden cardiac death (DI-SCD).8 , 9 Therefore, it stands to reason that the same phenomenon (DI-LQTS/DI-TdP) that has already halted 1 chloroquine/hydroxychloroquine clinical trial7 and led the Food and Drug Administration to caution against the use of chloroquine/hydroxychloroquine outside the hospital setting/clinical trial10 could also be contributing, at least in small part, to the increase in sudden deaths observed in some COVID-19 epicenters.

In addition, the COVID-19 pandemic has already highlighted alarming health disparities in the United States. For example, in Illinois where age, sex, and racial demographic data are reported for all COVID-19 cases, African Americans account for 26% of confirmed COVID-19 cases but 43% of COVID-19 deaths.11 A similar trend has been observed across the United States where COVID-19 mortality rates in predominantly black counties are 6-fold higher than that in predominantly white counties.12 Although this phenomenon is likely explained by the convergence of multiple cultural and socioeconomic factors,12 an underlying genetic susceptibility to SARS-CoV-2 infection, its sequelae (such as hypoxia and inflammation), or the potentially lethal side effects of COVID-19–directed therapies (ie, DI-TdP and DI-SCD), assuming equal exposure to these medications, could also contribute.

Current evidence supports the notion that the common ion channel variants p.Asp85Asn-KCNE1 and p.Ser1103Tyr-SCN5A confer an increased risk of DI-LQTS and DI-SCD (Table 1 ).13 Importantly, p.Ser1103Tyr-SCN5A is seen almost exclusively in individuals of African descent and its frequency in that population (∼8%) is higher than that of p.Asp85Asn-KCNE1 (0.2%–2.5% depending on ancestry; 0.2% in individuals of African origin)
(Table 1).13 Furthermore, unlike p.Asp85Asn-KCNE1 whose proarrhythmic potential is largely limited to DI-LQTS risk, the modest increase in late/persistent sodium current generated by p.Ser1103Tyr-SCN5A is accentuated markedly by hypoxia/acidosis and has been linked to an increased risk of ventricular arrhythmia (VA) and sudden cardiac death (SCD) in African Americans across the age spectrum.13, 14, 15, 16

Table 1

Epidemiological and functional data supporting a role for p.Ser1103Tyr-SCN5A and p.Asp85Asn-KCNE1 in DI-LQTS risk

Gene / dbSNP ID / Amino acid change / Overall MAF (gnomAD) / African MAF (gnomAD) / Asian MAF (gnomAD) / European MAF (gnomAD)∗ / Latino MAF (gnomAD) / Electrophysiological phenotype (in vitro) / Odds ratio (95% confidence interval) / References

SCN5A / rs7626962 / S1103Y† / 0.008 / 0.08 / 0.00003 / 0.0003 / 0.004 / Increased sustained/late INa secondary to altered inactivation gating that is accentuated by intracellular acidosis / 8.7 (3.2–23.9) / 16, 17

KCNE1 / rs1805128 / D85N / 0.009 / 0.002 / 0.003 / 0.01 / 0.003 / Decreased IKs and/or IKr secondary to altered activation/inactivation kinetics / 9.0 (3.5–22.9) / 33

dbSNP = Single Nucleotide Polymorphism Database; DI-LQTS = drug-induced long QT syndrome; gnomAD = Genome Aggregation Consortium; IKs = slowly activating delayed rectifier potassium current; IKr = rapidly activating delayed rectifier potassium current; INa = sodium current; MAF = minor allele frequency.

Adapted from Giudicessi et al,13 with permission. Copyright © Lippincott, Williams and Wilkins, 2018.

∗Includes individuals of both Finnish and non-Finnish European ancestry.

†Based on the reference transcript used. p.Ser1103Tyr-SCN5A is also occasionally listed as p.Ser1102Tyr-SCN5A.


Given the potential of p.Ser1103Tyr-SCN5A to exacerbate outcome-related health disparities in the COVID-19 pandemic, this review was assembled to raise awareness of the multiple mechanism(s) whereby the proarrhythmic p.Ser1103Tyr-SCN5A common variant may increase the risk of VA/SCD in those of African descent as well as the importance of identifying modifiable risk factors for mortality during the COVID-19 pandemic.

Heterozygous and homozygous carriers of SCN5A-p.Ser1103Tyr, a common genetic variant with functional effects among African-Americans, have an increased risk of sudden death.

-- SCN5Aallelic expression imbalance in African-Americans heterozygous for the common variant p.Ser1103Tyr, by Stacy AS Killen, Jennifer Kunic, Lily Wang, Adele Lewis, Bruce P Levy, Michael J Ackerman & Alfred L George Jr.


p.Ser1103Tyr-SCN5A and VA/SCD susceptibility in individuals of African descent

In individuals of African descent, the common SCN5A-encoded Nav1.5 sodium channel variant p.Ser1103Tyr-SCN5A has been associated with an increased risk of VA/SCD.14 , 15 , 17 Of note, this proarrhythmic potential has been reported to be enhanced by nongenetic risk factors known to reduce cardiac repolarization reserve (eg, hypokalemia and QTc-prolonging medication exposure; odds ratio 8.7; 95% confidence interval 3.2–23.9; P = .00003)17 and/or structural heart disease (relative risk 8.4; 95% confidence interval 2.1–28.6; P = .001) (Table 1).14 , 15 Furthermore, p.Ser1103Tyr-SCN5A was associated with potentiation of the QT-prolonging effect of hypokalemia in the 4476 participants of the Jackson Heart Study, suggesting that p.Ser1103Tyr-SCN5A contributes to decreased cardiac repolarization reserve at a population-specific level.18 In addition, 2 population-based studies reported that p.Ser1103Tyr-SCN5A is overrepresented in African American sudden infant death syndrome decedents,16 , 19 providing additional epidemiological evidence that p.Ser1103Tyr-SCN5A confers an increased risk of sudden death in African Americans regardless of age.

Besides this epidemiological evidence, in vitro functional characterization by 2 independent groups demonstrated that p.Ser1103Tyr-SCN5A alters the inactivation gating of the Nav1.5 sodium channel (negative shift in the voltage dependence of steady-state inactivation [V1/2]) and accentuates the sustained/late sodium current that is also the signature of the electrophysiological phenotype displayed by the type 3 long QT syndrome (LQT3) pathogenic variants.16 , 17 , 20 That said, the experimental conditions—physiological pH vs low intracellular pH—under which p.Ser1103Tyr-SCN5A increased the late sodium current differed in the studies of Splawski et al17 and Plant et al,16 respectively. Furthermore, neither study demonstrated an in vitro or in silico ability of p.Ser1103Tyr-SCN5A to prolong the action potential duration (APD) in the absence of a “second hit” such as blockade of the rapid component of the delayed rectifier potassium current or intracellular acidosis. This appears to be consistent with (1) the exaggerated QTc response to hypokalemia observed in p.Ser1103Tyr-SCN5A–positive participants of the Jackson Heart Study18 and (2) a circumstance-dependent proarrhythmic state in infants (respiratory acidosis caused by hypoxia/apnea)16 , 19 and older (DI-LQTS in the setting of ≥1 QTc-prolonging drug and advanced structural heart disease) p.Ser1103Tyr-SCN5A–positive African Americans.14, 15, 16

Implications of p.Ser1103Tyr-SCN5A during the COVID-19 pandemic

Direct and/or indirect myocardial injury/stress, as assessed by cardiac biomarkers such as troponin I and brain-type natriuretic peptide, has emerged as both a prominent and a prognostic feature in COVID-19.21, 22, 23 Of note, in an adjusted Cox regression model, the mortality risk associated with elevated cardiac biomarkers/acute cardiac injury was more significant than age and high-risk comorbid conditions such as chronic obstructive/fibrotic pulmonary disease, diabetes, and a history of cardiovascular disease.23 , 24 In addition, life-threatening VAs (eg, ventricular tachycardia/ventricular fibrillation) have been documented in ∼6% of hospitalized patients with COVID-19 and appear to be driven by underlying myocardial injury.25

The proposed mechanisms of acute myocardial injury and resulting VA risk in patients with COVID-19 include (1) direct SARS-CoV-2 myocardial infection (eg, myocarditis), (2) myocardial stress induced by hypoxemic respiratory failure, and/or (3) an exaggerated immune response that results in high levels of circulating cytokines (ie, interleukin-6 [IL-6], tumor necrosis factor-α, etc) directly injuring cardiomyocytes (Figure 1 ).25, 26, 27 Notably, IL-6 may prolong the ventricular action potential via modulation of cardiac ion channel expression/function.27

Image
Figure 1. Potential gene-environment interactions leading to an increased risk of ventricular arrhythmias and sudden cardiac death in p.Ser1103Tyr-SCN5A–positive patients with COVID-19. APD = action potential duration; CHF = congestive heart failure; CKD = chronic kidney disease; COPD = chronic obstructive pulmonary disease; COVID-19 = coronavirus disease 2019; IL-6 = interleukin-6; INa = sodium current; QTc = heart rate–corrected QT; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2; SCD = sudden cardiac death; SSRI = selective serotonin reuptake inhibitor; VA = ventricular arrhythmia.

Under normal physiological circumstances, Nav1.5 cardiac sodium channels conduct a tiny amount of persistent/late sodium current that contributes minimally to the maintenance of the action potential plateau (ie ≤0.5% of the peak sodium current [INa]).28 However, in the setting of hypoxia, myocardial ischemia, heart failure, and LQT3-causative SCN5A gain-of-function variants, the relative contribution of the late sodium current can increase up to 10-fold to 4%–5% of the peak INa.16 , 20 , 28 , 29 In turn, this “pathological” late sodium current can prolong ventricular APD and predispose to VA/SCD.

As discussed previously, p.Ser1103Tyr-SCN5A Nav1.5 sodium channels function normally under physiological conditions (eg, intracellular pH of 6.9–7.1).16 However, when intracellular pH is decreased in vitro to levels consistent with respiratory acidosis that occurs secondary to hypoxia/prolonged apnea (eg, intracellular pH of 6.6–6.8), p.Ser1103Tyr-SCN5A Nav1.5 sodium channels generate a proarrhythmic, LQT3-like increase in persistent/late sodium current (∼5% of the peak INa).16 This mechanism was put forward initially to explain the gene-environment interaction(s) responsible for the association between p.Ser1103Tyr-SCN5A and sudden infant death syndrome.16 However, the profound hypoxia observed in many COVID-19 cases raises reasonable concern that p.Ser1103Tyr-SCN5A could produce a similar African American–specific susceptibility to hypoxia-induced VA/SCD in the setting of SARS-CoV-2 infection/COVID-19 (Figure 1).

Unfortunately, the increased risk of VA/SCD linked to the potentially proarrhythmic p.Ser1103Tyr-SCN5A common variant is likely not limited to the possibility of hypoxia-induced VA/SCD. As succinctly outlined in recent work by Lazzerini et al,27 the exaggerated immune response triggered by SARS-CoV-2 infection, specifically elevation of IL-6, likely increases arrhythmia risk via (1) modulation of cardiac ion channel expression/function leading to APD prolongation (eg, direct IL-6–mediated blockade of hERG/Kv11.1 potassium channels), (2) cardiac sympathetic nervous system hyperactivity, and (3) inhibition of cytochrome P450 enzymes involved in the metabolism of some QTc-prolonging drugs (eg, IL-6 and CYP3A4) (Figure 1). The latter effect of IL-6 is particularly important given that a number of COVID-19 pharmacotherapies (eg, hydroxychloroquine ± azithromycin and lopinavir/ritonavir) under investigation and/or in use clinically are known to prolong the QTc interval and predispose to DI-TdP/DI-SCD (Table 2 ).8 , 30

Table 2

COVID-19–directed pharmacotherapies with DI-TdP/DI-SCD risk

Possible COVID-19 therapy / In vitro inhibition of SARS-CoV-2 / CredibleMeds classification / VT/VF/TdP/LQTS in FAERS∗ / Cardiac arrest in FAERS∗ / References

Repurposed antimalarial agents: Chloroquine / Yes / Known TdP risk / 72 / 54 / 34, 35, 36

Hydroxychloroquine / Yes / Known TdP risk / 222 / 105 / 37,38

Repurposed antiviral agents; Lopinavir/ritonavir / Unknown† / Possible TdP risk / 27 / 48 / 39, 40, 41

Adjunct agents: Azithromycin / Unknown / Known TdP risk / 396 / 251 / 42,43

COVID-19 = coronavirus disease 2019; DI-SCD = drug-induced sudden cardiac death; DI-TdP = drug-induced torsades de pointes; FAERS = Food and Drug Administration Adverse Event Reporting System; LQTS = long QT syndrome; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2; TdP = torsades de pointes; VF = ventricular fibrillation; VT = ventricular tachycardia.

Adapted from Giudicessi et al,8 with permission. Copyright © Elsevier, 2020.

∗Adverse event reporting from postmarketing surveillance does not account for prescription volume and is often subjected to significant bias from confounding variables, quality of reported data, duplication, and underreporting of events.

†Lopinavir/ritonavir inhibits other SARS viruses in vitro. However, a recent randomized trial demonstrated no benefit in COVID-19.


Taken together, these data suggest that 1 in 13 African Americans may be at a substantially increased risk of potentially lethal VAs, most notably DI-TdP, during the COVID-19 pandemic because of the perfect storm of (1) intrinsic genetic susceptibility (ie, p.Ser1103Tyr-SCN5A), (2) modifiable environmental risk factors (eg, electrolyte abnormalities and concurrent QTc-prolonging drug use), and (3) COVID-19–specific risk factors (eg, profound hypoxemia and cytokine storm) (Figure 1). Whether population-specific genetic risk factors such as p.Ser1103Tyr-SCN5A are contributing to the spike in sudden deaths and racial health disparities observed in COVID-19 epicenters remains to be proven, and given the lack of banked DNA in these epicenters, this speculation may not even be testable.

Nevertheless, given the potential for COVID-19 to exacerbate known gene-environment interactions pertaining to the potentially proarrhythmic p.Ser1103Tyr-SCN5A common variant, it seems reasonable (1) to avoid using COVID-19–directed QTc-prolonging drugs (eg, hydroxychloroquine ± azithromycin and lopinavir/ritonavir) unless careful, and preferably personal protective equipment–sparing, cardiac monitoring can be implemented (Figure 2 )8 , 31; (2) to explore the association between p.Ser1103Tyr-SCN5A and rates of sudden death and COVID-19–related mortality in areas with medical record–linked DNA biobanks (eg, UK Biobank); (3) to investigate further the feasibility of point-of-care p.Ser1103Tyr-SCN5A genetic testing; and (4) to determine the clinical utility of QTc-shortening agents such as late sodium current blockers (eg, mexiletine and lidocaine) and anti-IL-6–targeted therapies (eg, tocilizumab and sarilumab)27 , 32 to better protect at-risk individuals, especially African Americans in the context of the ongoing COVID-19 pandemic.

Image
Figure 2. Proposed approach to mitigating the risk of DI-TdP/DI-SCD in patients with COVID-19 treated with ≥1 QTc-prolonging drug. The estimated 99th percentile QTc values, derived from otherwise healthy individuals, that place a patient in the “green light” category are <460 ms before puberty, <470 ms in men, and <480 ms in women. We estimate that the baseline QTc assessment will place 90% in the “green light,” 9% in the “yellow light,” and 1% in the “red light” category. No randomized controlled trial data are available to support the clinical efficacy of any of the COVID-19–directed QTc-prolonging drugs despite the Food and Drug Administration’s Emergency Use Approval of hydroxychloroquine. COVID-19 = coronavirus disease 19; CV = cardiovascular; DI-SCD = drug-induced sudden cardiac death; DI-TdP = drug-induced torsades de pointes; ECG = electrocardiogram; QTc = heart rate–corrected QT; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2; TdP = torsades de pointes. Adapted from Giudicessi et al,8 with permission. Copyright © Elsevier, 2020.

Conclusion

A potentially pro-arrhythmic common variant, p.Ser1103Tyr-SCN5A, present in 1 out of 13 individuals of African descent has the potential to increase the risk of drug- and hypoxia-induced ventricular arrhythmias/sudden cardiac death and contribute to observed racial health disparities in the COVID-19 pandemic. As such, the use of unproven, QTc-prolonging COVID-19-directed therapies, most notably the combination of hydroxychloroquine and azithromycin, should be limited to settings where careful cardiac monitoring can be implemented (e.g. hospital setting or clinical trial).

Footnotes

This work was supported by the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program.

Dr Ackerman is a consultant for Abbott, Audentes Therapeutics, Boston Scientific, Invitae, LQT Therapeutics, Medtronic, MyoKardia, and UpToDate. Dr Ackerman and Mayo Clinic are involved in an equity/royalty relationship with AliveCor. However, AliveCor was not involved in this study. The rest of the authors report no conflicts of interest.

References

1. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. [PMC free article] [PubMed] [Google Scholar]
2. Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533–534. [PMC free article] [PubMed] [Google Scholar]
3. Deaths from cardiac arrests have surged in New York City. The Economist. https://www.economist.com/graphic-detai ... -york-city Published April 13, 2020. Accessed April 29, 2020.
4. Katz J., Lu D., Sanger-Katz M.U.S. coronavirus death toll is far higher than reported, C.D.C. data suggests. The New York Times. https://www.nytimes.com/interactive/202 ... total.html Published April 28, 2020. Accessed April 29, 2020.
5. Williams M. Hydroxychloroquine prescription volume changes during COVID-19. Swoop Web site. https://www.swoop.com/news/hydroxychlor ... g-covid-19
6. Chorin E, Dai M, Shulman E, et al. The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin [published online ahead of print April 24, 2020]. Nat Med. 10.1016/j.hrthm.2020.05.014. [PubMed] [CrossRef]
7. Borba M.G.S., Val F.F.A., Sampaio V.S. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA Netw Open. 2020;3 [PubMed] [Google Scholar]
8. Giudicessi J.R., Noseworthy P.A., Friedman P.A., Ackerman M.J. Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19) Mayo Clin Proc. 2020;95:1213–1221. [PMC free article] [PubMed] [Google Scholar]
9. Wu C.-I., Postema P.G., Arbelo E. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes. Heart Rhythm. 2020;17:1456–1462. [PMC free article] [PubMed] [Google Scholar]
10. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-safety-a ... setting-or. Accessed April 26, 2020.
11. COVID-19 statistics Illinois Department of Health Web site. https://www.dph.illinois.gov/covid19/covid19-statistics Accessed April 29, 2020.
12. Yancy C.W. COVID-19 and African Americans. JAMA. 2020;323:1891–1892. [Google Scholar]
13. Giudicessi J.R., Roden D.M., Wilde A.A.M., Ackerman M.J. Classification and reporting of potentially proarrhythmic common genetic variation in long QT syndrome genetic testing. Circulation. 2018;137:619–630. [PMC free article] [PubMed] [Google Scholar]
14. Burke A., Creighton W., Mont E. Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation. 2005;112:798–802. [PubMed] [Google Scholar]
15. Sun A.Y., Koontz J.I., Shah S.H. The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fraction. Circ Cardiovasc Genet. 2011;4:163–168. [PMC free article] [PubMed] [Google Scholar]
16. Plant L.D., Bowers P.N., Liu Q. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y. J Clin Invest. 2006;116:430–435. [PMC free article] [PubMed] [Google Scholar]
17. Splawski I., Timothy K.W., Tateyama M. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science. 2002;297:1333–1336. [PubMed] [Google Scholar]
18. Akylbekova E.L., Payne J.P., Newton-Cheh C. Gene-environment interaction between SCN5A-1103Y and hypokalemia influences QT interval prolongation in African Americans: the Jackson Heart Study. Am Heart J. 2014;167:116–122.e111. [PMC free article] [PubMed] [Google Scholar]
19. Van Norstrand D.W., Tester D.J., Ackerman M.J. Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome. Heart Rhythm. 2008;5:712–715. [PMC free article] [PubMed] [Google Scholar]
20. Bennett P.B., Yazawa K., Makita N., George A.L., Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature. 1995;376:683–685. [PubMed] [Google Scholar]
21. Wang D., Hu B., Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069. [PMC free article] [PubMed] [Google Scholar]
22. Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult inpatients with COVID19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. [PMC free article] [PubMed] [Google Scholar]
23. Shi S., Qin M., Shen B. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802–810. [PMC free article] [PubMed] [Google Scholar]
24. Guo T., Fan Y., Chen M. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:811–818. [PMC free article] [PubMed] [Google Scholar]
25. Driggin E., Madhavan M.V., Bikdeli B. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. 2020;75:2352–2371. [PMC free article] [PubMed] [Google Scholar]
26. Akhmerov A., Marban E. COVID-19 and the heart. Circ Res. 2020;126:1443–1455. [PMC free article] [PubMed] [Google Scholar]
27. Lazzerini P.E., Boutjdir M., Capecchi P.L. COVID-19, arrhythmic risk and inflammation: mind the gap! Circulation. 2020;142:7–9. [PubMed] [Google Scholar]
28. Makielski J.C. Late sodium current: a mechanism for angina, heart failure, and arrhythmia. Trends Cardiovasc Med. 2016;26:115–122. [PMC free article] [PubMed] [Google Scholar]
29. Belardinelli L., Giles W.R., Rajamani S., Karagueuzian H.S., Shryock J.C. Cardiac late Na(+) current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress. Heart Rhythm. 2015;12:440–448. [PubMed] [Google Scholar]
30. Roden D.M., Harrington R.A., Poppas A., Russo A.M. Considerations for drug interactions on QTc in exploratory COVID-19 treatment. Circulation. 2020;141:e906–e907. [PubMed] [Google Scholar]
31. Giudicessi J.R., Noseworthy P.A., Ackerman M.J. The QT interval: an emerging vital sign for the precision medicine era? Circulation. 2019;139:2711–2713. [PubMed] [Google Scholar]
32. Mitra R.L., Greenstein S.A., Epstein L.M. An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: possible benefits of intravenous lidocaine. HeartRhythm Case Rep. 2020;6:244–248. [PMC free article] [PubMed] [Google Scholar]
33. Kaab S., Crawford D.C., Sinner M.F. A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Circ Cardiovasc Genet. 2012;5:91–99. [PMC free article] [PubMed] [Google Scholar]
34. Wang M., Cao R., Zhang L. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269–271. [PMC free article] [PubMed] [Google Scholar]
35. Traebert M., Dumotier B., Meister L., Hoffmann P., Dominguez-Estevez M., Suter W. Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells. Eur J Pharmacol. 2004;484:41–48. [PubMed] [Google Scholar]
36. Stas P., Faes D., Noyens P. Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine. Int J Cardiol. 2008;127:e80–e82. [PubMed] [Google Scholar]
37. Yao X., Ye F., Zhang M. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis. 2020;71:732–739. [PMC free article] [PubMed] [Google Scholar]
38. Chen C.Y., Wang F.L., Lin C.C. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clin Toxicol (Phila) 2006;44:173–175. [PubMed] [Google Scholar]
39. Chen F., Chan K.H., Jiang Y. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol. 2004;31:69–75. [PMC free article] [PubMed] [Google Scholar]
40. Cao B., Wang Y., Wen D. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N Engl J Med. 2020;382:1787–1799. [PMC free article] [PubMed] [Google Scholar]
41. Soliman E.Z., Lundgren J.D., Roediger M.P., INSIGHT SMART Study Group Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations. AIDS. 2011;25:367–377. [PMC free article] [PubMed] [Google Scholar]
42. Giudicessi J.R., Ackerman M.J. Azithromycin and risk of sudden cardiac death: guilty as charged or falsely accused? Cleve Clin J Med. 2013;80:539–544. [PMC free article] [PubMed] [Google Scholar]
43. Arellano-Rodrigo E., Garcia A., Mont L., Roque M. Torsade de pointes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome [in Spanish] Med Clin (Barc) 2001;117:118–119. [PubMed] [Google Scholar]